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ABSTRACT 
Transforming sound vibrations into neural signals, the process of mechano-electrical 
transduction (MET), is achieved via the movement of rows of stereocilia located atop cochlear 
hair cells, activating non-selective MET channels. Recording MET currents using whole-cell 
patch clamp electrophysiology has allowed for various investigations centred on the MET 
channel.  
There is a statistically significant difference in MET current amplitudes between mid-apical and 
mid-basal outer hair cells. The larger MET current, flowing through basal hair cells explains a 
key contributory element to their increased susceptibility to the ototoxic effects of 
aminoglycoside antibiotics, as they are thus able to enter these cells more readily, in greater 
abundance.  
The cell penetrating peptides D-TAT and D-JNKi1 have been studied in cochlear hair cells. They 
are both high affinity, voltage dependent, permeant blockers of the MET channel in inner 
(IHCs) and outer hair cells (OHCs). Whilst ototoxic at higher concentrations, they may have 
therapeutic potential at lower concentrations, providing ototoprotection against 
aminoglycoside induced ototoxicity by competitively blocking the MET channel. There is an 
apical to basal gradient in the OHC MET channel block caused by D-TAT and D-JNKi1, the 
affinity of the block increasing from apex to base. Compellingly, the first evidence of a gradient 
in the MET channel properties of IHCs is presented here, a gradient in D-JNKi1 block.  
Properties of an anomalous mechano-sensitive current, elicited by inverse stimuli relative to 
the MET current, have been elucidated via the use of the compounds dihydrostreptomycin 
(DHS) and FM1-43. When compared with the MET current, DHS block of the anomalous 
current is two orders of magnitude less strong and FM1-43 block has altered voltage 
dependence. TRPC3/6 knock-out mice, whilst previously thought to have a basal OHC specific 
MET deficit, have been shown to exhibit normal MET currents. In addition, so too have 
TRPC1/3/6 and TRPC1/3/5/6 knock-out mice. 
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AIMS 
The aims of this thesis were as follows: 
 
 The overarching aim was to investigate the properties of the MET channel. 
 
 To investigate the efficacy of the D-TAT and D-JNKi1 peptides as blockers of the MET 
channel in outer and inner cochlear hair cells. 
 
 To further illuminate the apical to basal gradient in macroscopic MET current size by 
comparing recordings from a large number of OHCs in mid-apical and mid-basal 
cochlear regions, with a particular view to looking at the difference in the 
efficaciousness of the block by D-TAT and D-JNKi1 in these regions.   
 
 To test the kinetics and concentration dependence of the channel block of 
dihydrostreptomycin and FM1-43 on the anomalous current in cochlear outer hair 
cells. 
 
 
 To investigate the effects of knocking out TRPC 1/3/6, TRPC 1/3/5/6, and reviewing 
previous data on TRPC 3/6 mice, on mechano-electrical transduction in cochlear outer 
hair cells. 
16 
 
1 INTRODUCTION 
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1.1  Form and function of the cochlea 
 
The processing of sound, which allows it to be interpreted by the brain, is a complex, intricate 
and finely tuned process.  Sound vibrations, once amplified and funnelled through the ear 
canal, aided by the pinna, are then sent to the middle ear. Here the tympanic membrane 
(eardrum) and three bones of the middle ear: the malleus, incus and stapes, vibrate due to 
longitudinal pressure waves of sound (Pickles, 2008). Impedance matching from the relatively 
sizeable, low impedance tympanic membrane to the smaller, high impedance oval window is a 
very important function of the middle ear. Without it, the energy in the system would be lost, 
with only a tiny fraction being transmitted (Reichenbach and Hudspeth, 2014). The movement 
of the malleus, incus and finally the stapes, pushes this pressure through the oval window, 
generating a travelling wave in the fluid-filled middle cochlear chamber, the scala media. The 
three cochlear compartments are distinct from one another. The scala vestibuli sits at the top, 
the scala tympani at the bottom and the - organ of Corti containing - scala media in the middle. 
The scala media contains endolymph whilst the scala vestibuli and scala tympani contain 
perilymph (Pickles, 2008).  
Sound evokes a full cycle of up and down basilar membrane motion. The stapes is pushed into 
and pulled out of the oval window, in a piston like fashion. Fluid motion of the perilymph in the 
scala vestibuli is generated by this motion and due to the elasticity of the cochlear 
membranes, the fluid moves not only forward but also downward, causing the elastic basilar 
membrane to move downward, displacing the endolymph in the scala media. This results in an 
increase in pressure in the scala tympani, pushing the round window outwards and then 
inwards again when the stapes moves back. The basilar membrane is then pushed upwards 
(Pickles, 2008).    
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The conversion of vibrations of high displacement but low pressure, into those appropriate for 
the cochlea - which cause low displacement but are higher in pressure - is achieved by 
conducting the vibrations from the larger tympanic membrane to the smaller footplate of the 
stapes, so they in effect become concentrated. Additionally, the longer armed malleus, 
pushing on the shorter armed incus increases force but decreases velocity before the 
vibrations are transmitted through the stapes (Pickles, 2008) (FIGURE 1-1).   
 
The basilar membrane is tonotopically mapped, such that the distance which an incoming 
sound wave propagates along the length of the basilar membrane is frequency dependent; 
there are different regions of maximum basilar membrane deformation for different frequency 
waves. Higher frequencies cause greater movement in the stiff basal region, causing energy to 
dissipate more quickly, thus the wave propagates less far, whereas lower frequency waves will 
propagate further (Reichenbach and Hudspeth, 2014). Travelling waves for each frequency 
component of a given sound are generated in the basilar membrane, which increase in size 
whilst their wavelengths and propagation-velocities are reduced, thus the frequency of the 
waves stay the same, until the peak is reached at a particular region (Ren, 2002; Reichenbach 
and Hudspeth, 2014). This is because, basilar membrane thickness increases and rigidity 
decreases along its length from base to apex, as the elastic fibres from which it is formed are 
increasingly long but less densely packed (Pickles, 2008). 
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FIGURE 1-1 - Anatomy of the ear 
 
 
 
 
 
 
 
 
FIGURE 1-1 : Anatomy of the ear. Component parts of the outer, middle and inner ear 
illustrated. 
20 
 
1.1.1 Inner and outer cochlear hair cells 
 
On top of the basilar membrane is where the highly specialised sensory hair cells reside. The 
placental mammalian complement consists of a single row of inner hair cells (IHCs) and three 
rows of outer hair cells (OHCs) (Pickles, 2008). In humans there are approximately 3,500 IHCs 
and 11,000 OHCs, compared with closer to 800 and 2,500, respectively, in a house mouse 
(Ehret and Frankenreiter, 1977). They are two distinct varieties of hair cell. Inner hair cells have 
many afferent auditory nerve fibre innervations and are thus the true sensory cells of the inner 
ear. Outer hair cells are primarily innervated by efferent nerve fibres with only a few afferent 
fibre innervations, important for their role in amplification (FIGURE 1-2).  
 
On top of each hair cell is V-shaped hair bundle formed of rows of stereocilia which are 
ordered from tallest to shortest, although overall height varies with position along the length 
of the basilar membrane, decreasing from apex to base (Roth and Bruns, 1992). The OHCs are 
in contact within the gel-like tectorial membrane, which lies above them, and surrounded by 
supporting cells. Whilst the IHCs are also surrounded by supporting cells the stereocilia atop 
them are free-standing, not coming into contact with the tectorial membrane. Vibrations 
generated by sound stimuli generate tiny motions of the basilar membrane which displace the 
hair bundles. Whilst perilymph possesses the usual complement of ions expected of an 
extracellular fluid containing a high concentration of Na+, endolymph contains a high 
concentration of K+. Cochlear hair cells reside above the basilar membrane, with their 
basolateral surfaces immersed in perilympth. The apical surfaces of the cells, where the hair 
bundle forming stereocilia sit, are bathed in endolymph (FIGURE 1-2). 
 
OHCs act as active mechanical amplifiers of the inputted auditory signals they receive, 
augmenting the movement of the basilar membrane, thereby crucially heightening the 
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frequency selectivity and sensitivity of the cochlea (Hudspeth, 2008).  OHC somatic 
electromotility is thought to be generated by the motor protein prestin (Zheng et al., 2000), 
which is expressed in the basolateral membrane of OHCs. When the basilar membrane moves 
upward, stereocilia are deflected in the excitatory direction, towards the tallest stereocilia. 
This in turn causes the opening of the mechano-electrical transducer (MET) channels and 
subsequent depolarisation of the OHCs. Prestin then causes the OHCs to shorten, enhancing 
the motion of the basilar membrane and increasing tension on IHCs. When the OHCs are then 
hyperpolarised by the downward motion of the basilar membrane, prestin causes the OHCs to 
lengthen, decreasing tension on IHCs. This process is proposed to be driven by changes in 
membrane potential (Santos-Sacchi and Dilger, 1988). The high frequency encoding basal 
region of the cochlea is most reliant on amplification driven by somatic motility (Hudspeth, 
2008). 
A hair bundle motor component has also been proposed, involving the MET channel itself. 
Evidence for this is based on results which demonstrate reduced bundle motion after the MET 
channel is blocked with dihydrostreptomicin (DHS) by Kennedy et al. (2006). Somatic motility 
was also assessed here using salicylate, known to interfere with electromotility (Shehata et al., 
1991). The MET-channel based motor component is proposed to interact with the somatic 
motility component due to the witnessed reductions in hair bundle motion, by inhibiting the 
two motors, adding up to a greater than 100% reduction when summated. They state that if 
these mechanisms were acting independently, their contributions should total 100% of 
motility, or less than this if there is yet another component (Kennedy et al., 2006).   
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FIGURE 1-2 - Inner and outer hair cells in the organ of Corti 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1-2 : Inner and outer hair cells in the organ of Corti. Illustration of a cross section 
of the organ of Corti with inner and outer hair cells. 
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1.1.2 The endocochlear potential 
 
The endocochlear potential (EP) is the pivotal driving force for mechano-electrical transduction 
(MET) in the cochlea. It is established chiefly by the stria vasicularis as it contributes 
significantly to the high K+ content of the endolymph (Tasaki and Spyropoulos, 1959). 
Homeostasis and the establishment and maintenance of the endocochlear potential are 
crucial. The ~ +80 mV transepithelial EP is generated by the abnormally highly concentrated K+ 
in the endolymph which is contained within the endolymphatic space of the scala media. The 
source of the EP is the stria vasicularis (Tasaki and Spyropoulos, 1959), a two-layer epithelium, 
which resides on the lateral wall of the cochlea adjacent to the spiral ligament. Formed of a 
layer of marginal cells on the endolymphatic wall, followed by an intermediate region of 
capillaries and intermediate cells, with flat basal cells on the side where it is in contact with the 
spiral ligament, it transports and secretes K+ ions. Both the separation of component cells and 
connections between the constituent compartments of the stria vasicularis are vital for the 
generation of the EP. Here, tight junctions and gap junctions are pivotal components in 
creating cohesion (Marcus et al., 2002).   
The EP increases from apex to base along the length of the cochlea. This is the greatest 
transepithelial voltage generated within mammalian anatomy (Wangemann, 2006). This in 
turn contributes to generation of a large potential across the apical surface of cochlear hair 
cells of 140 mV, allowing the MET currents to flow across the MET channel. This large potential 
drives the MET process.  
All the mice used in my experiments were 2 postnatal days old (P2) and grown in culture for 1 
(P2 + 1) or 2 (P2 +2) days. This growth in culture effectively represented maturation to P3 and 
P4 developmental stages, respectively (Waguespack et al., 2007). The endocochlear potential 
during the first few postnatal days is however very small (Rybak et al., 1992). 
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1.1.3 The mouse as a model for hearing research 
 
Mice can hear higher frequency sounds than us of some 2.3 – 85.5 kHz (at 60 dB SPL), often 
communicating at frequencies beyond the human range of perception. Human hearing lies in 
the range of 31 Hz – 17.6 kHz (at 60 dB SPL) (Heffner and Heffner, 2007). Nonetheless, the 
mouse genome and the anatomy of the inner ear are similar to those of humans. Their 
vulnerability to damage by noise makes them good candidates for assessing hearing loss. 
Moreover, the shortness of their lifespan makes them ideal for studying age related hearing 
loss. The creation of knock out and mutant mouse models by knocking out or mutating certain 
genes has allowed for the emulation and studying of conditions akin to those suffered by 
humans (Ohlemiller et al., 1999; Avraham, 2003).  
1.1.4 Hair cell development and the P2 mouse 
 
The cochlea undergoes morphological and functional changes as it develops. The V-shaped 
hair bundle arrangement  atop the hair cells is the most distinctive morphological feature, 
forming during the first few days after birth (Waguespack et al., 2007). MET also begins to 
develop at this stage. The onset of hearing in mice is at around P12 but some properties, 
including the complete differentiation of inner and outer hair cells, will only be fully developed 
by the end of the third postnatal week (Pujol et al., 1998). 
 
P2 is in many ways the optimal developmental stage at which to prepare and grow the mouse 
organ of Corti in culture. At this stage, an intact preparation of the coil is easiest to achieve due 
to the bones surrounding the cochlear and the cochlear capsule not yet being ossified, whilst 
being firm enough as not to bounce away when manipulated. Moreover, it has been 
demonstrated that P2 mice have 100% functionally mechanotransducing OHCs in basal 
cochlear regions and 80% in the apical regions (Lelli et al., 2009), with peak amplitudes being 
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reached and sustained between P2 and P4, apical hair cell maturity following that in the base 
(Lelli et al., 2009; Kim and Fettiplace, 2013). Additionally, hair cells mature in culture and thus 
are more like those from P3, P4 or P5 mice after 1, 2 or 3 days in culture, respectively. By 
having cultured them at the P2 stage, one also avoids the witnessed decline in the amount of 
functional OHCs seen after P2, thought to be caused by damage to the hair cells where bones 
are more ossified. It should also be noted that experimentation on OHCs is preferred 
compared to that on IHCs because they are far easier to access, more plentiful and can be 
stimulated with greater ease (Lelli et al., 2009). 
 
1.2 The mechano-electrical transduction complex  
 
In order for functional hearing to occur, the mechanical stimulation generated by the 
movement of fluid in the cochlea must be converted into electrical signals in the form of 
graded receptor potentials so that signals can be sent along the afferent auditory nerve fibres 
to the auditory brain regions (Pickles, 2008). This is achieved by the MET channels. Whilst the 
molecular identity of the MET channel remains elusive, several components of the MET 
machinery have been identified. 
MET channels are opened when the stereocilia on hair cells are deflected in the excitatory 
direction (towards the tallest stereocilia) (Pickles, 2008). Recent research has suggested that 
there are two MET channels per stereocilium and whilst the location of the MET channel is still 
somewhat debated,  they are widely thought to be located at the base of the tip links in the 
second and third stereociliary rows (Beurg et al., 2009).  
There are many pieces of biological machinery which are involved in the complex process of 
MET, and variations on their locations and interactions have been postulated.  Tip links are 
thought to gate the MET channels either by being directly connected or ‘tethered’ to them or 
by being anchored next to them (Peng et al., 2011). Protoadherin 15 (PCDH15) and cadherin 23 
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(CDH23) are thought to form part of the tip links. The upper tip link density (UTLD) is thought 
to contain Myo7a, harmonin-b and Sans (Grati and Kachar, 2011) and the lower tip-link density 
is believed to be formed of myosin XVa , whirlin (Delprat et al., 2005) and Eps8 (Manor et al., 
2011).  
It is generally assumed that in the undisturbed tip link the lower end is composed of PCDH15 
and the upper end CDH23 (Kazmierczak et al., 2007). However, when tip links undergo 
damage, either through sound exposure or experimental manipulation, they are able to 
spontaneously regenerate. The initial phase of this regeneration process appears to be the 
formation of a shorter tip link composed solely of PCDH15 at both the upper and lower ends. 
The MET currents produced by hair cells undergoing this phase of regeneration are of normal 
magnitude but the adaptation of these currents (dominated by fast adaptation) was reduced 
and had a much slower time constant. In spite of apparent full tip link recovery and MET 
current amplitude by 12 hours post damage, until CDH23 levels are fully restored at around 
the 48 hour time point, adaptation remains abnormal. Indzhykulian et al. (2013) posit that this 
may be due to the shortened tip links altering the angle of the stereocilia sufficiently to induce 
this shift in adaptation. 
 
1.2.1 The gating spring 
 
The concept of the gating spring was developed by Corey and Hudspeth (1983).  The 
gating-spring model entails that the MET channel opens due to the tension of the gating 
spring. Tension increases as the hair bundle moves in the excitatory direction (towards the 
tallest stereocilia) and decreases as it is deflected in the inhibitory direction. The channel is 
either opened or closed and changes between these two states rapidly. Even when the gating 
spring is in its resting state there is still a certain level of probability that the channel will open. 
This resting open probability is somewhere in the region of 0.1 to 0.5 (Howard and Hudspeth, 
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1988; Farris et al., 2006; Beurg et al., 2010) but is assumed in the work within this thesis to be 
0.3 based on previous work on the neonatal mouse done in the group in which I have worked  
(Kros et al., 1992; Kros et al., 1996). This means a certain proportion of channels are open at 
rest, causing a resting current to flow. Increasing tension on the gating spring increases the 
open probability of the MET channel, without there being a fixed level of tension which will 
cause the channel to open. The MET channel changes between open and closed very quickly 
and tension on the tip link at a given time controls the amount of time that the channel is open 
(Corey and Hudspeth, 1983).  
The identity of the gating spring remains unknown. High resolution examination of the tip link 
using electron microscopy revealed that it is too stiff for purpose (Kachar et al., 2000), so the 
gating spring is thought to reside at the top or the bottom of the tip link, with the lower end 
being more likely due to the discovery of an elevated tent-like membrane, apparently 
responsive to tip link deflection (Powers et al., 2012; Reichenbach and Hudspeth, 2014). 
1.2.2 The MET channel pore  
 
Farris et al. (2004) measured the MET channel diameter in isolated auditory papillae of red 
eared terrapins by applying a range of pharmacological channel blockers to the apical surface 
of cochlear hair cells. Curare, the largest compound tested, has a maximum diameter region of 
17 Å (1.7 nm) and penetrates 45% of the way into the membrane electrical field. In order for 
this to occur, there must be a channel pore region large enough to accept this blocking part of 
the compound, resulting in the open channel block. Additionally, the rest of the channel must 
therefore be smaller but must be large enough to accommodate the minimum diameter of the 
compound (9 Å for curare). Simple amine compounds (methylammonium, 
trimethylammonium, tetramethylammonium, triethylammonium, tetraethylammonium, 
tetrapropylammonium and tetrabutylammonium) were also utilised to study the dimensions 
of the channel pore. They were able to penetrate a similar distance through the electrical field 
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of the membrane, with smaller amines generally able to penetrate further than larger ones, 
leading to the conclusion that this is the distance where the channel diameter becomes 
smaller. Minimum pore diameter was calculated by Iamine/INa (current able to flow through the 
channel in the presence of a simple amine compound divided by the current in the presence of 
sodium) plotted against the calculated dimensions for the compounds they tested, fitted with 
a curve, the equation of which assumed a circular pore and spherical amines. This yielded a 
minimum pore diameter estimation of ~12 Å (1.2 nm). Using the equation which assumed the 
channel pore is cylindrical, they were thus able to calculate an estimate of the MET channel 
pore length (31 Å or 3.1 nm) based on the single channel conductance of the MET channel and 
the estimated diameter of the pore. Taken together this led to the conclusion that the MET 
channel pore varies in size, tapering down from the wider channel mouth of 17 Å to 12 Å 
further through the channel towards the intracellular face. This provided the evidence for a 
large electronegative vestibule within the MET channel pore. 
Farris et al. (2004) proposed that the MET channel contained a large outer vestibule based on 
the open channel block witnessed where large molecules entered the channel. To test if there 
was in fact a vestibule which was concentrating ions thus increasing their availability to carry 
the MET current, similar to the intracellular vestibule in BK channels (Brelidze et al., 2003), 
Beurg et al. (2006) utilised an extracellular medium of low ionic strength which, as expected, 
resulted in reduced MET current sizes in apical and mid-coil IHCs and OHCs. Additionally, they 
found that there was less reduction in inner than in outer hair cells, offering a factor to 
account for the witnessed larger single channel MET current size and calcium permeability in 
apical IHCs. The origin of these differences was proposed to lie in different vestibule isoforms, 
with the IHC isoform containing more negatively charged residues. They also predicted that 
the basal OHCs, with the largest single channel conductance, would have a vestibule more 
similar to IHCs, which have uniform single channel conductance along the cochlear length. The 
existence of the vestibule may explain the much higher affinity block caused by extracellular 
29 
 
compared with intracellular application of channel blockers such as the aminoglycoside 
antibiotic dihydrostreptomycin (Marcotti et al., 2005; van Netten et al., 2007). 
 
1.2.3 The MET current  
 
As a non-selective cation channel, the MET channel permits the flow of multiple ions and thus 
it has been demonstrated that the MET current can be carried by a variety of ions. The most 
plentiful ion in the vicinity in vivo is K+ and as a result much of the MET current is carried by it. 
Ca2+, also carries a proportion of the MET current, although it blocks the channel somewhat 
and thus its conductance is low relative to its permeability (Corey and Hudspeth, 1979,  Ricci et 
al., 2003). 
1.2.4 Fast adaptation  
 
The MET current behaves in such a way that shortly after being evoked it then rapidly 
decreases in spite of continued stimulation. The current can however be recovered by using 
greater stimulation. This process is known as adaptation. Both fast (submillisecond) and slow 
(over tens of milliseconds) adaptation components exist in some systems (Vollrath and Eatock, 
2003). In the mammalian system the fast component, occurring on a millisecond or a 
submillisecond basis, is thought to be the major component involved. It is very widely agreed 
to be a Ca2+ dependent process where Ca2+ influences MET channel closure when bound at or 
near the intracellular face of its channel pore, shifting its operating point. Studying the Ca2+ 
dependence of adaptation has been achieved through the use of varying concentrations of 
internal and external Ca2+ and using Ca2+ buffers. Peng et al. (2013) have however recently 
challenged this model, appearing to show that fast adaptation is independent of Ca2+ entry due 
to their ability to elicit currents which adapt even at positive potentials and in the presence of 
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the calcium chelator 1,2-bis(o-aminophenoxy) ethane-N,N,N’,N’-tetraacetic acid (BAPTA) 
applied intracellularly.  
1.2.5 Slow adaptation  
  
Additionally, a slow component (Wu et al., 1999) which has also been posited to be calcium 
dependent (Corns et al., 2014) is believed to be involved. After MET channels are opened in 
response to stereociliary movement in the excitatory direction, the stereociliary attached 
region at the top of the tip links slides down and tip link tension declines (Wu et al., 1999). 
Myosins such as myosin 7a, are Ca2+ sensitive motor proteins which operate along actin 
filaments, and several isoforms are present in stereocilia. Thus, myosins and especially 
myosin IC were key mammalian motor protein candidates (Gillespie and Cyr, 2004), as in the 
bullfrog (Corey and Hudspeth, 1983), thought to detach and then reattach to the stereocilial 
actin core, allowing the sliding and climbing action. The finding that myosin 1C is at the upper 
end of the tip links (Assad and Corey, 1992), whilst the MET channels reside at the lower end 
(Beurg et al., 2009), makes it seem unlikely to be responsible for slow adaptation, as well as 
some stating that the resultant motility would be too slow to be responsible for adaptation in 
the mammalian cochlea (Pickles, 2008). What is also contrary to the idea of myosin 1C 
involvement is the fact that both fast and slow adaptation have been found to be relatively 
equally altered by changes in intracellular and extracellular Ca2+ concentration (Corns et al., 
2014). This makes it seem plausible that both these elements arise from the same structure, in 
this case the MET channel (Corns et al., 2014). Although, some still believe that myosin 1C is a 
feasible candidate, citing the relatively small contribution of slow adaptation in OHCs relative 
to that in vestibular hair cells, suggesting that calcium entry though the MET channel might be 
able to drive myosin 1c to some degree even though it is at the upper end of the tip link (Pan 
and Holt, 2015). In vestibular hair cells slow adaptation is the major if not the only adaptation 
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mechanism and there is good evidence for myosin 1C being the adaptation motor (Holt et al., 
2002). 
1.2.6 Hair bundle stimulation methods  
 
There are two primary stimulation methods used for electrophysiologically studying MET 
currents; stimulation with a fluid jet and stimulation with a stiff probe. The method I have used 
to undertake the work in this thesis is stimulation generated by a fluid jet (FIGURE 1-3). I used 
this stimulus as it allows for studying of the maximum size of the MET currents, as the flow of 
the fluid which it generates is evenly directed at the entire bundle (Corns et al., 2014) if 
correctly placed. Additionally, it provides the required level of pushing forward and pulling 
backward of stereocilia essential for eliciting excitatory and inhibitory responses. An 
alternative stimulation method involves using a stiff probe to push directly on a proportion of 
the stereocilia, dependent upon its shape. It has been suggested that the stiff probe may cause 
damage to the stereocilia. Alternatively, it may just not stimulate the hair bundle evenly, 
primarily pushing on the tallest bundle, in turn resulting in a broadened current-displacement 
(I-X) relationship (Fettiplace and Kim, 2014). This is a particular problem where stimulating IHC 
bundles as they are more uneven than OHC hair bundles (Fettiplace and Kim, 2014). 
Indzhykulian et al. (2013) investigated the effects on adaptation of different positioning when 
using a stiff probe as stimuli to open and close MET channels by pushing on stereocilia. They 
found that placing the probe at a higher level and pushing only on the tallest front row of 
stereocilia caused increased, faster adaptation of MET currents than when the probe was 
placed lower down, giving more even stimulation of all bundles. Nam et al. (2015) compared 
different types of probes for stereocilia stimulation finding the large rounded probe, that they 
usually used, elicits currents with increased adaptation compared to the other kinds of probes 
they tested. They discovered that all the probe types that they tested caused bundle deflection 
which resulted in a broadened I-X relationship, relative to the ideal bundle deflection that they 
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modelled. They also found that a large flat probe which specifically stimulates only the 
shortest rows of stereocilia and a thin probe which only pushes on the tallest stereocilia, 
resulted in a broadened I-X relationship relative to the normal round probe that they use. They 
did not, however, make a comparison of stimulation using a fluid jet with the stiff probes that 
they tested. 
Inhibitory stimulation is difficult to achieve with the stiff glass probe as it may detach from the 
bundle when pulled backwards towards the shortest stereocilia as Nam et al. (2015) found to 
be the case where they used a thin probe which only made contact with the tallest row of 
stereocilia. They did nonetheless show that the probes which offered less even bundle 
stimulation elicited currents which showed reduced, not increased, adaptation relative to the 
probe that they normally use for such experiments. The distinction between the kind of 
uneven stimulation provided by these probes was distinct from that demonstrated by 
Indzhykulian et al. (2013) as one was large and flat pushing only on the shorter bundles and 
although the other did push exclusively on the tallest stereocilia it was very thin. They 
additionally noted that the thin probe did not adhere well to the bundle, as the retraction of 
the bundles in the inhibitory direction did not close the MET channels sufficiently well. 
However, where they used a silicon bundle shaped probe, with pushed on all bundles more 
evenly than the normal probe, currents which adapted more quickly and strongly were elicited 
(Nam et al., 2015). Given that different probe shapes and the height at which they are placed 
appears to affect adaptation, it seems feasible that using a glass probe instead of a fluid jet 
may stimulate the bundle in a way which elicits a current which displays apparent enhanced 
decay which looks like adaptation but is actually an Ca2+ independent artefact (Corns et al., 
2014). Therefore, the finding of calcium independent adaptation (Peng et al., 2013) is 
questionable. On the other hand, the faster speed of probe stimulation means the stiff probe 
can be used for studying the kinetics of the MET current, where fluid jet stimulation may only 
be capable of relatively slow bundle displacements. It is nevertheless possible to study 
33 
 
adaptation characteristics of the MET current, albeit with some distortion, on a submillisecond 
time scale  (Corns et al., 2014). 
On the other hand, the faster speed of probe stimulation means the stiff probe can be used for 
studying the kinetics of the MET current, where fluid jet stimulation may only be capable of 
relatively slow bundle displacements. It is nevertheless possible to study adaptation 
characteristics of the MET current, albeit with some distortion, on a submillisecond time scale  
(Corns et al., 2014). 
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FIGURE 1-3 - Stereocilia atop a hair cell being stimulated by a fluid jet  
 
 
 
 
 
 
FIGURE 1-3 : Stereocilia atop a hair cell being stimulated by a fluid jet. The fluid 
moving out of the fluid jet will push the stereocilia in the excitatory direction, towards 
the tallest stereocilia, opening the majority of MET channels which were not open at 
rest.   
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1.3 Mechano-electrical transducer channel channel candidates 
 
After the creation of a large number of Drosophila mutants, the mutations in those 
demonstrating abnormalities in mechanosensation were studied, including mutations in 
nompC. In Drosophila possessing nompC mutations, bristle organ MET currents and receptor 
potentials were lacking. It was subsequently discovered that nompC is a member of the 
transient receptor potential (TRP) family and is thus now known as TRPN1. TRPN1 has been 
found to be directly involved in auditory transduction channel gating in Drosophila (Effertz et 
al., 2012).  TRPN1 also localises to the kinociliary tips in zebrafish and is likely thought to play 
some part in hair cell function as it is present in these cells and TRPN1 removal results in larval 
deafness (Sidi et al., 2003, Pickles, 2008). This discovery, however, only provided a starting 
point for the discovery of candidate channels in the mammalian system, as there is no TRPN1 
analogue to be found there.  
 
Later the Drosophila Nanchung (Nan) protein was discovered, similar to vanilloid-receptor-
related (TRPV) channels. A Nan mutation entirely eliminated sound-evoked potentials, 
suggesting that it is a crucial component in this process (Kim et al., 2003). TRPV4 is expressed 
in mammalian hair cells (Ishibashi et al., 2008) and knock out mice have a delayed onset 
hearing loss but are able to hear for the first 8 weeks of their life, so evidently this channel is 
not a primary part of the MET channel or the attached complex (Tabuchi et al., 2005). 
 
TRPML3 mutant mice have early onset hearing loss (Palma et al., 2002) and impaired MET, 
although MET currents with normal polarity and adaptation characteristics are present (Van 
Aken et al., 2008). This, in addition to the fact that the channels are localised at the base of the 
stereocilia, makes them poor candidates for components of the MET channel as the MET 
channels are located at the tops. 
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TRPA1 channels are activated by pungent compounds such as allyl isothiocyanate (AITC) and 
play a role in mechanosensation in Drosophila (Walker et al., 2000) and zebrafish (Sidi et al., 
2003). TRPA1 was previously thought to be a candidate in the search for the MET channel, as 
TRPA1 antibody labelling was evident at the tips of the stereocilia and where MET was 
disrupted this labelling disappeared, additionally TRPA1 disruption interfered with MET (Corey 
et al., 2004).  In spite of this it has now been eliminated as a candidate because TRPA1 knock-
out mice show normal MET and hearing (Kwan et al., 2006). Additionally, application of TRPA1 
activating pungent compounds does not alter MET (Kwan et al., 2006). TRPA1 channels have 
an estimated pore size of somewhere in the region of 1.1 nm (Karashima et al., 2010), 
somewhat smaller than the MET channel pore size estimates made by Farris et al. (2004). In 
addition to pungent compounds such as AITC and mustard oil, TRPA1 channels can also be 
activated by endogenous products of lipid peroxidation, such as 4-hydroxynonenal, which are 
produced as the result of exposure to loud noise and aminoglycosides (Huth et al., 2011). 
Electrophysiological recordings of TRPA1 channels have shown that they share characteristics 
of susceptibility and reactivity to permeant blockers with the MET channel. Unpublished data 
by Karashima and Nillius has shown that DHS blocks the TRPA1 channel in a voltage dependent 
manner, with stepping the cell to extreme negative potentials resulting in the block being 
relieved (Nilius et al., 2011).   
Texas red conjugated gentamicin (GTTR) and FM1-43 were both found to be capable of 
entering OHCs, where tip links had been severed by pre-incubation in a calcium-free solution 
containing the calcium chelator BAPTA (Stepanyan et al., 2011). This only occurred in wild-type 
and not TRPA1 knockout mice, thus appearing to be a result of TRPA1 activation and 
subsequent entry through these channels. TRPA1 was activated by the endogenous molecule 
4-hydroxynonenal (4-HNE), a phospholipid membrane peroxidation product caused by reactive 
oxygen species (ROS) reacting with the hair cell membrane in endogenous stress. Creation of 
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4-HNE can occur after exposure to aminoglycosides, cisplatin (Rybak and Whitworth, 2005) or 
noise (Yamashita et al., 2004). These results suggest that TRPA1 may provide a secondary 
route for aminoglycosides entry into hair cells. 
The neoteric MET channel candidates are the transmembrane channel (TMC)-like membrane 
proteins TMC1 and TMC2, which have been localised to cochlear hair cells (Kawashima et al., 
2011). However, discovering the elusive MET channel is no easy feat, as it seems that there 
may be many subunits and additional structural components which form the MET complex 
(TABLE 1).  
Aside from the identity of the MET channel, an additional undiscovered feature of the MET 
apparatus is how the two identified MET channels, located at the lower ends of the tip links of 
the second and third rows of stereocilia (Beurg et al., 2009), interact with one another. The 
question is, is their gating dependent or independent of the gating of one another in a 
cooperative or anti-cooperative way? The general consensus is that they are independent and 
that, in single channel recordings, one is indeed witnessing the currents flowing through a 
single channel (Ricci et al., 2003). However, this may not be the case and ‘single channel 
recordings’ may instead represent a cohesive current flow through multiple channels 
(Reichenbach and Hudspeth, 2014).   
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Candidate 
Channel 
Evidence for mammalian MET channel 
candidacy 
Evidence against candidacy 
TRPN1 Direct involvement in auditory transduction 
channel gating in Drosophila (Effertz et al., 
2012).  Localises to the kinociliary tips in 
zebrafish and is likely to play some part in hair 
cell function as it is present in these cells and 
TRPN1 removal results in larval deafness (Sidi 
et al., 2003; Pickles, 2008). 
No mammalian TRPN1 analogue 
(Pickles, 2008). 
TRPV4 Expressed in mammalian hair cells (Ishibashi 
et al., 2008) and knock out mice have delayed 
onset hearing loss (Tabuchi et al., 2005). 
Mutant mice are able to hear for 
the first 8 weeks of life (Tabuchi 
et al., 2005). 
TRPML3 Mutant mice have early onset hearing loss 
(Palma et al., 2002) and reduced MET current 
size (Van Aken et al., 2008). 
MET currents with normal 
polarity and adaptation 
characteristics are present (Van 
Aken et al., 2008). 
TRPA1 Plays a role in mechanosensation in 
Drosophila (Walker et al., 2000) and zebrafish 
(Sidi et al., 2003). TRPA1 antibody labelling at 
the tips of the stereocilia and where MET was 
disrupted this labelling disappeared, 
additionally TRPA1 disruption interfered with 
MET (Corey et al., 2004). 
TRPA1 knock-out mice show 
normal MET and hearing (Kwan 
et al., 2006). MET remains 
unchanged after application of 
TRPA1 activating pungent 
compounds (Kwan et al., 2006). 
Estimated pore size in the region 
of 1.1 nm (Karashima et al., 
2010), smaller than the minimum 
MET channel pore size of 1.2 nm 
Farris et al. (2004). 
TMC1 + 
TMC2 
Mutations in TMC1 and TMC2 caused hearing 
loss. TMC1 expression found to occur in the 
cochlear hair cells and required for the cells 
to function normally (Kurima et al., 2002). 
Mice with targeted deletions of TMC1, TMC2 
have no evident MET currents (Kawashima et 
al., 2011). Ca2+ permeability and single 
channel current size are both reduced after 
altering TMC1 (Pan et al., 2013). TMC1 
localised to the stereocilia of hair cells  
(Kawashima et al., 2011; Beurg et al., 2014), 
located at the tips of the two shortest rows of 
stereocilia (Kurima et al., 2015). Block by 
extracellular and intracellular DHS is reduced 
in Bth mutant mice, which harbour a point 
mutation in the gene encoding TMC1 (Corns 
et al., 2016). 
Inverse polarity MET current 
present in TMC1; TMC2 double 
mutant mice are present (Kim et 
al., 2013) with different onset, 
adaptation and drug block 
characteristics (Marcotti et al., 
2014). 
 
TABLE 1 - MET channel candidates 
Met channel candidates are presented with the evidence which validated their candidacy and 
that which proved that they were not in fact the MET channel.  
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1.4 Elucidating the properties of the mechano-electrical 
transducer channel using electrophysiology 
 
Electrophysiological techniques have been used to elucidate the mechanisms by which hair 
cells function, in terms of the gating mechanisms and activation potentials of the channels 
contained in their membranes the currents which flow through them, as well as eliminating 
MET channel candidates. Single channel and macroscopic current recordings can offer 
different insights. 
1.4.1 The location of the MET channel 
 
Fluorescent Ca2+ indicator dyes of the Fluo4 family have been utilised to locate the MET 
channel, as a sufficiently large proportion of the MET current is carried by Ca2+ and the 
intracellular concentration of it in hair cells is relatively low. Stimulating the hair bundles of rat 
IHCs and OHCs, thus eliciting MET currents, in the presence of the dye whilst using fast 
confocal imaging allowed Beurg et al. (2009) to see where the Ca2+ was flowing into the 
channel and thus where it was located. They discovered that Ca2+ signals were far greater and 
more rapid in the second and third rows of stereocilia when compared with the first row and 
also indicated that the channels were at the bottom end of the tip links. The channel pore is 
arguably the channel’s defining feature and thus using electrophysiological techniques in 
combination with channel blockers such as ions or compounds to discover its attributes can be 
very illuminating. 
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1.4.2 MET current rectification  
 
Current voltage curves plotted, in 1.3 mM Ca2+ stepping the membrane potential of the HCs 
from -164 to +94 mV in 20 mV steps, show both inward and outward rectification. This occurs 
because Ca2+ and Mg2+ plug the channel pore as they flow through it but are increasingly 
released, permeating the channel, at extreme depolarised (inward current) or hyperpolarised 
(outward current) potentials, due to the positively charged ions being pulled into the 
intracellular space or pushed into the extracellular space, respectively (Kros et al., 1992). The 
MET current was initially thought to be non-rectifying. This was a consequence of conducting 
experiments where hair cells were not stepped to extreme enough membrane potentials to 
provide the driving force for rectification to occur and/or the use of intracellular BAPTA, which 
is a faster acting, stronger Ca2+ chelator when compared with others such as EGTA or EDTA, 
meaning that intracellular Ca2+ was not available to cause the rectification characteristics of 
outward MET currents. Farris et al. (2004) described the MET channel as being ‘minimally 
rectifying’, having used 1 mM BAPTA in the intracellular solution and stepping the cells to a 
maximally hyperpolarised potential of -120 mV, compared with the 1 mM intracellular EGTA 
and the maximally hyperpolarised membrane potential of -164 mV used in other studies 
Marcotti et al. (2005) and in this thesis, where characteristic double rectification of the MET 
current is evident.  
Pan et al. (2012) offered a plausible explanation for the fact that some channel blockers block 
the MET channel far less effectively from in intracellular side than from the extracellular side. 
Intracellular channel block is inversely voltage dependent, such that maximum block occurs at 
highly positive potentials, where the polycationic compounds are driven out of the intracellular 
space into the MET channel pore. At -120 mV they found that the KD for intracellular FM1-43 
was 30x that previously reported by Farris et al. (2004) for extracellular FM1-43. They deemed 
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access to the internal face of the MET channel was not to be the issue, through the use of 
fluorescent Alexa 488 tagged dextrans (polysaccharides) in two photon microscopy 
experiments. These experiments revealed that there was not a diffusion barrier impeding 
access of the compounds to this region. 
Farris et al. (2004) found evidence of the asymmetric MET channel pore size, decreasing from 
the external mouth of the channel to its internal face. They intracellularly applied two similarly 
sized molecules, one that was planar and asymmetric (guanidine) and one that was 
geometrically symmetrical (methyl guanidine). They found that the asymmetric guanidine 
blocked the channel more effectively and was thus evidently gaining access via its short axis. 
Intracellularly application of a number of different compounds, which when Farris et al. (2004) 
applied internally were pushed into the channel at depolarised potentials, allowed them to 
find that pore size at hyperpolarised potentials was half that at depolarised potentials . Pan et 
al. (2012), posit the ability of the pore size to change its size dependent on whether Ca2+ 
binding sites are empty or full as Ca2+ occludes the MET channel pore. They postulated that the 
large negatively charged vestibule near the outer face of the channel is responsible for an 
increased current flow into the MET channel at negative membrane potentials. This in turn 
causes dehydration and concentration of the ions carrying the current. This is the driving force 
behind Ca2+ removal from the channel, effectively increasing the functional size of the channel 
pore.  At positive membrane potentials, the outward current flow is comparatively reduced as 
it occurs from the intracellular face of the MET channel, away from the vestibule. Therefore, 
the driving force is reduced and more Ca2+ remains bound in the pore, occluding it, resulting in 
decreased pore size.  
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1.5 The Hill coefficient, the two barrier-one binding site model 
and the nature of different types of MET channel block 
 
In-depth cognisance of the properties of the MET channel pore has been gained through the 
use of various permeant channel blockers including aminoglycoside antibiotics (Marcotti et al., 
2005) and the fluorescent dye FM1-43 (Gale et al., 2001). The Hill coefficient (nH) is a measure 
of the degree of cooperativity of the binding process of the blocker to the binding site (Hille, 
2001). The slope of the curves which have been fitted with the Hill equation can determine 
cooperativity of interaction between binding sites within the MET channel pore.  
 
Woodhull, (1973) found that when putting frog nerve cells into a solution with elevated H+ 
concentration, H+ ions would enter, bind and consequently block Na+ channels in a manner 
that was dependent upon the membrane potential. This in turn decreased Na+ permeability. It 
was noted that seemingly this would need to be the result of the H+ binding site being a great 
enough distance across the membrane that changing the voltage across the membrane would 
influence the movement of ions into the channel. Working with assumptions made based on 
the apparent nature of the block, a model was fitted from a rate theory of ion kinetics (Eyring 
and Eyring, 1963; Woodbury, 1971) including two barriers; one on the inside and one on the 
outside which led to the conclusion that “if a positive ion blocks mainly by entering from the 
outside… raising the membrane potential relieves the block. If the block is mostly from the 
[inside]… raising potential increases blocking by driving ions into the blocking position“, where 
the applied voltage fractionally adds to the heights of the energy barriers and to the energy 
well (binding site). Changing the heights of the energy barriers and the electrical distance of 
the binding site from the barriers, in the equation, has a significant effect on the level of 
voltage dependence of the block. Ergo, an increased distance of the binding site, based on the 
number of positive charges which a compound has, from the outside of the cell results in a 
steeper voltage dependence (Hille, 2001). In the case of Na+ ions, raising the membrane 
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potential resulted in relief of the block and thus H+ was seen to be blocking from the outside. 
Woodhull (1973) therefore found that a simpler model, that assumed only entry from the 
extracellular solution, was sufficient.  
 
DHS is only able to block the open MET channel and this is evident when applying an excitatory 
mechanical step at -84 mV, as the presence of DHS has no effect on the onset kinetics of the 
MET current and thereafter settles to a steady state block, increasing with concentration. 
Stepping the cell to +96 releases the block and when stepping it back to -84 mV, the time 
constant of the ensuing block is again suggestive of an open channel block (Marcotti et al., 
2005). DHS has a Hill coefficient of 1 at all holding potentials and was fitted with a two-barrier 
one-binding site model (Marcotti et al., 2005). Conversely, FM1-43 is able to reside in both the 
open and the closed MET channel, as is apparent from the similarity of the kinetics when 
applying an excitatory or inhibitory step. Gale et al. (2001)  used a one barrier model to fit their 
data on FM1-43 MET channel block, identifying that there were at least two binding sites for 
FM1-43 in the MET channel pore, based on Hill coefficients (nH) ranging from 1 at the extreme 
positive (+96 mV) and negative (-164 mV) membrane potentials to 2 at potentials near 0 mV. 
Later, the interactional profiles of FM1-43 and DHS with the MET channel were used to further 
developed the two-barrier one-binding site model to allow for consideration of using it to fit 
blockers with Hill coefficients other than 1 (van Netten et al., 2007). 
 
The “punch through” effect describes molecules being pulled from the binding site in the 
channel into the cytoplasm of the cell (van Netten et al., 2007). For DHS this occurs at extreme 
negative potentials below -80 mV (Marcotti et al., 2005). Failing to step cells down to 
sufficiently negative membrane potentials previously meant that the punch-through effect was 
not evident for DHS and it thus was thought for a time to be an impermeant MET channel 
blocker (Kroese et al., 1989). If the blocker was not permeating through the channel pore, one 
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would expect to see the block getting increasingly strong without release of block at extreme 
hyperpolarised potentials. FM1-43 has a somewhat different profile, blocking the MET channel 
maximally around 0 mV, where nH = 2. At more positive or negative potentials than this nH 
decreases to 1 at the extreme ends. A blocker which was unable to permeate the channel 
would not demonstrate this apparent decrease in fractional block of the current at increasingly 
hyperpolarised potentials. 
 
Equation (1): The Hill equation  
Equation from Marcotti et al. (2005), for equations and explanations on calculating KD see 
Marcotti et al. (2005). 
The two-barrier-one-binding-site model suggests that the MET channel has an inner and outer 
electrical barrier and a binding site within it, representing the “energy minimum in the 
movement of an ion [through the channel]” (Woodhull, 1973). 
Conformational change can result from the binding of ligands to allosteric sites (sites other 
than the active site) on proteins. The Monod-Wyman-Changeux model describes the 
cooperativity between binding sites on proteins with multiple subunits by means of allosteric 
transitions (Monod et al., 1965). When applied to cooperativity of ligand-gated channels, this 
model does not consider the possibility of any direct interaction between the binding sites on 
different subunits. Instead the cooperativity arises from binding at one site causing 
conformational change in the subunit that it’s on. The interfaces where the subunits are 
packed together then cause changes in protein conformation and ultimately affect the binding 
at another binding site. This is not applicable to the MET channel, which is mechanically gated 
and any change in the size of the channel pore is thought to occur through Ca2+ binding (Pan et 
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al., 2012). However, as described by Jackson, (2002) the Weber theory (1992), which built 
upon the Monod-Wyman-Changeux model (Monod et al., 1965), to include consideration of 
direct interaction between binding sites can offer some insights, as no allosteric transitions are 
necessary to cause cooperative change in binding sites, but instead distortion at a binding site, 
induced by binding of ligands, in turn causes distortion at other binding sites altering the 
affinity of these sites. This is analogous to the binding of compounds with multiple binding 
sites, in the MET channel. This theory applies the idea of coupling energies which equate to the 
free energy of one binding site when an additional site is empty or occupied by a given 
compound. It turns out that where absolute cooperativity is considered; infinite coupling 
energies become a requisite, an argument for interpreting the Hill coefficient as the minimum 
number of binding sites and not the absolute number (Jackson, 2002). 
 
1.6 Cooperativity and negative cooperativity 
 
From the Hill coefficient (Hille, 2001) we may firstly be able to infer whether there is a single or 
multiple binding sites for the compound in question. Secondly, if there are multiple binding 
sites we can gain a measure of the level of cooperativity between them. A neutral 
cooperativity of nH = 1 may lead us to believe that there is a single binding site. However, this 
is only one possible explanation. Withal, a Hill coefficient of one indicates zero or neutral 
cooperativity, which may in fact represent the fact that there are multiple binding sites with 
equal affinities which are independent of one another. The nH = 1 which has been found for 
DHS channel block, however, does not vary with holding potential (Marcotti et al., 2005). 
Therefore, making the least assumptions it seems fair to posit that there is only one binding 
site for DHS in the MET channel. Additionally, according to the energy profile presented by 
Marcotti et al. (2005), because of its electrical distance from the extracellular side this binding 
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site is likely to be nearer narrow region of the channel pore. Positive cooperativity is indicated 
by a Hill coefficient of greater than 1, which will obtained from a steeper fitted curve than the 
former. It means that the binding of one molecule to one binding site, increases the chances of 
another molecule of the same compound binding to another binding site within the channel. 
The binding profile of FM1-43 is an interesting example, in so far that it varies with the voltage 
at which the cell is held during patch clamp manipulation. At the extreme ends of the positive 
and negative holding potentials, the Hill coefficient is around 1. This varies at positive and 
negative holding potentials near zero, where the Hill coefficient gets closer to 2 meaning 
positive cooperativity is dramatically increased. Perhaps the influence of the binding of the 
first molecule on the other molecules is less at extreme negative or positive potentials due to 
the net forces pulling the molecules to the inside or outside of the cell.  
A Hill coefficient of less than 1 equates to negative cooperativity and interpreting negative 
cooperativity is more complex. It may result from the existence of distinct binding sites with 
different binding affinities binding independently. Alternatively, it may mean that the binding  
of one molecule reduces the likelihood of a second molecule binding (Ferguson et al., 1975; 
Jackson, 2002). Additional information about the channel is required to work out which of 
these is more likely potentially achievable by molecular analysis of receptor structure (Jackson, 
2002). 
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2   METHODS 
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2.1 Cultured cochlea preparation 
 
OHCs from CD1, C57/SV129, TRPC 3/6, TRPC 1/3/6 and TRPC 1/3/5/6 were studied in 
organotypic cultures. Mice were killed by cervical dislocation in accordance with UK Home 
Office regulations and with approval of the local ethical committee. The pups were postnatal 
day 2 (P2) in age at the time of dissection and the cultures were grown on collagen-coated, 
round glass coverslips for between 1 (P2 + 1) and 3 (P2 + 3)  days at 37°C in Maximow slide 
assemblies in a medium containing 93% DMEM/F12 (v/v), 7% fetal bovine serum (v/v). 
Cochlear coils were then dissected into apical and basal segments two apical and two basal 
cochlear coils were placed onto each coverslip. Alternatively, coils were kept whole and a 
single whole coil was placed onto each coverslip. 
 
2.2 Live cell imaging using a light microscope 
 
In order to observe phosphatidylserine (PS) externalisation (as described by Goodyear et al., 
2008), Alexa Fluor 488 conjugated annexin V was added at a dilution of 1:50 when testing each 
culture. In order to compare their toxicity D-JNKi1 and D-HIV-TAT (D-TAT) were tested at a 
concentration of 5 µM (based on a previous assessment of the effects of different 
concentrations of the compounds, at 5 µM a consistent PS externalising affect from apex to 
base was witnessed). In order to study entry into the cells, Texas Red conjugated D-JNKi1 (TR 
D-JNKi1) and D-TAT (TR D-TAT) were also used in separate experiments at a concentration of 
5µM. A Zeiss AxioPlan II light microscope was used for live imaging. The coverslips with four 
adherent cochlear cultures, two apical and two basal, were transferred from the Maximow 
slide assemblies into a glass-bottom, Perspex slide chamber and 0.5 ml of HEPES-buffered (10 
mM, pH 7.2) HBHBSS was added. The cultures were located using a 10x lens and then the hair 
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cells were viewed using a 63x water-immersion lens. Nomarski interference contrast optics 
were utilised. Images were captured after addition of Alexa Fluor 488 conjugated annexin V 
and the compound to be tested. Exposure to illumination was restricted to the times necessary 
to focus and capture the images, in order to prevent phototoxicity and keep photobleaching to 
a minimum. Images were taken from fields in the middle region of each coil with a Spot RT 
slider digital camera, fixed exposure times were used: 3 seconds for the green channel and 0.5 
seconds for the red channel and the images were then saved and stored on a computer. The 
FITC (green) filter set was used to visualise annexin V fluorescence (indicating PS 
externalisation) and the Rhodamine (red) filter set was used for viewing Texas Red 
fluorescence. See Goodyear et al., 2008. 
 
2.3 Fixation and immunofluorescence labelling  
 
Coverslips with the adherent cultures were firstly removed from the slide chambers and then 
placed in 35-mm-diameter plastic culture dishes and washed three times with HBHBSS, this 
represented 20 minutes of exposure to a given compound. Cultures were fixed for 1 hour in 
3.7% (v/v) formaldehyde in 0.1 M sodium phosphate buffer (pH 7.4). After fixation, cultures 
were washed three times in PBS, preblocked and permeabilised for a short 15 minute period in 
10% (v/v) horse serum in PBS with 0.1% (v/v) Triton X-100 added. The cultures were then 
washed three times with PBS, and labelled with rabbit anti-Alexa Fluor 488 IgG at a dilution of 
1:100 and Texas Red phalloidin at 1:300 overnight. Then the cultures were washed three times 
with PBS and the secondary antibody, Alexa Fluor 488-goat anti-rabbit IgG was then added.  
2.4 Confocal microscopy  
 
Stained and mounted cultures were viewed with a LSM 510 Meta confocal microscope using a 
100x, NA 1.4, oil-immersion lens. Images were acquired with the LSM 510 Meta using the 
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488 nm Argon laser line in order to excite Alexa Fluor 488 annexin V and the 543 nm HeNe 
laser line to excite Texas Red. Images were taken at different levels in order to visualise both 
hair bundle staining with annexin V and loading of Texas Red conjugated compounds into the 
hair cells. 
2.5 Analysis of cell culture microscopy data and figure 
creation 
 
A series of composite images were created using Photoshop CS2. Pseudo-colouring via 
Photoshop CS2 was used to illustrate Texas Red (red channel) fluorescence. In order for the 
difference in fluorescence levels of the Texas Red conjugated D-JNKi1 and D-TAT pseudo-
coloured images to be observable and comparable, the contrast and brightness of these 
images were altered by creating a ‘Levels Adjustment Layer’ in Photoshop CS2. Within 
FIGURE 4-4, alterations were kept to the same level in order for the images to remain 
comparable.  
For the purpose of generating numerical data, 10x magnification light micrograph composites 
of the hair cells were used (FIGURE 4-3). Using Photoshop CS2, measurement of arbitrary grey 
levels from hair cells responding to treatment with the compound, in a given culture, were 
taken. Grey levels were measured using Photoshop CS2. The grey level was obtained using the 
Histogram tool, which provided the arbitrary reading entitled ‘mean’. All the hair cells which 
were externalising PS, to an arbitrary grey level which was calculated to be the threshold as it 
was above the background fluorescence level, were counted. This level was calculated to be 
anything above 0.40, using the Histogram tool. This was done for two apical or basal cultures 
tested and then the values obtained were added together. The average number of hair cells in 
the apical and basal cultures used were calculated and multiplied by two. The resulting value 
from the addition of the two cultures added together was then divided by the average total 
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number of hair cells in a culture of the same type and then this was multiplied by 100 in order 
to obtain a percentage of cells externalising PS for those cultures. 
2.6 Experimental equipment for electrophysiology 
 
The cultured organ of Corti preparations were viewed using an upright light microscope 
equipped with a x60 water-immersion objective lens and Normarski interference contrast 
optics utilised as well as a x15 eyepiece. The cultures were sat in a bath chamber, with an 
inflow and outflow tube to allow constant perfusion of fresh extracellular solution. This sat 
atop a rotating stage to allow access to the cells from different angles. Cultured preparations 
were perfused with an extracellular solution in the bath chamber at a rate of 0.12ml/min using 
a peristaltic pump (Cole-Palmer, IL, USA). Perfused extracellular solution was pre-filtered using 
a Millipore Millex syringe filter unit and tubes were connected to the inflow and outflow of the 
bath. To reduce noise picked up by the bath chamber from the peristaltic pump the chamber 
was grounded through a 63 μF capacitor, connected to the inflow, to the headstage, in parallel 
with the bath electrode. Hair cells from apical and basal coils at room temperature (~ 21°) 
were whole-cell voltage clamped and recorded from using the patch-clamp amplifier. The 
setup, including the microscope, was placed on an air table and inside a Faraday cage to 
reduce movement and electrical noise. 
 
To deliver compounds to the culture, a gravity fed system was used. This was comprised of 
filled syringes with taps, connected to tubes which were fed into a system of very fine tubes 
bound together using dental cement and parafilm, all leading to the same relatively large end 
(in comparison to the size of the cochlear culture), out of which any of the solutions could flow 
if the tap connected to the syringe containing it was open. This was placed two and a half turns 
of the focus knob above the preparation in the bath. Manual control of the syringe taps 
52 
 
allowed for application of and fast changes between solutions. There was always a control 
solution and 1-3 solutions containing compounds. 
 
The patch electrode, comprised of a silver chloride wire coupled to a polycarbonate electrode 
holder with a pin headstage connector, connected to a Cairn Optopatch head-stage and an 
Optopatch patch-clamp amplifier. The signal was filtered through an 8-pole Bessel filter at 
2.5 kHz prior to being inputted into a Power1401 data acquisition interface (Cambridge 
Electronic Design) allowing for analogue to digital conversion.  
 
Using an upright glass puller (Narishige, Tokyo, Japan) cleaning pipettes were pulled from 
borosilicate glass capillaries and patch pipettes from soda glass capillaries. A cleaning pipette, 
with an attached syringe to provide suction, made of glass with a tip diameter around 7 µm, 
filled with extracellular solution, was used to remove supporting cells, in order to expose the 
basolateral surface of the OHCs. A patch pipette with a resistance of around 1.8-2.8 MΩ was 
used to patch the basolateral membranes of the OHCs. Patch pipettes were coated, from half 
way down the shaft to within 100 µm of the tip, with a thin layer of wax (Mr Zogs SexWax, 
Carpinteria, CA, USA).  
 
2.7 Solution composition for electrophysiology 
 
The patch-pipettes were filled with a caesium chloride based intracellular solution, used in 
order to block potassium channels, so that potassium currents would not be recorded as this 
would interfere with MET current visualisation. This solution contained (mM) 135 CsCl, 
2.5 MgCl2 , 2.5 Na2ATP, 1 EGTA-CsOH, 5 HEPES, 10 Na2phosphocreatine. The solution had a 
final pH of 7.28 and an osmolarity of, ± 5 mOsm kg-1, ~295 mosm kg-1; (10-15 mOsm below 
extracellular).   
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The high Na+ extracellular (perilymph mimicking) solution contained (mM) 135 NaCl, 1.3 CaCl2, 
5.8 KCl, 0.9 MgCl2, 10 HEPES-NaOH, 5.6 D-glucose, 0.7 NaH2PO4 and 2 sodium pyruvate, Eagle’s 
minimum essential medium (MEM) concentrated amino acids and vitamins . The solution had 
a final pH of 7.48 and an osmolarity of, ± 5 mOsm kg-1, 308 mOsm kg-1. (10-15 mOsm above 
intracellular). 
Control extracellular solution used for drug superfusion was composed of (in mM) 135 NaCl, 
1.3 CaCl2, 5.8 KCl, 0.9 MgCl2, 10 HEPES-NaOH, 5.6 D-glucose, 0.7 NaH2PO4 and 2 sodium 
pyruvate. The solution had a final pH of 7.48 and an osmolarity of, ± 5 mOsm kg-1, 305 mOsm 
kg-1. (10-15 mOsm above intracellular). 
For recording the anomalous currents, cells were bathed in a Ca2+-free, BAPTA-containing 
extracellular solution (in mM: 141 NaCl, 5.8 KCl, 0.7NaH2PO4, 5.6 D-glucose, 10 HEPES NaOH, 
5 Na4BAPTA) for 5 minutes prior to exchanging the bath solution with normal extracellular 
solution twice. 
 
2.8 Compounds 
 
D-TAT was obtained from Enzo Life Sciences and later was synthesised for us by LifeTein. The 
stock solution was prepared from 500 µM D-TAT powder which was diluted to 100 µM by 
weighing out and adding 1 part 500 µM D-TAT to 4 parts H2O.  D-JNKi1 was obtained from Enzo 
Life Sciences and later was synthesised for us by Invitrogen. Solutions were prepared from 
100 µM D-JNKi1 stock solution prepared by weighing out and adding 1 part 500 µM D-JNKi1 
powder to 4 parts H2O. The stock solutions for both peptides were stored in small aliquots 
which were only freeze-thawed once in order to prevent any degradation caused by the 
freeze-thawing process.  Superfusion stock solution of concentrations varying from 3 nM to 1 
µM was prepared daily by adding the 100 µM stock to control extracellular solution.  
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DHS was obtained from Sigma-Aldrich. FM1-43 was obtained from Life Technologies. Fresh 
solutions were prepared each day by adding the powder compounds to extracellular solution 
to make solutions ranging in concentration from 100 µM to 3 mM DHS and 1 µM to 30 µM 
FM1-43.  
 
2.9 MET current recording in whole cell mode 
 
Hair cells were recorded from using the whole cell patch clamp technique. This was achieved 
by applying mouth pressure through tubing connected to the patch electrode. Positive 
pressure allowed for seeing dimpling in the cell membrane of the hair cells. Following this, light 
suction was applied in order to pull a patch of membrane with the aim of forming a Gigaohm 
seal. The membrane potential was then stepped to -80 mV and capacitive transients were 
compensated for. Additional light suction is then applied to break the cell membrane open, 
allowing for access to the cell so that the intracellular solution in the cell and the patch pipette 
became continuous: the ‘whole cell’ configuration is thus established. Compensation for the 
membrane capacitance (Cm) and series resistance (Rs) was applied and noted, providing 
information about the cell size and quality of the seal. In order to eliminate the potential 
disparity in voltage clamp recordings between clamped potential and the actual membrane 
potential of the cell caused by voltage-drop of membrane currents across Rs, compensation of 
the latter of between 50% and 80% was applied using the Optopatch patch clamp amplifier. 
Membrane capacitance (Cm) of outer and inner hair cells varied from 5.5 to 10 pF (with inner 
hair cells having a larger Cm) and Rs after compensation varied from 0.5 to 2.5 MΩ. 
 
In patch-clamp experiments which aim to measure MET currents, a cesium based intracellular 
solution was used to block K+ channels. This is helpful because otherwise the large basolateral 
currents carried by K+ that flow upon depolarization would dwarf the MET current recordings. 
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In the main protocol I have used in this thesis, the cells are stepped from a negative (-164 mV) 
to a positive (+94 mV) potential in 20 mV incremental voltage steps. However, in order to 
ascertain if some aspects of the blocking profile of a given drug are related to some second-
order component of the drug block which is slow relative to the time scale of the voltage steps 
in the protocol, it may be useful to use a protocol that steps from a positive to a negative 
potential. An example of this is where a drug appears to be blocking at positive potentials. One 
wishes to see if this is the effect of having the drug pulled into the channel over multiple 
negative voltage steps, or if this block still readily occurs where the first step applied is highly 
positive. Additionally, voltage steps applied in conjunction with mechanical stimuli in the form 
of square steps can be used to see the kinetics of channel block.   
Eliciting MET currents was achieved by utilising a fluid jet, a borosilicate glass pipette with a 
diameter of  ~10 µm (a larger tip of ~14 µm for recording anomalous currents), attached to a 
glass encased Piezo driver. The fluid jet was placed at the modiolar side of the hair bundle, 
optimised for close positioning and diameter in order to maximally stimulate the bundle. A 
protocol which applied four successive 45 Hz sine waves was used with a driver voltage of 40 
V, with a positive driver voltage equating to a force which pushed the bundle in the excitatory 
direction, towards the tallest row of stereocilia. The voltage applied to the Piezo driver was 
filtered through an 8-pole low-pass Bessel filter at 1.0 kHz. 
During a given experiment, recordings were made before drug application, with positioning 
and height readjustments made as necessary in order to attempt to obtain recordings of the 
maximum obtainable MET current amplitude. Compounds were then applied using the gravity 
fed superfusion system, placed two and half turns of the focus nob above the preparation in all 
experiments. After the application of the drug via the superfusion system, a small constant 
negative pressure at the fluid jet ensured it would suck up the compound so that it could be 
applied at the correct concentration to the MET channel. The sine wave stimulus was applied 
several times until a consistent level of MET current block was seen. The control solution was 
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then applied and the same procedure was followed where possible (if the cell continued to be 
viable) to obtain washout recordings where control ECS was applied to wash the compound 
away from the hair cells, in an attempt to release any MET channel block. 
2.10 Data Acquisition and Analysis 
 
Data was acquired using Signal 4.3 software (Cambridge Electronic Design). Protocols were 
written to set the command voltage and apply the sine wave stimulus to the hair bundle. The 
cells were held at -80 mV using an external voltage calibrator. During a given recording the cell 
was stepped in 20 mV increments from -164 to +94 mV, whilst a sine wave stimuli was applied 
driving the piezo driver. The sampling rate used was 10 kHz. 
The traces were saved as text files in Signal 4.3 and opened in Origin 7.0 for analysis. The peak 
and trough of the third (FIGURE 2-1) or fourth sine wave were measured for each recording 
condition with measuring consistency being kept between recordings which were going to be 
compared (before and during the drug application). If there was evident electrical noise in the 
traces, an average of two or three sine waves was taken. The trough measurement (the leak) 
of the sine wave was then taken away from the peak current. Measurements were taken from 
the control recording prior to the application of a given compound, one of a number of 
recordings where the compound was being applied and where recording due to cell viability 
was possible a washout recording. 
 
2.11 Statistical analysis  
 
GraphPad Prism 4 was used for statistical analysis. To look at the effect of location (apical or 
basal) and voltage (-164 mV through to +94 mV) on mean current amplitudes in chapter 3, a 
two-way ANOVA followed by Bonferroni’s test was used. To compare the mean number of 
channels in apical and basal OHCs in chapter 3, an unpaired t-test was used. To look at voltage 
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and concentration dependence in chapter 6, statistical comparisons of mean current 
amplitudes at the different membrane potentials (-164 mV through to +96 mV) where 
different concentrations of a given compound were used, were made using a two-way ANOVA 
followed by Bonferroni’s test. <0.05 was used as the criterion for statistical significance. Mean 
values are quoted ± S.E.M in text and figures. For calculating whether the KDs in chapter 4 were 
significantly different, Origin 7.0 was used. The graphs were plotted using a 95% confidence 
interval and thus upper and lower limits at this level could be obtained. Where a given pair of 
limit values (upper and lower) was not within the same range as another this difference had a 
statistical significance of P < 0.05.  
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FIGURE 2-1 - MET current measurements 
 
 
 
 
 
 
 
 
FIGURE 2-1: MET current measurements. Illustration of the regions that MET current 
‘peak’ and ‘trough’ measurements were taken from. The example trace used here was 
obtained at a membrane potential of -164 mV. The dashed grey line indicates the zero 
(baseline) line of the trace. The dashed blue line indicates the level of the current 
flowing through the MET channels which are open at rest due to their resting open 
probability. The purple line with the arrowhead indicates the region and what is 
measured when taking the ‘peak’ measurement. The orange arrowhead indicates 
where the trough measurement is taken and the red line indicates the leak current 
which is deducted from the peak current (peak – trough = measured current size). 
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3 A GRADIENT IN OUTER HAIR CELL 
MECHANO-ELECTRICAL TRANSDUCER CHANNEL 
PROPERTIES FROM APEX TO BASE 
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3.1 Introduction 
 
There are a number of characteristics which vary from apex to base in the cochlea. Adaptation 
is faster in basal hair cells compared to apical hair cells (Ricci et al., 2005), the resting open 
probability of the MET channel decreases from base to apex (Dallos et al., 1982; Johnson et al., 
2011), hair bundle height decreases from apex to base whilst the number of stereocilia 
increases (Roth and Bruns, 1992; Beurg et al., 2006). As basilar membrane flexibility increases 
and thickness decreases from base to apex, levels of displacement differ such that the basal 
region is selectively sensitive to high frequency sounds and low frequency sounds are encoded 
at its apex. There are also variations in the characteristics of the outer hair cells. Single channel 
conductance of the MET channels is greater in basal hair cells in both rats (Ricci et al., 2003) 
and mice (Beurg et al., 2006). More recently, a gradient in macroscopic MET currents in the 
mouse has been found (Kim and Fettiplace, 2013) . Thus, there is evidence for multiple channel 
isoforms, which account for differences in single channel conductance, potentially in addition 
to a greater number of MET channels from apex to base contributing to larger macroscopic 
MET currents.  
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FIGURE 3-1 - Mid-apical and mid-basal cochlear regions 
 
 
 
     
 
 
 
 
 
FIGURE 3-1 : Apical and basal regions in the mouse cochlea. Illustration of apical (orange) 
and basal (aquamarine) cochlear regions, with mid-apical and mid-basal regions indicated. 
Positions are plotted according to Bekesy (1960) and corresponding frequencies are 
plotted according to Viberg and Canlon (2004), Müller et al. (2005) as in Sanz et al. (2015). 
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3.2 Results 
 
Where MET currents were evoked by a fluid jet, whilst hair cells were whole-cell patch 
clamped, there is an evident difference in the average MET current sizes of mid-apical and 
mid-basal OHCs. This is congruent with previous data from apical and basal cochlear hair cells 
illustrating a gradient in both rats (Ricci et al., 2003;  Beurg et al., 2006) and mice (Kim et al., 
2013), demonstrating differences in single channel current sizes. As well as this, apical and 
basal MET current peak amplitudes have been characterised as consistently varying in 
amplitude when compared at different developmental stages (from P1 to P10 in apical OHCs 
and P1 to P5 in basal OHCs) in mice (Kim and Fettiplace, 2013). Thanks to high n-numbers, my 
results provide strong evidence of an increase from apex to base in macroscopic MET current 
size in the P2 (+1-3) mouse cochlear OHCs.  A two-way ANOVA test followed by Bonferroni’s 
test, comparing the size of the currents in different locations (apical or basal regions) and at 
different membrane potentials (-164 mV to +96 mV), revealed that a statistically significant 
(P<0.0001) correlation between the variation of voltage and location, meaning that location 
had an effect on the amplitude of the current at every membrane potential. Moreover, the 
variation in current size with location is statistically significant (P<0.0001) and thus there is a 
statistically significant difference between the currents recorded from mid-apical and mid-
basal OHCs.   
In order to gain an estimate of the amount of MET channels atop apical and basal OHCs, I 
analysed the macroscopic MET currents recorded from each individual cell in both the apical 
and basal regions at a membrane potential of -84 mV. I then divided those values with the 
single channel recordings obtained by Kim et al. (2013) at the same potential of 5.2 pA in apical 
P4-P5 OHCs and 8.5 pA in basal P3 OHCs. I was then able to calculate a mean number of 
channels ± S.E.M (TABLE 2). There were found to be 134 ± 6 channels in apical cells (n = 75) 
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and 102 ± 9 in basal cells (n = 19). There was a significant difference (P < 0.05) between these 
two values, as determined by using an unpaired t-test. 
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FIGURE 3-2 - Difference in amplitude of apical and basal OHC MET 
currents 
 
 
FIGURE 3-2 : Difference in amplitude of apical and basal OHC MET currents. A, B, Illustrative 
traces from mid-apical (A) and mid-basal (B) OHCs. C, Averaged current-voltage curves from 
mid-apical and mid-basal CD-1 outer hair cells (C). Half the voltage steps used are shown for 
clarity (-144, -104, -64, -24, +16, +56, +96 mV). Driver voltage (45 Hz sinusoid, 40 V 
amplitude) plotted above the current traces. At -104 mV the size of mid-apical OHC MET 
currents was -696 ± 29 pA (mean ± S.E.M., n = 75), this was significantly different (p < 0.0001; 
two-way ANOVA with Bonferroni’s test comparing the currents at the different voltage steps 
and concentrations) from mid-basal coil CD-1 OHCs (-884 ± 41 pA, n = 19). This illustrates the 
tonotopic gradient in OHCs that is believed to exist. 
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Single channel 
current (pA)  
at -84 mV 
Mean whole cell 
MET current (pA) 
at -84 mV 
Number of channels 
(single channel/macroscopic MET 
current) 
Apical OHC 
At -84 mV 
5.2 -510 ± 21 134 ± 6 
Basal OHC 
At -84 mV 
8.5 -654 ± 31 102 ± 9 
Apical OHC 
Max 
macroscopic 
current 
at -84 mV 
5.2 -877 -877 / 5.2 = 168 
Basal OHC 
Max 
macroscopic 
current 
at -84 mV 
8.5 -1173 1173 / 8.5 = 138 
 
TABLE 2 – Number of MET channels in apical and basal OHCs 
 
Single channel current size, whole cell MET current size and number of channels per hair cell. 
Mean values are quoted ± S.E.M. Macroscopic averages I obtained at-84 mV: averages 
of -510 ± 21 pA in apical OHCs (n = 75) and -654 ± 31 pA in basal OHCs (n = 19). The largest 
macroscopic currents recorded at -84 mV: -877 pA in apical OHCs and -1173 pA in basal OHCs. 
Single channel recordings obtained by Kim et al. (2013): 5.2 ± 0.1 pA in apical P4-P5 OHCs and 
8.5 ± 0.2 pA in basal P3 OHCs. Number of channels per hair cell was calculated by dividing 
whole cell MET current from each individual hair cell, from both the apical and basal regions, 
by the single channel conductance obtained by Kim et al. (2013) and then obtaining a mean 
number of channels ± S.E.M. This yielded 134 ± 6 in apical cells (n = 75) and 102 ± 9 in basal 
cells (n = 19).  
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3.3 Discussion & conclusions 
 
It has previously been shown that MET current size increases from apex to base in both single 
channel (Ricci et al., 2003; Beurg et al., 2006; Kim et al., 2013) and macroscopic MET current 
recordings (Kim and Fettiplace, 2013). This seems to account, at least in part, for the increased 
susceptibility of basal OHCs to damage by ototoxic agents (Kamimura et al., 1999). The unique 
insight offered by my data lies in the large number of cells recorded from in two specific areas 
of the cochlea, namely the mid-apical and mid-basal regions. As there is some variation in the 
sizes of MET currents recorded, even from hair cells in the same region, in mice of the same 
age, a large n-number is useful for reliability of the data.  
Single channel currents are larger in basal than in apical OHCs indicating that there are 
different channel isoforms in these cells (Beurg et al., 2006; Kim and Fettiplace, 2013). This is 
consistent with an increasing pool of evidence that suggests that the MET channel is composed 
of subunits which can vary dependent upon location along the cochlear, based on increasing 
channel pore size or the number of negatively charged residues within the channel pore (Beurg 
et al., 2006; Kim et al., 2013). It has been postulated that it may not only be the increased 
single channel conductance from apex to base which results in increased macroscopic MET 
current size; there may also be also a greater number of channels in basal OHCs due to the 
additional stereocilia found atop OHCs in this region (Fettiplace and Kim, 2014). The data 
presented here, however, are at odds with the latter assertion. By dividing the macroscopic 
MET current size from each individual recording in mid-apical and mid-basal OHCs obtained 
here by the respective average single channel current size obtained by Kim et al. (2013), I have 
obtained an estimate of the number of channels in apical and basal OHCs (TABLE 2). The data 
suggest that there are in fact more channels in apical than in basal OHCs. The averages 
obtained at -84 mV suggest that there are 134 ± 6 channels per apical OHC but only 102 ± 9 per 
basal OHC. Moreover, the macroscopic MET currents with the highest amplitudes which I 
67 
 
recorded are most representative of the true size of the currents. Therefore, they are 
representative of the actual number of MET channels which a P2 OHC is likely to possess, as 
one can assume that the least channels have been lost in these cells and the maximum amount 
are being stimulated. Using these currents to calculate the number of MET channels yields a 
noticeably higher value, with an even greater disparity between apical and basal OHCs: 168 in 
apical OHCs and 138 in basal OHCs (TABLE 2). Therefore, it appears that it is only an increase in 
single channel conductance from apex to base which results in increased macroscopic MET 
current amplitude.  
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4 GRADIENTS IN THE INTERACTION OF THE 
OTOTOXIC PEPTIDES, D-TAT AND D-JNKI1, WITH 
THE MECHANO-ELECTRICAL TRANSDUCER 
CHANNELS IN COCHLEAR OUTER HAIR CELLS 
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4.1 Aminoglycoside ototoxicity  
 
Ototoxicity is the property of being reversibly or irreversibly toxic to the cochlea or auditory 
nerve. Noise trauma and the actions of ototoxic compounds such as aminoglycoside 
antibiotics, cisplatin (and other platinum containing compounds used in chemotherapy), 
aspirin (as well as other nonsteroidal anti-inflammatory drugs), heavy metals and quinine can 
all cause ototoxicity (Cheng et al., 2005). Aminoglycosides are not entirely selective for 
bacterial (prokaryotic) rRNA, also binding to a proportion of cytoplasmic rRNA in eukaryotic 
cells (Böttger et al., 2001). They damage hair cells via a variety of possible mechanisms, after 
entering hair cells through the MET channel (Marcotti et al., 2005). 
Aminoglycosides are broad-spectrum bactericidal antibiotics that are particularly effective 
against gram-negative, aerobic bacteria as well as Mycobacterium tuberculosis (Kumana and 
Yuen, 1994). They are used to treat serious illnesses such as cystic fibrosis (Tan et al., 2003), 
multidrug-resistant tuberculosis (Gonzalo et al., 2014) and septicaemia (Picard et al., 2014). 
The prevalence of life threatening conditions in developing countries such as South Africa 
(Petersen and Rogers, 2015) as well as their low cost and efficacy means that they are 
especially widely used there, as well as still being used in countries with richer economies, 
albeit more sparingly than in previous decades. Estimates of the number of aminoglycoside 
induced hearing loss sufferers varies but is somewhere in the region of 17-33% of the people 
who are given them (Fischel-Ghodsian, 2005).  
Lacking the inherent ability to regenerate hair cells that fish (Lombarte et al., 1993) and birds 
(Weisleder and Rubel, 1993) have, ototoxic agents such as aminoglycosides can result in 
irreversible damage to mammalian cochlear hair cells and thus to the hearing of individuals. 
Many attempts have been made at deconstructing the process of hair cell development with a 
view to understanding (Li et al., 2015), and ultimately harnessing the ability to enable 
regeneration of hair cells from precursor cells, in the organ of Corti, using reagents. Recruiting 
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supporting cells as facultative progenitor cells and manipulating cell fates (Fujioka et al., 2015) 
and the use of manipulated stem cells (Hu and Ulfendahl, 2013) are under investigation.  
 
A number of genes which are involved in the cell death cascade in hair cells, as well as other 
cell types, have been identified. Caspases are proteases which have been found to play a role 
in the breakdown of cells. 14 caspase family members have been identified in the human 
genome (Strasser et al., 2000) and caspase inhibitors appear to convey protection against 
aminoglycoside ototoxicity  (Cunningham et al., 2002, Matsui et al., 2003), although exactly 
which caspases are involved remains unclear. 
Apoptosis, or programmed cell death, is a natural and necessary process which helps to 
maintain cellular density equilibrium within an organism. Bax is a pro-apoptotic Bcl-2 protein 
which regulates cell death. Bcl-2 proteins form heterodimers of the proapoptotic, 
antiapoptotic or neutral variety which provide signals for the cell leading to release of 
cytochrome-c, a component of the electron transport chain in mitochondria which is involved 
in the initiation of apoptosis. After hair cell treatment with aminoglycosides, mitochondrial 
membrane potential loss has been observed and Bax molecules, which promote pore 
formation in mitochondrial membranes increasing their permeability, result in the loss of the 
mitochondrial membrane potential (Gross et al., 1998).  
The increased formation of ROS in response to oxidative stress is thought to be the main 
component in aminoglycoside ototoxicity (N. Abi-Hachem et al., 2010), having a number of 
effects which are disruptive to the cell (Huth et al., 2011). ROS have been found to show 
elevated levels in hair cells undergoing noise (Ohlemiller et al., 1999), aminoglycoside (Hirose 
et al., 1999) and cisplatin (Kopke et al., 1997) induced damage.  In vivo, antioxidant application 
which lessens free radical damage, has been shown to protect against ototoxicity (Garetz et al., 
1994).  
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The c-jun NH2-terminal kinase (JNK) pathway is one of the mitogen-activated protein (MAP) 
pathways, is also important in cell death. JNK phosphorylates and activates c-jun, a 
transcription factor, which has been found to occur in hair cells treated with aminoglycosides 
(Matsui et al., 2004). Inhibitors of MAP kinases have been demonstrated to be protective 
against noise and aminoglycoside induced ototoxicity (Pirvola et al., 2000; Ylikoski et al., 2002), 
although it has been noted that in large doses some cell penetrating peptides (CPPs) can cause 
toxicity via membrane perturbation (Saar et al., 2005). 
 
Increased susceptibility to aminoglycoside ototoxicity is thought to result from maternally 
inherited genetic factors (Hu et al., 1991).  A nucleotide 1555 A to G substitution in the 
mitochondrial 12S rRNA gene has been implicated which, by an as yet not fully understood 
mechanism, causes tighter binding of aminoglycosides to rRNA (Prezant et al., 1993; Tono et 
al., 2001; Zhao et al., 2004).  
It has recently been discovered that those with the most serious illnesses are more likely to be 
susceptible to the destructive ototoxic effects of aminoglycosides. Utilising a model of sepsis 
and inflammation, using bacterial lipopolysaccharides to induce endotoxemia in mice,  Koo et 
al. (2015) discovered that doing so increases the cochlear level of aminoglycosides, via 
increased trafficking across the blood-labyrinth barrier, thus increasing their adverse effects. 
Cochlear and serum levels of inflammatory markers were also increased. This enhanced effect, 
is highly undesirable, since those who are most ill, who need the highest dose and/or longest 
course of treatment, will be additionally affected in a deleterious manner (FIGURE 4-1). 
 
There is an evident imperative for the discovery and utilisation of preventative measures 
against aminoglycoside ototoxicity. Attempts to tackle both the ototoxic consequences of 
aminoglycoside treatment and the increasing problem of drug resistant bacterial strains 
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rapidly emerging have been made via the creation of non-toxic derivative of the 
aminoglycoside paromomycin, which were found to be efficacious at treating bacterial 
infection as well as being highly selective at ribosomal targets (Duscha et al., 2014).  
 
The potential for the use of a calcium chelator such as BAPTA, co-administered with 
aminoglycosides has been put forward by Vu et al. (2013). Because tip links can readily, 
spontaneously regenerate upon removal of the calcium chelator, temporarily breaking tip links 
could prevent aminoglycoside uptake and then tip links could regenerate restoring hearing 
(Duscha et al., 2014). However, causing complete hearing loss, even if only temporarily, may 
seem like a troubling prospect in a human subject and the exact timeline of tip link recovery 
and corresponding potential to elicit MET currents has not yet been documented. Zhao et al. 
(1996) noted that MET currents were still absent 1 hour after BAPTA treatment in chick basilar 
papilla. In mouse OHCs, whilst the fast and slow components of transduction were recovered 
at the first time point measured at 3 hours after BAPTA treatment, only very small MET 
currents could be observed (Lelli et al., 2010). Indzhykulian et al. (2013) reported that some 
regenerated tip links could be seen 1 hour after BAPTA treatment. They found that initially a 
shorter tip link composed of PCDH15 at both the upper and lower ends was formed and whilst 
there appeared to be a full complement of tip links present 12 hours after BAPTA application, 
CDH23 levels were only fully restored around 48 hours after BAPTA treatment. MET currents 
recorded up until this point, whilst normal in magnitude did not adapt as normal MET currents 
do (Indzhykulian et al., 2013). 
 
As well as treating bacterial infections, the fact that aminoglycosides can bind to a proportion 
of cytoplasmic rRNA means that they can be used to treat genetic disease that result from 
nonsense mutations or premature stop codons in cytoplasmic ribosomes by supressing them, 
allowing for successful protein encoding (Burke and Mogg, 1985; Keeling et al., 2012). 
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Additionally, it has been found that it is primarily mitochondrial protein synthesis that is 
inhibited by aminoglycosides (Shulman et al., 2014). Creation of aminoglycosides which 
selectively inhibit cytoplasmic and not mitochondrial ribosomes seems a promising way of 
ameliorating ototoxicity for the purpose of treating genetic diseases in this way (Shulman et 
al., 2014).  
 
Aminoglycosides which have good efficacy but are less able to penetrate the cochlear MET 
channels have been created. These antibiotics are altered to have fewer positive charges along 
their length and are thus less able to interact with the negatively charged residues which 
reside in the MET channel. A patent for these antibiotics was secured (Huth et al., 2015).  The 
large scale potential of using zebrafish for initially screening for compounds which protect 
against aminoglycoside induced ototoxicity (Owens et al., 2008), makes this a very viable 
option. Once narrowed down, selected candidates can be assessed on cochlear cultures and 
their competitive blocking of the MET channel as well as the characteristics of the block can be 
assessed using electrophysiological techniques. 
 
Streptomycin and dihydrostreptomycin have been estimated to have a diameter of 1.04 nm, 
gentamicin a diameter of 0.98 nm and neomycin a diameter of 0.96 nm (Alharazneh et al., 
2011) and are thus able to pass through the MET channel. It has been found that 
aminoglycoside antibiotics, FM1-43 and a host of other compounds are MET channel blockers 
(Gale et al., 2001; Marcotti et al., 2005) and thus MET channels are considered to be necessary 
for entry of these compounds into the hair cells and the subsequent ototoxic effects (Marcotti 
et al., 2005; Alharazneh et al., 2011). However, the question as to whether there are other 
facilitators for the entry of these compounds, such as via TRPA1 channels, remains (Stepanyan 
et al., 2011). Many possible routes of entry have been proposed including entry directly 
through nerve terminals which are adjacent to the hair cells (Alharazneh et al., 2011). Another 
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proposed method of entry is via endocytosis as both the apical and basolateral membrane of 
cochlear hair cells have been found to contain endocytotic pathways (Lim, 1986, ; Hashino and 
Shero, 1995).  Whilst these other routes of entry may play a small role in the accumulation of 
aminoglycoside antibiotics in cochlear hair cells, the MET channel is clearly the main route of 
entry (Marcotti et al., 2005). 
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FIGURE 4-1 - Endotoxemia potentiates aminoglycoside ototoxicity via increased 
vasodilation 
 
 
 
 
 
 
 
 
 
 
Figure 4-1 : Endotoxemia potentiates aminoglycoside ototoxicity via increased 
vasodilation. The polycationic aminoglycosides enter through the endothelial cells 
which line capillary walls via an as yet unknown mechanism, against the electrical 
gradient of +90 mV of the blood-labyrinth-barrier, then move across marginal cells 
into the endolymph. Once they have crossed the endolymphatic space to where 
the hair cells are located, they are able to enter into them via the MET channels 
atop the stereocilia. From Kros and Desmonds (2015). 
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4.2 Competitive MET channel blockers 
 
The stryl dye FM1-43, due to its small dimensions (0.78 x 0.5 nm (Gale et al., 2001)) has been 
demonstrated to enter into hair cells, gaining rapid access via the MET channel in an open 
state and acting as a permeant channel blocker Gale et al., (2001), as well as entering many 
other types of sensory cell through non-selective ion channels (Meyers et al., 2003). As well as 
this FM1-43 has been shown to enter hair cells via other ion channels (Meyers et al., 2003). 
This entry and subsequent labelling is only evident in sensory cells and thus appears to require 
a specifically sensory entry point such as the MET channel. Further, the labelling is prolonged 
and sustained after washing the drug out (Gale et al., 2001 ; Meyers et al., 2003; Marcotti et 
al., 2005; Goodyear et al., 2008). FM1-43 is not ototoxic, at least at the levels previously 
tested. It has a KD of 1.2 µM at a holding potential of 0 mV and has been demonstrated to offer 
protection against aminoglycoside induced ototoxicity in vivo (Gale et al., 2001). 
 
The ideal channel blocker to compete with ototoxic aminoglycosides would have a high affinity 
for the MET channel, would not be ototoxic and would also be a blocker which does not 
permeate through the channel. Annexin V is a calcium-dependent phospholipid binding 
protein with anticoagulant properties which selectively binds to negatively charged PS. If 
applied externally to the apical surface of hair cells in the cochlea, the binding of annexin V 
indicates that PS is present on the outer leaflet of the cell membrane. Annexin V can be used 
to detect apoptosis of certain cell types (Vermes et al., 1995). Thus, using Annexin V, can assist 
in assessing the suitability of a compound for competitive blocking potential based on 
assessing its potential to damage hair cells, using real time using fluorescence imaging 
(Goodyear et al., 2008). DHS causes rapid and reversible PS-externalisation and blebbing in 
cochlear hair cells, indicative of the damage occurring. However, PS-externalisation in cochlear 
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hair cells does not necessarily indicate that they are undergoing apoptosis as externalisation 
occurs very rapidly and can be reversible (Goodyear et al., 2008).  
 
4.3 Cell penetrating peptides, D-TAT and D-JNKi1 
 
4.3.1 The molecular structure of D-TAT and D-JNKi1  
 
D-TAT is a 12-amino acid peptide (MW 1590 Da) containing 8 potentially positively charged, 
basic amino acids. An inhibitor of Jun c N-terminal kinase, D-JNKi1 (MW 3822 Da), which is the 
D-retro inverso form of L-JNKi1 consisting of D-amino acids in reversed sequence, comprises 19 
amino acids (4 of which are basic) from the human JNK inhibitory protein, coupled with 
D-HIV-TAT (making a total of 12 basic amino acids) (FIGURE 4-2).  
With D-TAT measuring in at 30 Å and D-JNKi1 at a much larger 80 Å in length, both with more 
modestly sized end-on diameters of 15 Å; these peptides are sizeable when compared with the 
largest published MET channel blockers to date. Especially where D-JNKi1 was concerned, 
these peptides seemed somewhat unlikely to be able to act as permeant blockers of the MET 
channel. However, the polycationic elongated structure of D-TAT and D-JNKi1 appears to allow 
them both to be drawn into and permeate the MET channel, in a voltage dependent manner, 
as I will demonstrate.  
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FIGURE 4-2 Molecular models of D-TAT, D-JNKi1 
 
 
By Prof Simon Ward, University of Sussex (2012). 
 
D-TAT sequence: H-PP-RRRQRRKKRG-NH2 (MWt 1589.5 Da) 
D-JNKi1 sequence: H-DQSRPVQPFLNLTTPRKPR-PP-RRRQRRKKRG-NH2 (MWt: 3822.3 Da) 
 
 
 
 
FIGURE 4-2 : Modelled molecular structures of D-TAT and D-JNKi1 - Long polycationic 
structures illustrated. Blue = nitrogen, indicating a basic amino acid, red = oxygen, 
indicating a neutral amino acid in this instance. 
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4.3.2 Cell penetrating peptide routes of entry into cells 
 
The routes of entry of CPPs such as HV-TAT into cells have been widely debated and, whilst 
several routes of entry have been found, much conflicting evidence exists. Mechanisms of 
uptake of the TAT sequence other than endocytosis have been posited, as it can be 
internalised at 4˚ C (Vivès et al., 1997), a temperature at which endocytosis cannot occur 
(Silhol et al., 2002). However, it was subsequently found that endocytosis can facilitate entry 
(Richard et al., 2005). It has been postulated TAT may instead enter cells via direct 
translocation through the cell surface membrane (Vivès et al., 1997). Interaction with cell 
surface glycosaminoglycans (GAGs) is potentially thought to be involved in the translocation of 
some CPPs (Ziegler, 2008). Creation of a transient pore in the membrane has also been 
recently proposed. This would involve interaction with positively charged phosphate groups, 
which would cause a transient change in the cell surface membrane and the creation of the 
pore, allowing the diffusion of CPPs into the cell along the surface of the transient pore (Herce 
and Garcia, 2007). 
 
4.3.3 Clinical significance 
 
There is mounting interest in the therapeutic potential of cell penetrating peptides such as 
D-TAT for drug delivery (Zhang et al., 2012). However, there is now evidence that some 
retro-inverso cell penetrating peptides are toxic, thus clinical suitability must be carefully 
scrutinised (Holm et al., 2011). Studies have been conducted on D-JNKi1 (also known by the 
names XG-102 and AM-111) to evaluate its efficacy at treating several conditions caused by 
inhibiting the apoptosis caused by the JNK signalling pathway. D-JNKi1 has been demonstrated 
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to offer protective effects against colitis (Reinecke et al., 2012) and severe cerebral ischemia 
(Hirt et al., 2004). 
In guinea pigs, Eshraghi et al. (2006) asserted that D-JNKI1 prevents trauma-induced delayed 
hearing loss caused by cochlear implantation. Auditory brainstem response (ABR) thresholds 
are measurements of auditory evoked potentials in the brain taken using electrodes attached 
to the head. Distortion product otoacoustic emissions (DPOAE) are a measure of resultant 
distortion products emanating from the cochlea, after two simultaneous pure tone stimuli are 
presented. Having recorded these as reliable measures of the effects of the trauma, they 
found that the characteristic further decrease in DPOAE amplitudes and increase of auditory 
brainstem response (ABR) thresholds after initial trauma, were prevented. Omotehara et al. 
(2011) measured ABR changes in gerbils treated with 100 µM AM-111, which were subjected 
to transient cochlear ischemia, and found that cochlear damage was significantly reduced. 
It has been proposed that D-JNKi1 can protect against the ototoxic effects of aminoglycoside 
antibiotics (Wang et al., 2003), by interfering with the MAPK-JNK signalling pathway, 
preventing the binding of JNK to c-Jun by directly competing with it and thus preventing cell 
death (Bonny et al., 2001) or, as I have explored, by acting as a blocker of the MET channel, 
competing for entry with aminoglycosides. In 2003, a patent was obtained by Bonny for “cell-
permeable peptides that bind to JNK proteins and inhibit JNK-mediated effects in 
JNK-expressing cells” based on the data they acquired in guinea pigs which suggested 
protection against noise induced hearing loss was offered by these compounds.  
In 2007, Suckfuell et al. conducted a phase I/II study on 11 patients who had received noise 
exposure and thus acoustic trauma less than 24 hours before treatment. They were subjected 
to intratympanic treatment with 0.4 mg/ml or 2 mg/ml AM-111 (D-JNKi1). Suckfuell et al. 
(2007) noted that, based on pure tone audiometry, which helps to determine threshold 
hearing levels by the response of the subject to pure tone stimuli, and DPOAE readings, there 
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appeared to be a therapeutic effect offered by AM-111. However, they did also note some 
adverse effects, although they state that none of these were serious (Suckfuell et al., 2007). A 
follow up, larger phase II study (Suckfuell et al., 2014) was conducted on male and female 
human subjects between the ages of 18 and 60 with acute sensorineural hearing loss (at least 
30 dB and occurring no later than 48 hours prior to treatment). 0.25 ml AM-111 was 
administered on day 0, through intratympanic injection and again a higher 2 mg/ml and a 
lower 0.4 mg/ml dose were used on different patient cohorts in order to see if any effects 
were concentration dependent. This study was more comprehensive and involved a greater 
number of patients (n = 92); however, they did not find any statistically significant difference 
between the recovery of the placebo, low dose or high dose groups. In fact, when they 
quantified the least square means of the three groups, the recovery of the placebo group 
(24 dB) was better than that of the high dose group (22.5 dB). The recovery of the low dose 
group was slightly improved at 27 dB. This is interesting as it potentially points towards a 
therapeutic window, where negative effects are incurred at higher concentrations. They 
additionally note that further exploratory analyses revealed that in the low dose group 
recovery occurred more quickly and tinnitus remission in the patients in this group was 
reported more frequently than in controls. Whilst they state that there did appear to be a 
degree of recovery offered by AM-111, they admit that they did not find a great level of 
consistency in their results. They do mention, however, that AM-111 appears safe and well 
tolerated (Suckfuell et al., 2014). Another study found that XG-102 (D-JNKi1) was safe and well 
tolerated when intravenously infused into male volunteers (Deloche et al., 2014).  
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4.4 Results  
4.4.1 D-JNKi1 and D-TAT cause PS externalisation in treated cochlear 
cultures 
 
Cochlear cultures were treated with 5 µM D-TAT or D-JNKi1. Fluorescent Alexa 488 conjugated 
annexin V binding (added at a dilution of 1:50) was used to probe PS externalisation in hair 
cells, with PS presence on the outer leaflet of the plasma membrane of the cells indicating cell 
damage. A Zeiss AxioPlan II light microscope with a water-immersion lens was used for live 
imaging (see Goodyear et al., 2008). After 20 minutes of exposure to one of the compounds, 
the coverslips with the adherent cultures were fixed, preblocked and permeablised and then 
labelled with rabbit anti-Alexa Fluor 488 IgG at a dilution of 1:100 overnight, to increase the 
fluorescent signal. Texas Red phalloidin at 1:300 was also applied and left overnight to a make 
cell junctions visible. Then the secondary antibody, Alexa Fluor 488-goat anti-rabbit IgG, was 
added. Images of the whole coils were then captured using the light microscope and images 
different cellular levels were also obtained using a LSM 510 Meta confocal microscope with an 
oil-immersion lens. 
The preliminary data (n = 2 for each condition) presented here showed that, at a concentration 
of 5 µM, D-TAT caused PS-externalisation in 83% of OHCs in apical cochlear cultures and in 
97% of OHCs in basal cochlear cultures. At a concentration of 5 µM, D-JNKi1 causes PS-
externalisation in 27% of OHCs in apical cochlear cultures and 85% of OHCs in basal cochlear 
cultures (TABLE 3, FIGURE 4-3). D-TAT caused fairly uniform labelling of externalised PS in IHCs 
and OHCs from apex to base (FIGURE 4-3 A, C). D-JNKi1 caused greater labelling in basal OHCs, 
with increasingly sparse labelling towards the apical end of the coil. IHC labelling remained 
more consistent but also was not evident for the most apical cells (FIGURE 4-3 B, D).  
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   OHCs externalising PS Culture 1 –  
Number of OHCs 
Culture 2 – 
Number of OHCs 
Total OHCs % of total 
Apical coil total 1620 1570 1595 ± 25 N/A 
Basal coil total 
 
830 880 855 ± 25 N/A 
D-TAT in apical coil  
 
1388 1258 1323 ± 65 83% 
D-TAT in basal coil 
 
835 823 829 ± 6  97% 
D-JNKi1 in apical coil 
 
442 420 431 ± 11 27% 
D-JNKi1 in basal coil 
 
737 717 727 ± 10 85% 
 
TABLE 3 - Percentage of OHCs externalising PS in apical and basal cochlear cultures 
 
The number of OHCs in two cultures from the apical cochlear coil and two cultures from the 
basal coil were counted and divided by two to obtain an average number of OHCs in each of 
these regions. Then the number of OHCs fluorescing due to Alexa 488 conjugated annexin V 
binding to externalised PS were counted. For each cell, a grey level reading was obtained using 
the Histogram tool in Photoshop CS2 and a given cell was only counted if it reached above this 
threshold (see METHODS section 2.5). This again was measured in two cultures for each 
condition and averaged. These values were then used to obtain the percentage of cells 
externalising PS in a given condition, n = 2 for all conditions ± S.E.M. 
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FIGURE 4-3 - Phosphatidyl serine externalisation in cochlear 
 
 
 
FIGURE 4-3 : Phosphatidylserine externalisation in cochlear. Annexin V labelled cochlear 
cultures treated with D-TAT or D-JNKi1 - 10x magnification light micrograph montage of 
images  taken using a light microscope. 5 µM D-TAT (a, c), 5 µM D-JNKi1 (b, d) treated 
apical (a, b) basal (c, d) cochlear coil sections. D-TAT causes externalisation of PS in hair 
cells further towards the apical end of the cochlear culture (a) than D-JNKi1 (b). Blue 
squares indicate the mid-apical regions and mid-basal regions are indicated by red 
squares. Arrows indicate the ends of the apical cochlear cultures. 
 
a b 
c d 
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4.4.2 Texas Red conjugated D-JNKi1 and Texas Red conjugated 
D-TAT load into hair cells 
 
Texas red conjugated D-TAT (TR D-TAT) and D-JNKi1 (TR D-JNKi1) were used, in the same 
procedure described in section 4.4.1 and in the METHODS section for D-TAT and D-JNKi1. After 
the compounds were washed out of the bath after 20 minutes of exposure, the adherent 
cultures were fixed. The use of these fluorescent conjugated compounds and confocal 
microscopy allowed for visualisation of them loading into hair cell bodies (FIGURE 4-4). Both 
compounds did load into hair cells and the loading was consistent with the PS externalisation 
data. Loading was greater in basal OHCs treated with TR D-TAT or TR D-JNKi1. The greatest 
level of TR D-TAT loading occurred in basal OHCs (FIGURE 4-4, f), there was somewhat less 
loading evident in mid-apical OHCs (FIGURE 4-4, d) and less again in OHCs at the apical end of 
the cochlea (FIGURE 4-4, b). TR D-JNKi1 loading followed a similar pattern, decreasing from 
base (FIGURE 4-4, e) to mid-apex (FIGURE 4-4, c), but with a greater distinction between apical 
and basal OHCs. TR D-JNKi1 did not load into the apical end region of the cochlea cultures 
(FIGURE 4-4, a) as with the pattern of PS externalisation where D-JNKi1 was applied 
(FIGURE 4-3, b). This makes sense based on the large and even larger dimensions of D-JNKi1 
and TR D-JNKi1 respectively, if apical OHC MET channels are smaller in dimension than basal 
OHCs. 
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FIGURE 4-4 - Texas Red conjugated D-TAT and D-JNKi1 loading into 
hair cells 
 
 
FIGURE 4-4 : Texas Red conjugated D-TAT and D-JNKi1 loading into the hair cells. Confocal 
micrographs, at the OHC nuclear level: 5 µM TR D-JNKi1 (a, c, e), 5 µM TR D-TAT (b, d, f), the 
apical end region (a, b), the mid-apical region (c, d), the mid-basal region (e, f). The row of 
IHCs and the three rows of OHCs are labelled. 
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4.4.3 D-TAT and D-JNKi1 block mechano-electrical transduction in 
apical and basal outer hair cells in a reversible, concentration and 
voltage dependent manner 
 
OHCs were whole cell patch clamped and a 45 Hz sinusoidal force stimulus was used to elicit 
MET currents. Currents were recorded before and during the application of D-TAT and D-JNKi1 
at concentrations ranging from 3 nM to 1 µM. In 65% of cells, where a recording had been 
made before and during the application of a given compound, I was then able to take a 
recording where either partial or full washout of the drug was achieved. This was not possible 
in all cells as sometimes the seal onto the cell was lost before a recording during washout of 
the compound could be made. Both D-JNKi1 and D-TAT, in spite of their cumbersome size, do 
block the MET channel. This block, increases with the concentration of the compound used 
(FIGURE 4-5, 4-6, 4-7, 4-8, 4-9, 4-10). For both compounds the block is also reversible, as upon 
superfusing a control solution onto the OHCs, these compounds can be washed out of the 
channel (FIGURE 4-11). The degree to which MET current flow is inhibited by different 
concentrations of the compounds is dependent upon the membrane potential (FIGURE 4-12, 
4-13, 4-14). Current-voltage (IV) curves (FIGURE 4-12) were normalised to represent a 
proportion of the control MET current (averaged from all controls across all conditions), in 
order to eliminate the influence of MET current variation on the size of the currents illustrated.  
4.4.4 D-JNKi1 and D-TAT are permeant MET channel blockers as block 
is reduced at positive and extreme negative potentials 
 
MET channel block by D-TAT is increasingly completely released at positive potentials due to 
its polycationic structure causing it to be repelled from the channel. The block increases at 
negative potentials, with maximum block occurring at a membrane potential of -104 mV 
(FIGURE 4-13). Similarly D-JNKi1 increasingly reduces MET current size at more negative 
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holding potentials until maximum reduction is reached at -104 mV. D-JNKi1 block is also 
increasingly released at positive membrane potentials but to a lesser extent than of D-TAT, 
with release of block being less evident with increasing concentrations (FIGURE 4-13). This is 
probably due to the additional basic amino acids (potentially positive charges) along its length, 
in addition to its cumbersome size, making it less likely to be dislodged from the MET channel 
pore. 
For both peptides, a partial release of block is evident at extreme negative potentials, lower 
than -104 mV. This so called ‘punch-through’ effect (van Netten et al., 2007) indicates that the 
channel is being cleared by D-TAT or D-JNKi1 being pulled into the hair cells due to the highly 
negative driving force pulling the polycationic molecules into the intracellular space. This is the 
hallmark of a permeant channel block (FIGURE 4-13, 4-14).  
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FIGURE 4-5 - Block of apical and basal OHC MET currents by 3 nM 
D-TAT or 3 nM D-JNKi1 
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FIGURE 4-5 : Block of apical and basal OHC MET currents by 3 nM D-TAT or 3 nM 
D-JNKi1. A, B, D, E, G, H, J, K, MET currents recorded from apical (A, B, G, H) and basal (D, 
E, J, K) P2 CD-1 OHCs before and during superfusion with a solution containing 3 nM D-TAT 
(A, B, D, E) or 3 nM D-JNKi1 (G, H, J, K). Membrane potential stepped between -164 mV 
and +96 mV in 20 mV increments from a holding potential of -84 mV. Half the voltage 
steps used are shown for clarity (-144, -104, -64, -24, +16, +56, +96 mV). Driver voltage (45 
Hz sinusoid, 40 V amplitude) plotted above the current traces. C, F, I, L, Average 
current-voltage curves of apical (C, I) and basal (F, L) OHCs before and during superfusion 
of a solution containing 3 nM D-TAT (C, F) and 3 nM D-JNKi1 (I, L). Numbers of cells C:5, 
F:3, I:3, L:3. 
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FIGURE 4-6 - Block of apical and basal OHC MET currents by 10 nM 
D-TAT or 10 nM D-JNKi1 
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FIGURE 4-6 : Block of apical and basal OHC MET currents by 10 nM D-TAT or 10 nM D-
JNKi1. A, B, D, E, G, H, J, K, MET currents recorded from apical (A, B, G, H) and basal (D, 
E, J, K) P2 CD-1 OHCs before and during superfusion with a solution containing 10 nM 
D-TAT (A, B, D, E) or 10 nM D-JNKi1 (G, H, J, K). Membrane potential stepped 
between -164 mV and +96 mV in 20 mV increments from a holding potential of -84 mV. 
Half the voltage steps used are shown for clarity (-144, -104, -64, -24, +16, +56, +96 mV). 
Driver voltage (45 Hz sinusoid, 40 V amplitude) plotted above the current traces. C, F, I, 
L, Average current-voltage curves of apical (C, I) and basal (F, L) OHCs before and during 
superfusion of a solution containing 10 nM D-TAT (C, F) and 10 nM D-JNKi1 (I, L). 
Numbers of cells C:4, F:2, I:3, L:4. 
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FIGURE 4-7 - Block of apical and basal OHC MET currents by 30 nM 
D-TAT or 30 nM D-JNKi1 
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FIGURE 4-7 : Block of apical and basal OHC MET currents by 30 nM D-TAT or 30 nM 
D-JNKi1. A, B, D, E, G, H, J, K, MET currents recorded from apical (A, B, G, H) and basal (D, 
E, J, K) P2 CD-1 OHCs before and during superfusion with a solution containing 30 nM D-
TAT (A, B, D, E) or 30 nM D-JNKi1 (G, H, J, K). Membrane potential stepped between -164 
mV and +96 mV in 20 mV increments from a holding potential of -84 mV. Half the voltage 
steps used are shown for clarity (-144, -104, -64, -24, +16, +56, +96 mV). Driver voltage 
(45 Hz sinusoid, 40 V amplitude) plotted above the current traces. C, F, I, L, Average 
current-voltage curves of apical (C, I) and basal (F, L) OHCs before and during superfusion 
of a solution containing 30 nM D-TAT (C, F) and 30 nM D-JNKi1 (I, L). Numbers of cells C:5, 
F:3, I:4, L:5. 
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FIGURE 4-8 - Block of apical and basal OHC MET currents by 
100 nM D-TAT or 100 nM D-JNKi1 
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FIGURE 4-8 : Block of apical and basal OHC MET currents by 100 nM D-TAT or 
100 nM D-JNKi1. A, B, D, E, G, H, J, K, MET currents recorded from apical (A, B, G, H) 
and basal (D, E, J, K) P2 CD-1 OHCs before and during superfusion with a solution 
containing 100 nM D-TAT (A, B, D, E) or 100 nM D-JNKi1 (G, H, J, K). Membrane 
potential stepped between -164 mV and +96 mV in 20 mV increments from a holding 
potential of -84 mV. Half the voltage steps used are shown for clarity (-144, -104, -64, 
-24, +16, +56, +96 mV). Driver voltage (45 Hz sinusoid, 40 V amplitude) plotted above 
the current traces. C, F, I, L, Average current-voltage curves of apical (C, I) and basal 
(F, L) OHCs before and during superfusion of a solution containing 100 nM D-TAT (C, F) 
and 100 nM D-JNKi1 (I, L). Numbers of cells C:14, F:6, I:5, L:8. 
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FIGURE 4-9 - Block of apical and basal OHC MET currents by 
300 nM D-TAT or 300 nM D-JNKi1 
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FIGURE 4-9 : Block of apical and basal OHC MET currents by 300 nM D-TAT and 300 nM 
D-JNKi1. A, B, D, E, G, H, J, K, MET currents recorded from apical (A, B, G, H) and basal (D, 
E, J, K) P2 CD-1 OHCs before and during superfusion with a solution containing 300 nM D-
TAT (A, B, D, E) or 300 nM D-JNKi1 (G, H, J, K). Membrane potential stepped between -164 
mV and +96 mV in 20 mV increments from a holding potential of -84 mV. Half the voltage 
steps used are shown for clarity (-144, -104, -64, -24, +16, +56, +96 mV). Driver voltage (45 
Hz sinusoid, 40 V amplitude) plotted above the current traces. C, F, I, L, Average 
current-voltage curves of apical (C, I) and basal (F, L) OHCs before and during superfusion 
of a solution containing 100 nM D-TAT (C, F) and 100 nM D-JNKi1 (I, L). Numbers of cells 
C:14, F:6, I:6, L:10. 
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FIGURE 4-10 - Block of apical and basal OHC MET currents by 1 µM 
D-TAT or 1 µM D-JNKi1 
 
 
 
100 
 
 
 
FIGURE 4-10 : Block of apical and basal OHC MET currents by 1 µM D-TAT and 1 µM 
D-JNKi1. A, B, D, E, G, H, J, K, MET currents recorded from apical (A, B, G, H) and basal (D, 
E, J, K) P2 CD-1 OHCs before and during superfusion with a solution containing 1 µM D-TAT 
(A, B, D, E) or 1 µM D-JNKi1 (G, H, J, K). Membrane potential stepped between -164 mV 
and +96 mV in 20 mV increments from a holding potential of -84 mV. Half the voltage 
steps used are shown for clarity (-144, -104, -64, -24, +16, +56, +96 mV). Driver voltage (45 
Hz sinusoid, 40 V amplitude) plotted above the current traces. C, F, I, L, Average 
current-voltage curves of apical (C, I) and basal (F, L) OHCs before and during superfusion 
of a solution containing 1 µM D-TAT (C, F) and 1 µM D-JNKi1 (I, L). Numbers of cells C:8, 
F:5, I:5, L10. 
 
101 
 
FIGURE 4-11 - Block and washout of 1 µM D-TAT or 1 µM D-JNKi1 
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FIGURE 4-11 : Block and washout of 1 µM D-TAT or 1 µM D-JNKi1. MET currents from P2 
CD-1 OHC before (A, D), during (B, E) and after (C, F) superfusion with a solution 
containing 1 μM D-TAT and 1 µM D-JNKi1. Membrane potential stepped between -164 mV 
and +96 mV in 20 mV increments from a holding potential of -84 mV. Driver voltage (45 
Hz sinusoid, 40 V amplitude) plotted above the current traces.  
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FIGURE 4-12 - Current-voltage curves plotted at concentrations 
from 3 nM – 1 µM D-TAT or D-JNKi1 in OHCs 
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FIGURE 4-12 : A, B, C, D, Current-voltage curves plotted at concentrations from 
3 nM – 1 µM D-TAT or D-JNKi1 in OHCs. Apical D-TAT (A), Basal D-TAT (B), Apical 
D-JNKi1 (C), Basal D-JNKi1 (D). MET Currents and S.E.M. were normalised to 
represent a proportion of the averaged control current presented (from all control 
cells for a given condition e.g. apical D-TAT) as opposed to the averaged control for 
each concentration. N-numbers: Apical D-TAT: control: 42 , 3 nM: 5, 10 nM: 4, 30 
nM: 5, 100 nM: 14, 300 nM: 14, 1 µM: 8. Basal D-TAT: control: 25, 3 nM: 3, 10 nM: 
2, 30 nM: 3, 100 nM: 6, 300 nM: 6, 1 µM: 5. Apical D-JNKi1: control: 26, 3 nM: 3, 10 
nM: 3, 30 nM: 4, 100 nM: 5, 300 nM: 6, 1 µM: 5. Basal D-JNKi1: control: 34, 3 nM: 3, 
10 nM: 4, 30 nM: 7, 100 nM:  8, 300 nM 10:, 1 µM: 4.  
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FIGURE 4-13 - Fractional block of OHC MET currents by D-TAT 
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FIGURE 4-13 : Fractional block of OHC MET currents by D-TAT. A, B, MET currents as a 
fraction of the current in the control solution recorded from apical (A) and basal (B) 
OHCs before and during superfusion with D-TAT at concentrations from 3 nM to 1 µM. 
Numbers of cells from low to high concentrations A:6,4,5,14,14,8, B: 3,2,3,6,6,7. Fitted 
curves plotted according to equations (1) and (2) in Marcotti et al. (2005). 
 
107 
 
FIGURE 4-14 - Fractional block of OHC MET currents by D-JNKi1 
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FIGURE 4-14 : Fractional block of OHC MET currents by D-JNKi1. A, B, MET currents as a 
fraction of the current in the control solution recorded from apical (A) and basal (B) 
OHCs before and during superfusion with D-JNKi1 at concentrations from 3 nM to 1 µM. 
Numbers of cells from low to high concentrations A:8,4,5,8,8,7, B:3,4,7,8,10,4. Fitted 
curves plotted according to equations (1) and (2) in Marcotti et al. (2005). 
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4.4.5 There is a clear apical to basal gradient in the MET channel 
block caused by D-JNKi1 but not D-TAT 
 
D-JNKi1 causes PS externalisation up to the middle of the apical coil (FIGURE 4-3 b) and the 
loading of TR D-JNKi1 also follows this pattern (FIGURE 4-4 c). Compatible with this D-JNKi1 
shows a variable level of permeant block of the MET channel of a given OHC dependent upon 
its position along the cochlea. At -104 mV the D-JNKi1 KD in apical OHCs is 12 nM, considerably 
lower compared with apical OHCs with a KD of 61 nM, probably due to increased affinity of the 
peptide for the basal channel vestibule. Conversely, the KD of D-TAT is 27 nM in both apical and 
basal OHCs (FIGURE 4-15) but there does appear to still be a gradient in TR D-TAT loading 
(FIGURE 4-4 d, f). 
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FIGURE 4-15 Dose response curves at -104 mV 
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FIGURE 4-15 : Dose-response curves at -104 mV, illustrating block of apical and basal OHC 
MET currents by D-TAT and D-JNKi1. D-TAT treated mid-apical OHCs: red open symbols 
fitted with red dashed line fitted to the Hill equation (see Materials and Methods), KD = 27 
± 6 nM and nH = 0.59 ± 0.08. Number of cells from left to right: 3 nM (n = 5), 10 nM (n = 4), 
30 nM (n = 5), 100 nM (n = 14), 300 nM (n = 14), 1 µM (n = 8). D-TAT treated mid-basal 
OHCs: red closed symbols fitted with continuous line to the Hill equation, KD = 27 nM ± 10 
and nH = 0.55 ± 0.12. Number of cells from left to right: 3 nM (n = 3), 10 nM (n = 2), 30 nM 
(n = 3), 100 nM (n = 6), 300 nM (n = 6), 1 µM (n = 5). D-JNKi1 treated mid-apical OHCs: blue 
open symbols fitted with blue dashed line to the Hill equation, with KD = 61 nM ± 10 and nH 
= 1.03 ± 0.15. Number of cells from left to right: 3 nM (n = 3), 10 nM (n = 3), 30 nM (n = 4), 
100 nM (n = 5), 300 nM (n = 6), 1 µM (n = 5). D-JNKi1 treated mid-basal OHCs: blue closed 
symbols fitted with blue continuous line to the Hill equation, with KD = 12 nM ± 2 and nH = 
1.07 ± 0.13. Number of cells from left to right: 3 nM (n = 3), 10 nM (n = 4), 30 nM (n = 5), 
100 nM (n = 8), 300 nM (n = 10), 1 µM (n = 4). The KDs of D-TAT in mid-apical and mid-basal 
OHCs were not significantly different. The KDs of D-TAT in mid-apical and mid-basal OHCs 
were significantly different as calculated by looking at the upper and lower limits at a 
confidence interval of 95%, no overlap in the range of two sets of values from the lower to 
upper limit indicating a statistically significant difference of p < 0.05. 
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4.4.6 D-TAT has fairly uniform negative cooperativity with its binding 
site and the cooperativity of D-JNKi1 is neutral at negative membrane 
potentials. 
 
The KDs for D-TAT and D-JNKi1, fitted with equation (1), were evidently voltage dependent 
(FIGURE 4-13, 4-14, 4-16, 4-17, 4-18, 4-19). The Hill coefficients for D-TAT in both apical and 
basal OHCs, at voltages -164 mV through -64 mV, varied very little from 0.49 – 0.64, all 
showing negative cooperativity (FIGURE 4-16, 4-17). The Hill coefficients for D-JNKi1 in apical 
and basal OHCs measured at membrane potentials from -164 mV to -64 mV, remained steadily 
neutrally cooperative (near 1) ranging between 0.87 and 1.03 in apical OHCs (FIGURE 4-17) and 
1.01 and 1.09 in basal OHCs (FIGURE 4-18).  
A two-barrier one-binding-site model has been used to fit the data, based on the 
concentration and voltage dependent nature of D-TAT and D-JNKi1, yielding an energy profile 
for the two peptides (FIGURE 4-20). The energy profile for basal D-JNKi1 has a binding site with 
a relative electrical distance from the extracellular side of 0.40, with an energy well at the 
binding site of -16.50 kT below the free energy of the minima (at the intracellular and 
extracellular spaces surrounding the channel). This is slightly greater in electrical distance from 
the extracellular side than the binding site for apical D-JNKi1 (0.28), which additionally has less 
deep energy well at -15.50 kT. The profiles of D-TAT have a binding site with a greater relative 
electrical distance from the extracellular side than D-JNKi1 of 0.78 in apical OHC MET channels 
and 0.66 in basal OHCs. Moreover, the binding sites have a far shallower energy well 
of -5.52 kT in apical OHCs and -5.64 kT in basal OHCs. The profile for apical and basal D-TAT is 
very similar with the first energy barrier at a distance of 0 from the extracellular side: 15.20 kT 
in the apical and 15.90 kT in basal OHCs, and the second energy barriers at a distance of 1: 
21.60 kT in the apical OHCs and 21.80 kT in the basal OHCs. There is a distinct difference 
between the height of the energy barriers in the profiles of D-JNKi1 in apical and basal OHC 
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MET channels. The energy profile for apical D-JNKi1 has noticeably higher barriers with more 
free energy. For apical D-JNKi1 the height of the first barrier (again at 0) is 11.60 kT and the 
height of the second (also at 1) is 18.20 kT and for basal D-JNKi1 it is 8.95 kT and 14.55 kT 
respectively, with noticeably less free energy.  
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FIGURE 4-16 - Average KD and nH for D-TAT treated apical OHCs 
plotted as a function of membrane potential 
 
 
 
 
 
FIGURE 4-16 : Average KD and nH for D-TAT treated apical OHCs plotted as a function of 
membrane potential from -164 mV to -64 mV, including those shown at -104 mV in 
FIGURE 4-15. Number of cells that went into each dose-response curve used for obtaining 
the KDs and nHs (Hu):  3 nM (n = 5), 10 nM (n = 4), 30 nM (n = 5), 100 nM (n = 14), 300 nM 
(n = 14), 1 µM (n = 8).  At -164: KD = 142 ± 25,  nH = 0.51 ± 0.07. -144: KD =  88 ± 14,  nH = 
0.60 ± 0.08. -124: KD = 45 ± 10, nH = 0.57 ± 0.08.- 104: KD = 27 ± 6, nH = 0.59 ± 0.08, -84: KD 
= 49 ± 10, nH = 0.64 ± 0.08. -64: KD = 190 ± 45, nH = 0.53 ± 0.10. The fit through the KD data 
points is according to equation (1). 
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FIGURE 4-17 - Average KD and nH for D-TAT treated basal OHCs 
plotted as a function of membrane potential 
 
 
 
 
 
 
FIGURE 4-17 : Average KD and nH for D-TAT treated basal OHCs plotted as a function of 
membrane potential, from -164 mV to -64 mV, including those shown at -104 mV  in 
FIGURE 4-15. Number of cells that went into each dose-response curve used for 
obtaining the KDs and nHs (Hu):  3 nM (n = 3), 10 nM (n = 2), 30 nM (n = 3), 100 nM (n = 6), 
300 nM (n = 6), 1 µM (n = 5). At -164: KD = 154 ± 49 ,  nH = 0.64 ± 0.17. -144: KD = 87 ± 28 ,  
nH = 0.59 ± 0.14. -124: KD = 48 ± 21 ,  nH = 0.57 ± 0.13.- 104: KD = 27 ± 10,  nH = 0.55 ± 0.12, 
-84: KD = 31 ± 11,  nH = 0.60 ± 0.13 -64: KD = 69 ± 27, nH = 0.51 ± 0.13. The fit through the 
KD data points is according to equation (1). 
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FIGURE 4-18 - Average KD and nH for D-JNKi1 treated apical OHCs 
plotted as a function of the membrane potential 
 
 
 
 
 
 
FIGURE 4-18 : Average KD and nH for D-JNKi1 treated apical OHCs plotted as a function 
of the membrane potential, from -164 mV to -64 mV, including those shown at -104 mV 
in FIGURE 4-15. Number of cells used to create each dose-response curve from which 
measurements of KDs and nHs (Hu) were obtained: 3 nM (n = 3), 10 nM (n = 3), 30 nM 
(n = 4), 100 nM (n = 5), 300 nM (n = 6), 1 µM (n = 5). At -164: KD = 103 ± 18,  nH = 0.89 ± 
0.14. -144: KD = 80 ± 13, nH = 1.02 ± 0.16. -124: KD = 60 ± 9, nH = 0.98 ± 0.13 . - 104: KD = 
61 ± 10, nH = 1.03 ± 0.15, -84: KD = 72 ± 12, nH = 0.94 ± 0.14. -64: KD = 96 ± 13, nH = 0.87 ± 
0.10. The fit through the KD data points is according to equation (1). 
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FIGURE 4-19 - Average KD and nH for D-JNKi1 treated basal OHCs 
plotted as a function of membrane potential 
 
 
 
 
 
 
FIGURE 4-19 : Average KD and nH for D-JNKi1 treated basal OHCs plotted as a function of 
membrane potential, from -164 mV to  -64 mV, including those shown at -104 mV in 
FIGURE 4-15. Number of cells used to create dose response curves for each holding 
potential from which KD and nH (Hu) measurements were obtained: 3 nM (n = 3), 10 nM 
(n = 4), 30 nM (n = 5), 100 nM (n = 8), 300 nM (n = 10), 1 µM (n = 4). At -164: KD = 22 ± 3, 
nH = 1.03 ± 0.13. -144: KD = 16 ± 2, nH = 1.11 ± 0.14. -124: KD = 14 ± 2, nH = 1.06 ± 
0.12. - 104: KD = 12 ± 2, nH = 1.07 ± 0.13, -84: KD = 15 ± 3, nH = 1.09 ± 0.14. -64: KD = 19 ± 3, 
nH = 1.02 ± 0.14. The fit through the KD data points is according to equation (1). 
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FIGURE 4-20 Energy profiles of the two-barrier one-binding site 
model used to describe the blockage and permeation of the hair 
cell transducer channel by D-TAT and D-JNKi1 
 
 
Kros, C. & van Netten, S., unpublished. 
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FIGURE 4-20 : Energy profiles of the two-barrier one-binding site model used to describe 
the blockage and permeation of the hair cell transducer channel by D-TAT and D-JNKi1. 
The energy profiles have been estimated where Vm = 0 mV. The two barriers, one on the 
extracellular side and one on the intracellular side of the MET channel are at a relative 
electrical distance of 0 and 1 measured from the extracellular side. The estimated free 
energies (above the minima free energy level at the intracellular and extracellular sides) of 
the first barrier are as follows: apical D-TAT: 15.20 kT, basal D-TAT: 15.90 kT, apical 
D-JNKi1: 11.60 kT, basal D-JNKi1: 8.95 kT. For the second barrier: apical D-TAT: 21.60 kT, 
basal D-TAT: 22.80 kT, apical D-JNKi1: 18.20 kT, basal D-JNKi1 14.55 kT. Between the two 
barriers lies the D-TAT and D-JNKi1 binding sites, varying based on apical or basal MET 
channel location. These have free energies below the minima of: apical D-TAT: -5.52 kT 
(distance of 0.78), basal D-TAT: -5.64 kT (distance of 0.66), apical D-JNKi1: -15.50 kT 
(distance of 0.28) basal D-JNKi1: -16.50 kT (distance of 0.4). k = Boltzmann factor, 
T = temperature. 
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Equation (2) entry and exit rate constants 
From (van Netten and Kros, 2007). 
Entry rates for D-TAT and D-JNKi1 into apical and basal MET channel isoforms and their energy 
profiles were calculated as described by Van Netten and Kros (2007), an expanded version of 
that used by Marcotti et al. (2005) for DHS entry, in that it allows for Hill coefficients different 
from 1.  
Equation (2) describes the rate of entry into and out of the channel and into and out of the 
cell, in terms of their rate constants. The forward constant k1 describes movement into the 
channel, k2 relates to movement from the channel to the inside of the cell. The reverse rate 
constants describe movement from the inside of the cell into the channel (k-2) and from the 
channel into the extracellular space (k-1).  
 
Compound 
(region) 
E1 (kT) – d1 E2 (kT) – db Eb (kT) – d2 
100 nM 
(1/s) 
1 µM 
(1/s) 
D-TAT (AC) 15.20 – 0.00 21.60 – 1.00 -5.52 – 0.78 1580 2680 
D-TAT (BC) 15.90 – 0.00 22.80 – 1.00 -5.64 – 0.66 1540 2670 
D-JNKi1 
(AC) 
11.60 – 0.00 18.20 – 1.00 -15.50 – 0.28 44 72 
D-JNKi1 
(BC) 
8.95 – 0.00 14.55 – 1.00 -16.50 – 0.40 366 455 
 
TABLE 4 - Energy profile and entry rate data 
E1 = first energy barrier, E2 = second energy barrier, Eb = binding site energy, d = depth.  
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The obtained data for D-TAT and D-JNKi1 block of OHCs were fitted with the two barrier one 
binding site model. Calculations of entry into the cells were based on a driving force of -150 
mV, the physiological driving force across the MET channel, as this is the difference between 
the endocochlear potential (-80 mV) and the resting potential inside of the OHC (-70 mV). The 
rate constants (k1, k2, k-1, k-2) were measured at -84 mV, the potential at which the cells were 
held. To enable calculating k1 time constants of drug block to step responses at the holding 
potential of -84 mV were measured at two concentrations for each drug and cochlear location 
(data collected by Dr N. Kirkwood). The number of channels per hair cell (C) was as calculated 
in Chapter 3 (TABLE 2): 98 in apical OHCS and 77 in basal OHCs, and the popen  value was set 
as 0.3 (Marcotti et al., 2005; Johnson et al., 2011). 
At 1 µM the entry rate of D-TAT is 2680 molecules/s into apical OHCs and marginally less than 
that for basal OHCs (2670/s). D-JNKi1, in consonance with its larger dimensions enters much 
more slowly, with an apical to basal gradient evident, as for the loading of TR D-JNKi1 (FIGURE 
4-4). At an extracellular concentration of 1 µM, D-TAT enters apical OHCs at a rate of 72/s and 
basal OHCs at a rate of 455/s. 
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4.5 Discussion 
4.5.1 D-TAT and D-JNKi1 are both high affinity, voltage dependent, 
permeant blockers of the MET channel 
 
With very low KDs, D-TAT and D-JNKi1 are the highest affinity MET channel blockers profiled to 
date. The block that both of these compounds offer is clearly of a voltage dependent nature. 
As the Texas-Red conjugate loading data illustrate both D-TAT and D-JNKi1 enter into hair cells, 
permeating through the MET channel.  
The voltage dependence of the block is due to the polycationic compounds being sensitive to 
the membrane potential of the cell. Therefore, at very hyperpolarised potentials the MET 
channel may either be fully blocked or the block will be partially released due to the 
compound being pulled through into intracellular space of the hair cell (Woodhull, 1973; 
Marcotti et al., 2005). Entry into the OHCs is further substantiated by the electrophysiological 
evidence of permeant block of the MET channel, as there is a release of block at 
hyperpolarised potentials more negative than -104 mV. Moreover, it is thus clear that the MET 
channel is the primary route of entry taken by these peptides. 
 
4.5.2 A gradient in the MET channel pore properties is apparent and a 
re-estimate of MET channel pore size(s) necessary 
  
The higher affinity of D-JNKi1 relative to D-TAT block in basal OHCs may be due to the 
additional potentially positive charges (basic amino acids) along its length interacting with the 
negatively charged residues within the MET channel vestibule. Moreover, a gradient in the 
properties of the MET channel pore is evident, resulting in a decreasing ability of D-JNKi1 to 
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block the channel and permeate into the OHCs from base to apex. The D-JNKi1 gradient is 
distinct; consistent with the basal vestibule having greater dimensions than that the apical 
vestibule, as is apparent from the energy profile data which yields energy barriers of a 
decreased height for D-JNKi1 in basal OHC MET channels. Similarly, the lower energy barrier at 
the intracellular face of the channel is compatible with the exit from the narrow region of the 
pore into the cell being wider in the MET channels of basal OHCs. This is in agreement with the 
evidence of a corresponding gradient in single channel conductance (Beurg et al., 2006; Kim et 
al., 2013). The energy well of the D-JNKi1 binding site in the basal MET channel is slightly 
deeper (16.50 kT) than that in the apical (15.50 kT) MET channel suggesting that there may be 
a small number of additional positive residues in the basal MET channel vestibule, allowing 
D-JNKi1 to bind more tightly. In turn, this increases the blocking potential of D-JNKi1 in basal 
OHCs, meaning it has a lower KD. However, due to the similarity of the D-JNKi1 binding site 
energy wells in apical and basal OHCs, this is likely to only have a small effect on the increased 
affinity of D-JNKi1 to basal OHC MET channels relative to the heights of the energy barriers. 
An intrinsic difference in susceptibility to free radical damage between apical and basal OHCs 
has been proposed based on the fact that levels of the antioxidant glutathione were lower in 
basal OHCs and the number of surviving cells could be increased by addition of radical 
scavengers (Sha et al., 2001). Early studies indicated that basal OHCs were affected but further 
towards the apex they did not become as damaged by aminoglycosides, additionally IHCs 
appeared to be less susceptible to damage by aminoglycosides than OHCs in vivo in guinea pigs 
(Davis et al., 1958; Ward and Fernandez, 1961; (Brummett et al., 1972); Ylikoski 1973), in mice 
in vitro (Richardson and Russell, 1991) and in humans (Huizing and Groot, 1987). The precise 
defensive mechanism(s) of IHCS that result in this pattern are as yet unknown. Consistent with 
this, IHCs appear to be inherently more resistant to free radical damage (Sha et al., 2001). 
Additionally, it has been found that there is a gradient in susceptibility to aminoglycosides such 
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that the first (innermost) row of OHCs is most affected and the IHCs are relatively resistant 
(Schacht et al., 2012). 
Importantly, due to the large size of D-JNKi1, in light of the finding that it is a permeant blocker 
of the MET channel, a re-estimate the size of the narrow region of the MET channel pore 
seems necessary as the D-TAT end of D-JNKi1 at its widest is 15 Å, larger than the currently 
estimated 12.5 Å (Farris et al., 2004). 
4.5.3 Energy profiles, apical and basal MET channel isoforms 
 
The energy profiles of D-TAT and D-JNKi1 tell us about their interaction with the MET channel 
and reveal that they occupy binding sites in different parts of the channel pore. The electrical 
distance of the binding sites for the two vary sufficiently that this seems a fair assumption, 
given what we currently believe about the structure of the MET channel. The electrical 
distance of the D-JNKi1 binding site is 0.28 in apical cells and 0.40 in basal cells and thus 
D-JNKi1 appears to be binding in the highly electronegative vestibule, whilst the binding site 
for D-TAT is at a distance of 0.78 in apical cells and 0.66 in basal cells and thus seems to occupy 
a binding site nearer the narrow region of the channel pore, further towards the intracellular 
face of the channel. Moreover, the strong binding of D-JNKi1 in the vestibule is illustrated by 
the deep well of free energy at the binding site (FIGURE 4-19).  
 
D-JNKi1 has larger energy barriers of 11.60 kT (E1) and 18.20 kT (E2) in apical OHCs vs 8.95 kT 
(E1) and 14.55 kT (E2) in basal OHCs. The higher barriers impede the ability of D-JNKi1 to enter 
into the MET channel and then to permeate into the channel. This seems to indicate that the 
apical MET channel is smaller than the basal isoform. This is congruent with there being no 
difference in the affinity of D-TAT binding between apex and base, as its smaller dimensions 
and binding in the near the narrow part of the channel pore, mean that the size of the channel 
should intuitively have less effect on its binding affinity.  
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The entry rate of compounds into the hair cells is increasingly limited by energy barriers with 
more free energy and stronger binding sites (van Netten et al., 2007). The limiting factors for 
entry of D-TAT into apical and basal MET channels are similar as heights of the energy barriers 
(E1: 15.20 kT in apical and 15.90 kT in basal; E2: 21.60 kT and 22.80 kT, respectively) and the 
free energy of the binding sites (-5.52 kT and -5.64 kT, respectively). In line with this the entry 
rates are similar (at 100 nM: 1580 molecules/s in apical and 1540/s in basal; at 1 µM 2680 in 
apical and 2670 in basal), as predicted by the similar TR D-TAT loading into apical and basal 
OHCs (FIGURE 4-4). The binding site(s) for D-JNKi1 in the basal MET channel isoform have a 
slightly deeper energy well of -16.50 kT vs -15.50 kT in the apical isoform, causing D-JNKi1 to 
bind with somewhat greater affinity. Additionally the smaller energy barriers of the energy 
profile of D-JNKi1 interacting with the basal MET channel isoform (8.95, 14.60) vs the apical 
isoform (11.60, 18.20), indicate that the basal MET channel has larger dimensions, allowing 
D-JNKi1 to enter basal OHCs more rapidly (455/s at an extracellular concentration of 100 nM) 
compared with apical OHCs (72/s at 100 nM). The more rapid entry rate of D-JNKi1 into basal 
OHC MET channels is in agreement with the greater loading of TR D-JNKi1 into OHCs compared 
with apical OHCs (FIGURE 4-4 C, E).  Furthermore, the similarity of the entry rate of D-TAT into 
apical and basal OHCs is also in agreement with the TR D-TAT loading data, where loading is 
similar, although the slight difference in entry rates mean there is still a degree of difference in 
fluorescence in the cell bodies of the apical (FIGURE 4-4 D) and basal OHCs (FIGURE 4-4 F).  
The entry rate of D-TAT is similar for apical and basal OHCs. Surprisingly, it is slightly greater in 
apical OHCs at an extracellular concentration of 1 µM, 2680 molecules per second vs 2670/s in 
basal OHCs. This is also the case at 100 nM where the entry rate in apical OHCs (1580/s) is 
more rapid than in basal OHCs (1540/s). The entry rate of D-JNKi1 into OHCs is much slower 
than that of D-TAT, with a distinctively slower entry rate into apical OHCs (44/s at 100 nM and 
72/s at 1 µM) and basal (366/s at 100 nM and 455/s at 1 µM). This illustrates that there is a 
non-linear relationship between increased extracellular concentration and entry rate.  It has 
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been highlighted that entry rates of ototoxic compounds are important because inherent 
protective mechanisms against free radical damage (Sha et al., 2001) will be less likely to be 
counteract ototoxic effects where more rapid accumulation within the cells occurs (Alharazneh 
et al., 2011). Damage repair mechanism of reversible hair cell damage will stand a greater 
chance of protecting cells against compounds with more limited rates of entry. 
The fact that D-JNKi1 binds with high affinity, especially in the basal MET channel and lingers in 
the channel pore, entering into the cell slowly, means that it is a good competitive MET 
channel blocker for aminoglycoside antibiotics such as DHS. DHS was found to have an entry 
rate of 9000 molecules per second when tested under similar conditions to those of my 
experiments, albeit in the presence of 0.1 mM extracellular Ca2+, (0.05 fmol per hour), which 
was calculated to equate to 3 fA of the current flowing through MET channels of apical-coil 
OHCs, a minute proportion of the entire MET current. Thus, where entering through MET 
channels open at rest it would take 80 seconds to reach a 1 µM intracellular concentration 
(Marcotti et al., 2005). Using D-JNKi1 as a competitive blocker would, however, depend on 
being able to find a therapeutic concentration at which it is an efficacious channel blocker but 
ototoxic effects are ameliorated. 
 
4.5.4 The levels of cooperativity of D-TAT and D-JNKi1 with their MET 
channel binding sites allow further inferences to be made about the 
nature of the apical and basal MET channel isoforms 
 
A measure of the level of cooperativity of the MET channel binding sites with D-TAT and 
D-JNKi1 has been obtained from the Hill coefficient gained from the dose response curves at 
each holding potential. The principle of cooperativity describes the interaction of binding sites 
with one another. Where the MET channel is a concerned, a Hill coefficient of 1 is indicative of 
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the fact that there is one binding site for one molecule of a particular compound or multiple 
binding sites with equal affinity which do not interact, a Hill coefficient of more than 1 is 
suggestive of positive cooperativity between binding sites and thus the existence of multiple 
binding sites (Wyman, 1990, Krusek, 2004).  
D-JNKi1 shows consistently neutral cooperativity. The nH of apical D-JNki1 ranges from 0.87 to 
1.03 and the nH of basal D-JNKi1 ranges from 1.01 to 1.10 at membrane potentials from -164 
to -64. 
A hill coefficient of less than 1, signifying negative cooperativity, necessitates the existence of 
two or more binding sites within the channel. However, it does not necessarily indicate that 
the binding of a compound at one binding site negatively impacts binding at another site. 
Instead this is one of two possibilities, where negative cooperativity is concerned, the second 
being that the binding affinities for both sites are different (Ferguson et al., 1975; Wyman, 
1990;  Jackson, 2002).  
The cooperativity of D-TAT with both the apical and basal MET channel pore binding site(s) is 
consistently negative - apical nH ranging from 0.49 to 0.64 and basal nH ranging from 0.63 to 
0.79. This suggests that there are two D-TAT binding sites within the MET channel pore. 
Further, the negative cooperativity indicates either binding of a D-TAT molecule at one site 
preventing the binding of additional D-TAT molecules, or that the binding sites have different 
affinities, resulting in the negative cooperativity between the two. 
The membrane potential of the OHC has a greater effect on the free energy of areas nearer 
the intracellular face of the channel such as the narrow part of the channel pore and the 
internal barrier. Additional energy profile modelling for D-JNKi1 at membrane potentials other 
than 0 mV has shown that at more positive potentials the barrier on the innermost side of the 
channel becomes higher whilst the free energy of the outermost barrier in the channel is 
relatively unaffected. 
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In spite of the fact that D-JNKi1 does block the MET channel to some degree at positive 
membrane potentials, the model used for obtaining the KD and nH was not found suitable for 
fitting the data at these potentials. This is probably due to the KDs at these potentials being out 
of the range of the concentrations I have tested. Whilst there is no doubt that there is some 
degree of channel block by D-JNKi1 at positive potentials, overall it is quite variable 
(FIGURE 4-14). This may be the result of incomplete washout between recordings, due to 
D-JNKi1 lingering in the channel due to its large size and high affinity with its binding site(s). 
This would be less evident at negative membrane potentials as the block is much stronger.  
The principle of Occam’s Razor is stated as “pluralitas non est ponenda sine necessitate“ 
(plurality should not be posited without necessity) (William of Occam, 14th century; 
Encyclopedia  Britannica). In attempting to posit explanations for this this data I will use this 
merely as a useful guideline, by way of explaining what seems like an intuitive 
likelihood.  However, I wish to make it apparent that I take into account criticisms of this 
principle such as that of Emanuel Kant who offered his challenge, “entium varietates non 
temere esse minuendas“ (the variety of beings should not be rashly diminished) (Emanuel 
Kant, 1781; translation 1929). Nevertheless, given that I have attempted to analyse the data in 
a way which aims to explore it thoroughly and without exclusion, I feel that the explanation 
which requires the fewest assumptions is appropriate in this instance. In the case of D-JNKi1, 
due to its large dimensions, it seems most straightforward to posit that the neutral 
cooperativity in both apical and basal MET channel isoforms (nH = ~1) equates to there being a 
single binding site within both apical and basal MET channel isoforms. The negative 
cooperativity of D-TAT, defined by an nH of consistently less than 1, indicates the presence of 
multiple binding sites. These sites either influence one another such that binding at one site 
prevents binding at another or they have different affinities for D-TAT. Using rationale 
informed by parsimony here is certainly more difficult as whilst the former requires less 
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categories (types of binding site with different affinities), it may be more mechanistically 
complex. Therefore, I do not feel I can make an assessment based on the binding curves alone. 
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4.6 Conclusions 
 
In spite of being ototoxic at the relatively high concentrations (0.5 µM or greater), more recent 
results have shown that there appears to be a therapeutic window; D-TAT and D-JNKi1 are 
otoprotective, conveying protection against aminoglycoside antibiotics, at much lower 
concentrations. This indicates that there may be potential for use of one of these peptides in a 
clinic context.  Alternatively, they may provide a starting point for finding a similar high affinity 
blocker; a modified or similar molecularly structured compound which conveys otoprotection. 
Ideally, this compound would be able to block but not permeate the MET channel, as this 
would help in avoiding any potential negative effects caused after entering into the hair cells. 
These peptides are interesting in terms of what they elucidate about the MET channel 
isoforms. They are larger than the currently estimated narrow region of the MET channel pore 
(12.5 Å) and are able to permeate through it. Therefore, the width of this area must be in the 
region of the end on diameter of the two compounds: 15 Å. This means that the MET channel 
pore size needs to be re-estimated. The difference in susceptibility of apical and basal OHCs to 
D-JNKi1 falls in line with the idea that different channel isoforms exist. 
The negative cooperativity of D-TAT with the channel suggests that there are at least two 
binding sites in the MET channel which it is able to occupy. The neutral cooperativity of 
D-JNKi1 suggests that there may only be one binding site in the channel, however, as 
previously discussed, the Hill coefficient represents the minimum number of binding sites. The 
idea that more D-TAT than D-JNKi1 molecules can be accommodated in the MET channel 
accords with its smaller dimensions but may indicate that the MET channel pore is even larger 
than 15 Å.   
The energy profiles presented indicate that D-TAT binds near the narrow region of the MET 
channel pore, as DHS appears to (Marcotti et al., 2005), whilst D-JNKi1 seems to bind in the 
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vestibule. It was previously found by van Netten et al. (2007) that there appear to be two 
distinct binding sites within the MET channel pore, one for DHS and another for amiloride and 
benzamil. Energy profile modelling  (van Netten et al., 2007) of DHS showed that it bound at a 
distance of 0.80 from the extracellular face whilst, using data from Rüsch et al. (1994), they 
found that amiloride bound at a distance of 0.44 and benzamil at 0.55 . The fact that there 
appear to be these two distinct binding site regions combined with the fact that there is a 
different profile for D-JNKi1 binding in apical and basal OHC MET channels provides some 
further insights into the structure of the MET channel. The MET channel appears to be formed 
of subunits (Beurg et al., 2006), the pore containing the large electronegative vestibule and the 
narrow channel pore region; a variation of subunits along the length of the cochlea creating 
different isoforms. The higher barriers for D-JNKi1 in apical OHCs indicate that the apical MET 
channel isoform has smaller dimensions than the basal MET channel isoform. If this is the case 
then the basal channel must be even larger than 15 Å (the minimum end-on diameter of the 
compounds tested) as they are able to permeate the smaller apical channel. 
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5 BLOCKING OF THE MECHANO-ELECTRICAL 
TRANSDUCER CHANNELS IN COCHLEAR INNER 
HAIR CELLS BY D-TAT AND D-JNKI1  
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5.1 Lack of gradient from apex to base in IHCs 
 
As the bona fide sensory cells of the cochlear, inner hair cells are connected to ~95% of the 
afferent nerve fibres (Spoendlin, 1972) which send information to the central nervous system/ 
As well as this there are some efferent neurons which synapse onto the afferent connections 
(Pickles, 2008). The stereocilia of the IHCs not in contact with the tectorial membrane as OHCs 
are and respond to basilar membrane motion after it has been altered by the tectorial 
membrane and OHC motion (Lim, 1986). IHCs have a larger single channel conductance (Beurg 
et al., 2006), but smaller macroscopic MET current size (Kros et al., 1992) than those of apical 
and basal OHCs. It has been suggested that IHC MET channels contain a vestibule with more 
negatively charged residues within it, explaining the greater single channel conductance (Beurg 
et al., 2006).  Unlike for OHCs, there is no evidence of a gradient in IHC MET current size. Single 
channel recordings show that single channel conductance is the same size in apical and basal 
IHCs (Beurg et al., 2006). Congruently, macroscopic IHC currents have been found to be 
relatively uniform in size (Kim and Fettiplace, 2013).  
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5.2 Results 
5.2.1 D-TAT and D-JNKi1 act as permeant IHC MET channel 
blockers  
 
The block of IHC MET currents by D-TAT and D-JNKi1 is very similar to that in OHCs. D-TAT and 
D-JNKi1 are both permeant blockers of neonatal IHC MET channels. Where greater 
concentrations of the peptides are applied the block witnessed is stronger and thus the block 
is concentration dependent (FIGURE 5-1, 5-2, 5-3). Both compounds block the MET channel in 
a voltage dependent manner, being released at increasingly positive potentials, with maximum 
channel block at -104 mV. The block of both compounds is released at extremely 
hyperpolarised potentials indicating that the molecules are able to permeate the IHC MET 
channels, dragged through the channel pore because of the hyperpolarised membrane 
potential below -104 mV (FIGURE 5-4, 5-5). This is in line with the TR-conjugate loading data, 
which illustrates that both compounds are able to load into IHCs (FIGURE 4-4).  
 
 
135 
 
FIGURE 5-1 - Block of apical and basal IHC MET currents by 100 nM and 
300 nM D-TAT and apical OHCs by 1 µM D-TAT 
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FIGURE 5-1 : Block of apical and basal IHC MET currents by 100 nM and 300 nM D-TAT 
and apical OHCs by 1 µM D-TAT. A, B, D, E, G, H, J, K, M, N MET currents recorded from 
apical (A, B, G, H, M, N) and basal (D, E, J, K) P2 CD-1 OHCs before and during superfusion 
with a solution containing 100 nM (A, B, D, E) or 300 nM (G, H, J, K) D-TAT. Membrane 
potential stepped between -164 mV and +96 mV in 20 mV increments from a holding 
potential of -84 mV. Half the voltage steps used are shown for clarity (-144, -104, -64, -24, 
+16, +56, +96 mV). Driver voltage (45 Hz sinusoid, 40 V amplitude) plotted above the 
current traces. C, F, I, L, O Average current-voltage curves of apical (C, I) and basal (F, L) 
IHCs before and during superfusion of a solution containing 100 nM (C, F) and 300 nM 
D-TAT (I, L). Number of cells C:3, F:3, I:2, L:5, O: 4. 
 
 
 
137 
 
FIGURE 5-2 - Block of apical and basal IHC MET currents by 10 nM and 30 
nM D-JNKi1 
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FIGURE 5-2 : Block of apical and basal IHC MET currents by 10 nM and 30 nM D-JNKi1. A, 
B, D, E, G, H, J, K, MET currents recorded from apical (A, B, G, H) and basal (D, E, J, K) P2 
CD-1 OHCs before and during superfusion with a solution containing 10 nM (A, B, D, E) or 
30 nM (G, H, J, K) D-JNKi1. Membrane potential stepped between -164 mV and +96 mV in 
20 mV increments from a holding potential of -84 mV. Half the voltage steps used are 
shown for clarity ((-144, -104, -64, -24, +16, +56, +96 mV). Driver voltage (45 Hz sinusoid, 
40 V amplitude) plotted above the current traces. C, F, I, L, Average current-voltage 
curves of apical (C, I) and basal (F, L) IHCs before and during superfusion of a solution 
containing 10 nM D-JNKi1 (C, F) and 30 nM D-JNKi1 (I, L). Numbers of cells C:3, F:3, I:4, L:4. 
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FIGURE 5-3 - Block of apical IHC MET currents by 100 µM and 300 µM 
D-JNKi1 and basal IHC MET currents by 100 nM D-JNKi1 
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FIGURE 5-3 : Block of apical IHC MET currents by 100 µM and 300 µM D-JNKi1 and basal 
IHC MET currents by 100 nM D-JNKi1. A, B, D, E, G, H, MET currents recorded from apical 
(A, B, G, H) and basal (D, E, J, K) P2 CD-1 OHCs before and during superfusion with a 
solution containing 100 µM (A, B, D, E) or 300 µM D-JNKi1 (G, H). Membrane potential 
stepped between -164 mV and +96 mV in 20 mV increments from a holding potential 
of -84 mV. Half the voltage steps used are shown for clarity. Driver voltage (45 Hz sinusoid, 
40 V amplitude) plotted above the current traces. C, F, I, Average current–voltage curves 
of apical (C, I) and basal (F) OHCs before and during superfusion of a solution containing 
100 µM D-JNKi1 (C, F) and 300 µM D-JNKi1 (I). Numbers of cells C:2, F:5, I:2. 
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FIGURE 5-4 - Fractional block of IHC MET currents by D-TAT 
 
 
 
FIGURE 5-4 : Fractional block of IHC MET currents by D-TAT. A, B, MET currents as a fraction 
of the current in the control solution recorded from apical (A) and basal (B) IHCs before and 
during superfusion with D-JNKi1 at concentrations from 100 nM to 1 µM. Numbers of cells A: 
100 nM (n = 3), 300 nM (n = 1) and 1 µM (n = 4). B:  100 nM (n = 3), 300 nM (n = 5). 
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FIGURE 5-5 - Fractional block of IHC MET currents by D-JNKi1 
 
 
 
FIGURE 5-5 : Fractional block of IHC MET currents by D-JNKi1. A, B, MET currents as a 
fraction of the current in the control solution recorded from apical (A) and basal (B) 
IHCs before and during superfusion with D-JNKi1 at concentrations from 10 nM to 300 
nM. Numbers of cells A: 10 nM (n = 3), 30 nM (n = 4), 100 nM (n = 2), 300 nM (n = 2).B:  
10 nM (n = 3), 30 nM (n = 4), 100 nM (n = 5). 
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5.2.2 An apical to basal gradient of D-JNKi1 MET channel block 
and entry into IHCs 
 
There does not appear to be a significant difference between the block caused by D-TAT in 
apical and basal IHCs, just as in OHCs, whilst entry into basal hair cells is more rapid as is 
evident from the TR D-TAT loading data. Compellingly, there is a gradient in D-JNKi1 permeant 
channel block, its permeation rate into hair cells and TR D-JNKi1 loading (FIGURE 4-4). The KD 
(at -104 mV) in apical IHCs is 76 nM, whilst it is less than half that (30 nM) in basal IHCs. The KD 
for D-TAT in apical IHCs is 241 nM and whilst there is insufficient data to measure the basal KD, 
the fractional blocks at -104 mV for apical and basal IHCs where 100 nM (0.63 ± 0.06 and 0.64 
± 0.06 respectively) and 300 nM D-TAT (0.64 and 0.62 ± 0.07 respectively) were used were very 
similar (FIGURE 5-4). D-TAT was neutrally cooperative with the apical MET channel isoform (nH 
= 0.98 at -104 mV, FIGURE 5-6), whilst D-JNKi1 appeared somewhat positively cooperative with 
both apical and basal MET channel isoforms (nH = 1.18 at -104 mV for both, FIGURE 5-6), 
potentially indicating that it has multiple binding sites in the apical and basal IHC MET channel 
isoforms. This would necessitate them being substantially larger than the currently estimated 
OHC MET channel size, however. Given the relatively small number of recordings from IHCs, it 
is safe to say that nH is close to one for both D-TAT and D-JNKi1. 
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FIGURE 5-6 - Dose-response curves at -104 mV 
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FIGURE 5-6 : Dose-response curves at -104 mV, illustrating that D-TAT appears to block 
of apical and basal IHC MET currents equally well but there is a tonotopic gradient for 
D-JNKi1. D-TAT treated mid-apical OHCs: red open symbols fitted with red dashed line to 
the Hill equation, with KD = 241 nM ± 66 and nH = 0.98 ± 0.28. Number of cells from left 
to right: 100 nM (n = 3), 300 nM (n = 2), 1 µM (n = 4). D-TAT treated mid-basal OHCs: red 
closed symbols. Number of cells from left to right: 100 nM (n = 3), 300 nM (n = 5). D-
JNKi1 treated mid-apical IHCs: blue open symbols fitted with blue dashed line fitted to 
the Hill equation (see Materials and Methods), with KD = 76 nM ± 20 and nH = 1.18 ± 
0.33. Number of cells from left to right: 10 nM (n = 3), 30 nM (n = 4), 100 nM (n = 2), 300 
nM (n = 2). D-JNKi1 treated mid-basal IHCs: blue closed symbols fitted with continuous 
blue line to the Hill equation, with KD = 30 nM ± 5.57 and nH = 1.18 ± 0.26. Number of 
cells from left to right: 10 nM (n = 3), 30 nM (n = 4), 100 nM (n = 5). The difference 
between the KDs of D-JNKi1 in mid-apical and mid-basal OHCs was not quite significantly 
difference at a 95% confidence interval.  
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5.3 Discussion & conclusions 
 
Although the difference in KDs of D-JNKi1 in apical and basal IHCs was not found to be quite 
statistically significant at a confidence interval of 95%, the fact that there appears to be some 
form of gradient in D-JNKi1 MET channel block in IHCs is interesting since there is no evidence 
to suggest that there is a gradient in single channel current amplitude (Beurg et al., 2006). My 
data does seem to show a difference in the blocking efficacy of D-JNKi1 in apical and basal 
IHCs. This suggests that whilst they possess different isoforms of the channel which are 
blocked in a distinctive manner by channel blockers, single channel conductance is unaffected 
and thus is uniform along the length of the cochlea. The KD in the apical IHCs is very close to 
that for the OHCs in the same region: 76 nM vs 74 nM. The basal IHC MET channel isoforms 
appear to have a lower affinity for D-JNKi1, than those of OHCs in the same position, with a KD 
of 30 nM, more than double that in mid-basal OHCs (12 nM). This nonetheless is illustrative of 
the fact that IHCs are not necessarily more resistant to the entry of all ototoxic compounds. 
This is especially apparent, when taken in conjunction with the evidence of TR D-TAT and TR 
D-JNKi1 loading into IHCs (FIGURE 4-4) and the permeant nature of the MET channel block 
achieved by these compounds (FIGURE 5-4, 5-5). TR D-TAT loading inside IHC cell bodies 
extends further towards the cochlear apex than OHC labelling (FIGURE 4-3) and is thus more 
uniform, suggesting a gradient which is different from and less pronounced than the OHC 
gradient. Any resistance to damage (Davis et al., 1958; Ward and Fernandez, 1961; (Brummett 
et al., 1972; Ylikoski 1973; Richardson and Russell, 1991; Huizing and Groot, 1987) must be 
conveyed at a later stage by resistance to free radical damage or a more efficient repair 
mechanism. Additionally they may be protected by the OHCs, where these are present, but 
some as yet unknown mechanism (Brown and Feldman, 1978). D-TAT however, was ten-fold 
less effective at blocking the IHC MET channel, with a KD of 241 nM in mid-apical IHCs vs 25 nM 
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in the OHCs in the same region of the cochlea, so there are evidently some compounds which 
are unable to penetrate the IHC MET channel as effectively as the OHC MET channel. 
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6  DIFFERENTIAL BLOCKING OF ANOMALOUS 
MECHANOSENSITIVE CURRENT WITH 
DIHYDROSTREPTOMICIN AND FM1-43 IN 
COCHLEAR OUTER HAIR CELLS PRETREATED WITH 
BAPTA 
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6.1 The anomalous mechanosensitive current 
 
An anomalous mechanosensitive current has been observed which resembles the MET current 
but which is usually elicited by inverse polarity stimuli (Alagramam et al., 2011; Kim et al., 
2013; Marcotti et al., 2014). The anomalous current also differs from the MET current in its 
“adaptation” characteristics, as what looks like adaptation appears to be calcium independent 
and does not exhibit the characteristic inward and outward rectification that the MET current 
does (Marcotti et al., 2014). Moreover, there is no evident resting current and the anomalous 
current has a delayed onset after the  stimulus is applied (Marcotti et al., 2014).  Whilst the 
nature of the anomalous current is being explored, where it arises from is still unknown. 
6.1.1 The anomalous current in knockout and mutant mice 
 
6.1.1.1 Pcdh15 and cdh23 mutant mice 
 
Anomalous currents have been found to occur in a type of PCDH15 (av3J/av3J) as well as a 
CDH23 mutant (v2J/v2J) mouse (Alagramam et al., 2011).  Both of these mutants have point 
mutations which cause a premature stop codon to be created in the transcripts of the genes 
which encode respective aforementioned tip link components. Electrophysiological recordings 
revealed that resting currents were absent in these mice. The anomalous currents were mostly 
elicited by stimuli in the negative direction away from the tallest stereocilia and their 
amplitude was much reduced, especially at negative membrane potentials, where normal 
sinusoidal stimuli (35 V driver voltage) was used. It was noted that it was possible to elicit the 
largest currents at positive holding potentials. Congruent with the presence of anomalous 
currents in these mice, their hair cells have greatly disrupted bundles with almost no evident 
tip link like links. Additionally and compellingly, a further mutant mouse that was tested had 
an in-frame deletion “which is predicted to remove most of the 9th cadherin ectodomain from 
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PCDH15”. This mutation resulted in a far lesser degree of bundle disruption, with far more tip 
links remaining intact. In line with one potential theory about the necessity of tip links (or 
attached MET component such as TMHS) for normal MET current generation, these mice show 
normal MET currents, although they do appear somewhat reduced (Alagramam et al., 2011). 
Since the proportion of tip links is nonetheless reduced, it is unclear why, if lacking tip links is 
necessary for anomalous current generation, there is not any evident anomalous current in 
addition to the MET current apparent in these mice. Perhaps the stimulation applied was not 
great enough or greater n-numbers would have yielded recordings with such a profile. This too 
may explain the results in av3J and v2J mice, where large anomalous currents could be elicited 
at positive potentials but not at negative potentials, with stimuli of a normal magnitude. They 
did however note an instance of a av3J/av3J OHC where larger currents could be elicited when 
the stereocilia were stimulated with stronger sinusoidal stimuli (45 V driver voltage). In my 
experience, greater stimulation and repeating the stimuli over a prolonged period of time is 
sometimes necessary to elicit the anomalous currents, especially at the negative potentials.      
 
6.1.1.2 Shaker 6J mice 
 
Without acknowledging the opposite polarity of the currents, in characterising transduction in 
myo7a6J mutants, Kros et al. (2002) found that with greater stimulation, beyond the normal 
physiological range, MET-like currents could be elicited in these mice. They later realised that 
these were opposite in polarity and strikingly similar to the currents they could elicit in BAPTA 
pretreated hair cells in CD1 mice (Marcotti et al., 2014). 
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6.1.1.3 TMC1 and TMC2 
 
It was discovered that mutations in TMC protein isoforms TMC1 and TMC2 caused hearing 
loss, after positional cloning of hereditary deafness genes. TMC1 expression was found to 
occur in the cochlear hair cells and was identified to be required for the cells to function 
normally (Kurima et al., 2002). These channels subsequently became of great interest in the 
ongoing hunt for the MET channel candidates. 
Experiments by Kawashima et al. (2011) initially showed that hair cells of mice with targeted 
deletions of TMC1, TMC2 mice had no evident MET currents. Later they discovered that Ca2+ 
permeability and single channel current size are both reduced after altering TMC1 by making a 
methionine to lysine substitution at position 412 (Pan et al., 2013) suggesting that TMC1 was 
in fact the MET channel itself.  
TMC1 + TMC2 double knockout mice have severe balance deficits and are completely deaf.  
The presence of the anomalous MET current in these mice has been used to argue that these 
are not part of the main MET channel machinery. However, in light of the fact that the 
anomalous current appears to have such different characteristics, this argument does not 
stand up to critique.  
Kim et al. (2013) found evidence of inverse polarity MET current in TMC1; TMC2 double 
mutant mice, stating that TMC1 was the MET channel, due to their belief that the 
characteristics of both currents, such as conductance, were sufficiently similar in spite of the 
reverse polarity of the current. Furthermore, they stated that the susceptibility of the channel 
to FM1-43 and DHS was the same as for the normal MET channel. Although, after the 
publication of the data I collected which was presented in Marcotti et al. (2014) they 
reassessed this assertion and repeated their experiments, subsequently finding that DHS is in 
fact far less proficient at blocking the anomalous current compared with the MET current 
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(Beurg et al., 2014). The interpretation was that the TMC channels are some kind of necessary 
precursor to the localising and realisation of MET channel functionality but not part of the 
channel itself. Furthermore, they acknowledged that drawing large compounds such as DHS 
into the channel may require the MET channel vestibule (Beurg et al., 2006) which could 
feasibly be formed of TMC1 and TMC2 (Beurg et al., 2014b). 
The use of antibody labelling enabled TMC1 to be localised to the stereocilia of hair cells  
(Kawashima et al., 2011; (Beurg et al., 2014a). More recently Kurima et al. (2015) found that 
TMC1 and TMC2 are located at the tips of the two shortest rows of stereocilia, also by using 
antibody labelling and the creation of transgenic mice which express fluorphore-tagged TMC 
proteins, TMC1-mCherry and/or TMC2-AcGFP, under their native promoters. They assessed 
the ability of TMC1-mCherry and TMC2-AcGFP to restore MET currents in transgenic P3 and P7 
mice.  They confirmed the functionality of the TMC1-mCherry was in line with the native TMC1 
protein as the presence of TMC1-mCherry was able to restore hearing and normal MET 
currents in the mice. They also confirmed the incapability of TMC2 to compensate for lack of 
TMC1 in these mice, as hearing was not restored where only TM2-AcGFP was present, 
although partial MET current restoration does indicate its ability to partially compensate for 
TMC1. In developing (P3) mice MET currents of normal magnitude in OHCs and near normal 
magnitude in IHCs were present where both transgenes were expressed. Where only TMC1-
mCherry was expressed, currents were restored to some extent but were significantly smaller 
the native MET currents, especially in IHCs. TMC2-AcGFP expressed on its own, resulted in 
restored MET currents with a higher magnitude than for TMC1-mCherry in developing mice. 
Taken together, these are illustrative of the interplay of the two proteins in the developing 
cochlea. In mature (P7) IHCs, the expression of TMC2-AcGFP in addition to TMC1-mCherry, 
resulted in being able to elicit MET currents of amplitudes nearer the native size, compared 
with TMC1-mCherry alone. However, in OHCs, TMC2-AcGFP expression had no effect. This is 
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illustrative of increasing lack of expression of TMC2 as the cochlea matures (after an initial 
postnatal increase), in line with previous findings (Kawashima et al., 2011).  
 
Kurima et al. (2015) have discovered that TMC1 and TMC2 are localised along the length of the 
stereocilia in the developing cochlea. As the hair cells develop, TMC1 and TMC2 are 
increasingly localised only at the tips of the two shortest stereocilial rows, where the MET 
channels are thought to reside. Additionally, whilst TMC1 expression is maintained in maturity 
(P10) TMC2 expression is mostly only evident in the developing cochlea after an initial increase 
up until P3. Perhaps it is activating the channels, in the absence of tip links, which are localised 
along the length of the stereocilia during development and consequently being able to record 
from them, which underlies the anomalous current. An intriguing point is that TMC1-mCherry 
and TM2-AcGFP puncta remain located in some places along the stereocilia of mature mice, 
indicating that a reserve pool of MET channels may reside here. This is in concert with the 
finding that the anomalous current can be elicited in mice up to the P10, which was the latest 
age tested (Marcotti et al., 2014). 
A further addition to the complete picture of the MET channel complex is that there is an 
implicated role of Lipoma HMGIC fusion partner-like 5 (LHFPL5) (Beurg et al., 2014a), also 
known by the name TMHS, the absence of which has also been found to disrupt hair cell MET 
in a similar way. Homozygous null mutants, LHFPL5-/-,  mice have anomalous currents, 
decreased single channel conductance and lack the apical to basal gradient found in normal 
hair cells. Immunolabeling revealed that the stereocilary regions of LHFPL5-/-  mice lacked 
TMC1. They thus state that LHFPL5 is responsible for the correct localisation of TMC1. 
Moreover, without LHFPL5, a MET complex can still be formed but is instead located at a 
different region, where stimulation of the bundle in the opposite direction elicits current flow.  
The transmembrane protein TMIE has been shown, using protein interaction techniques, to 
have direct interactions with PCDH15 and LHFPL5. The hair cells of TMIE -/- mice also show 
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inverse polarity transduction (Zhao et al., 2014). They additionally noted that the presence of 
currents elicited by inverse polarity stimuli are likely to be representative of the presence of 
the MET channel in the aforementioned TMC knockouts and thus TMC1 and TMC2 are unlikely 
to form the MET channel. It seems parsimonious to me that TMIE and LHFPL5 form the part of 
the MET complex that connects PCDH15 to the MET channel itself.  
Kawashima et al. (2014) went on to reiterate and reaffirm that TMC1 and TMC2 may still viably 
be the MET channel,  as the unique characteristics of the anomalous current may in fact mean 
that is generated by a distinct mechanosensitive channel.  
 
6.1.2 The anomalous current in hair cells pretreated with BAPTA 
 
Tip links are a crucial part of the normal transduction apparatus, creating cohesive movement 
between stereocilia. Calcium chelators such as BAPTA disrupt tip links which are vital to MET 
channel function (Assad et al., 1991). When pre-treated with calcium chelators, FM1-43 hair 
cell entry is prohibited along the length of the cochlea (Gale et al., 2001). When treated with 
aminoglycosides, after breaking tip links with a BAPTA, most apical coil hair cells, as well as a 
proportion of basal coil hair cells do not externalise PS as loading into the hair cells is 
prevented (Goodyear et al., 2008). The anomalous current can be elicited IHCs and OHCs 
pretreated with BAPTA, in most cases by inverse polarity stimuli (Marcotti et al., 2014). 
 
6.1.3 The anomalous current in normal hair cells 
 
As reported in Marcotti et al. (2014), the anomalous current can be elicited in untreated cells 
which have not knowingly been damaged or had their tip links pharmacologically or 
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mechanically ablated. These can appear whilst reasonably large MET currents are also still 
present, as the MET currents begin to decrease, or on their own where no MET currents are 
apparent. A simple explanation may be to assume different degrees of damage have been 
done to tip links and that the anomalous current represents arises from the damaged 
proportion. However, given the variety of circumstances where anomalous currents have been 
witnessed, this does not seem very plausible.  
 
6.2 Terminology: the anomalous current and the 
protochannel from which it arises 
 
Throughout this chapter, as in (Marcotti et al., 2014), I will refer to the current in question as 
the “anomalous current”. In Marcotti et al. (2014) we propose that the channel through which 
the anomalous current flows is from a reserve pool of mechanosensitive precursor channels, 
therefore I will refer to this channel here as the “mechanosensitive protochannel” or 
“protochannel”. The witnessed difference in characteristics between the MET current and the 
anomalous current are thought to arise from a difference in the component subunits from 
which the channels are formed and the lack of gating by tip links (Beurg et al., 2014b). 
 
6.3 Characterising the anomalous current using channel 
blockers 
 
6.3.1 FM1-43 
 
Many known MET channel blockers have a blocking profile which has been characterised using 
patch clamping techniques. Therefore, using these channel blockers can aid in ascertaining 
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whether this aspect of the protochannel is similar to or different from the MET channel. As a 
high affinity MET channel blocker which has been well characterised (Gale et al., 2001), with a 
relatively small size which is estimated at 0.78 x 0.5 nm (Gale et al., 2001) when compared 
with aminoglycosides, which have diameters ranging from in the region of 0.96 -1.04 nm 
(Alharazneh et al., 2011), FM1-43 seemed a good candidate to attempt to block the underlying 
channel and characterise the anomalous current with.  
 
6.3.2 DHS 
 
DHS is another well characterised MET channel blocker, with a different blocking profile to 
FM1-43, therefore another good candidate to allow for making comparisons between the MET 
current and the anomalous current. DHS has an end-on diameter of 0.8 nM (Marcotti et al., 
2005). It is an open MET channel blocker, whilst FM1-43 is a closed MET channel blocker, able 
to reside in the closed MET channel. Additionally it had previously been reported that DHS 
offered a comparable degree of block of the anomalous current and the MET current (Kim et 
al., 2013). 
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6.4 Results 
 
6.4.1 FM1-43 acts as concentration dependent blocker of the 
anomalous current, with some evidence of voltage dependent 
block but with altered voltage dependence. 
 
After a 5 minute BAPTA pretreatment to break tip links (see METHODS), P2 CD1 OHCs were 
whole-cell patch clamped and solutions containing concentrations ranging from 1µM to 30 µM 
FM1-43 or 100 µM to 10 mM DHS were superfused onto the cochlear hair cells in culture, 
whilst the incremental voltage step protocol was run, in 20 mV steps from -164 mV to +96 mV. 
Traces were collected before, during and, where the patch seal lasted for long enough, after 
superfusion with any given concentration.  
The bundle stimulation required to record anomalous currents was unlike that used to evoke 
normal MET currents: a much more forceful stimulus was necessary, as noted by Marcotti et 
al. (2014). This was achieved by the use of a fluid jet with a larger tip diameter (~14 µm), 
positioned nearer the bundle than for a normal MET current recording. These currents 
appeared to materialise over time and increased in size, as more recordings were made. The 
currents recorded ranged in size dramatically from very small to larger than the normal MET 
current size.   
The anomalous currents have a ‘peaky’ appearance, especially at negative membrane 
potentials, compared with the more rounded form of the MET current. They have late onset 
kinetics, declining more rapidly than the MET current at negative membrane potentials and 
little or no resting current is evident (FIGURE 6-1, 6-2) as reported in (Marcotti et al., 2014). 
The anomalous current does not display the inward and outward double-rectification 
characteristics (FIGURE 6-3) that is a feature of the normal MET current (FIGURE 6-4), 
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indicating that it may have different ion permeation properties, also as previously reported in 
Marcotti et al. (2014). 
The recording made after the application of 30 µM FM1-43 (FIGURE 6-2, K) is interesting 
because of the apparent doubling of currents, elicited with both positive (towards the tallest 
stereocilia) and negative (towards the shortest stereocilia) deflections of the bundle. The 
characteristics of the currents suggest that they are both anomalous currents, with no 
evidence of resting transducer current, slow onset kinetics and a peaky appearance. This 
appearance of these doubled currents was previously reported, in line with the fact that 
currents, whilst usually elicited by stimuli in the negative direction, can on occasion be elicited 
by pushing the bundle in either direction  (Marcotti et al., 2014). As this was a noted feature of 
only a single recording this is anecdotal evidence, but it is none the less worth highlighting. 
FM1-43 blocks the anomalous current, the block is dependent upon the membrane potential 
and the degree of block becomes greater with higher concentrations in apical OHCs (FIGURE 
6-1). These findings were confirmed using a two-way ANOVA test followed by Bonferroni’s test 
(P<0.0001 for both). In basal OHCs (FIGURE 6-2), a two-way ANOVA confirmed the suspected 
concentration dependence of the block (P<0.001), however voltage dependence was not quite 
significant (P = 0.0882). 
The block by 10 µM FM1-43 of the anomalous (FIGURE 6-1, 6-2, 6-3, 6-5) and MET currents 
(FIGURE 6-4, 6-6) is of a similar magnitude. In apical OHCs there was 0.36 ± 0.10 (n = 3) of the 
anomalous current remaining (FIGURE 6-5, A) and 0.47 ± 0.07 (n = 5) in basal OHCs 
(FIGURE 6-5, B) at -104 mV. For the MET current the block was 0.36 ± 0.04 (n = 3) in apical 
OHCs (FIGURE 6-6, A) and 0.41 ± 0.14 (n = 3) in basal OHCs (FIGURE 6-6, B) at -104 mV.  
A comprehensive study of the block of the MET current by FM1-43 by Gale et al. (2001) found 
the maximum block to be at intermediate potentials, with block decreasing as the membrane 
potential was stepped away from 0 mV, in either the direction of negative or positive 
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membrane potentials. Whilst FM1-43 does block the anomalous current in a voltage 
dependent manner at least in apical OHCs, the block does not exhibit the same voltage 
dependence (FIGURE 6-5) as FM1-43 block of the normal MET current, with maximum block 
at -104 mV, not near 0 mV as in FIGURE 6-6 and Gale et al. (2001). As the maximum degree of 
MET current block offered by FM1-43 is around 0 mV, for comparison with the maximum block 
of the MET current we can take a measurement of the fractional proportion of current 
remaining at -24 mV (the closest measurable membrane potential, due to noise limiting the 
ability to measure the small currents at -4 mV), which is 0.19 ± 0 (n = 3) in apical OHCs (FIGURE  
6-6, A) and in basal OHCs it is 0.41 ± 0.25 (n = 3) (FIGURE 6-6, B). 
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FIGURE 6-1 - Block of anomalous currents in apical OHCs by 
different concentrations of FM1-43 
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FIGURE 6-1 : Block of anomalous currents in apical OHCs by different concentrations 
of FM1-43. A, B, C, D, E, F, G, H, I, J, K, anomalous currents recorded from apical OHCs 
from BAPTA pre-treated CD-1 P2 mice, before (A, D, G, I), during application of 1 µM (B) 
3 µM (E), 10 µM (H) and 30 µM (J) FM1-43 and after washout (C, F, K). Membrane 
potential stepped between -164 mV and +96 mV in 20 mV increments from a holding 
potential of -84 mV. Half the voltage steps used are shown for clarity. Driver voltage (45 
Hz sinusoid, 40 V amplitude) plotted above the current traces.  
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FIGURE 6-2 - Block of anomalous currents in basal OHCs by 
different concentrations of FM1-43 
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FIGURE 6-2 : Block of anomalous currents in basal OHCs by different concentrations of 
FM1-43. A, B, C, D, E, F, G, H, I, J, K anomalous currents recorded from basal OHCs from 
BAPTA pre-treated CD-1 P2 mice, before (A, D, G, J), during application of 1 µM (B) 3 µM 
(E), 10 µM (H) and 30 µM (K) FM1-43 and after washout (C, F, I). Membrane potential 
stepped between -164 mV and +96 mV in 20 mV increments from a holding potential 
of -84 mV. Half the voltage steps used are shown for clarity. Driver voltage (45 Hz 
sinusoid, 40 V amplitude) plotted above the current traces. 
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FIGURE 6-3 - FM1-43 current-voltage curves 
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FIGURE 6-3 : FM1-43 current-voltage curves, FM1-43 blocks the anomalous current at 
negative and to a lesser extent at positive potentials. The anomalous current does not 
display double-rectification characteristics. A, B, C, D, E, F, G, H, Average 
current-voltage curves of anomalous currents from BAPTA pre-treated apical (A, C, E, G) 
and basal (B, D, F, H) OHCs before and during superfusion of a solution containing 1 µM 
(A, B), 3 µM (C, D), 10 µM (E, F), 30 µM (G, H) FM1-43. Number of cells: Apical: 1 µM 
(n = 3), 3 µM (n = 3), 10 µM (n = 3), 30 µM (n = 3). Basal: 1 µM (n = 6), 3 µM (n = 4), 10 
µM (n = 5), 30 µM (n = 1). 
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FIGURE 6-4 - FM1-43 block of anomalous currents in apical and 
basal OHCs is similar to control MET currents in apical OHCs 
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FIGURE 6-4 : FM1-43 block of anomalous currents in apical and basal OHCs is similar to 
control MET currents in apical OHCs. A, B, D, E, G, H, J, K. currents recorded from apical 
(A, B, D, E) and basal (G, H, J, K) OHCs from BAPTA pre-treated CD-1 P2 mice (D, E, J, K), 
before (D, J), during application of 10 µM FM1-43 (E, K) compared with control MET 
currents (A, B, G, H) before (A, B) and during application of 10 µM FM1-43 (G, H) in 
normal P2 OHC MET channels. C, F, I, L, Average current-voltage curves of MET currents 
before and during superfusion with 10 µM FM1-43 (C, I) and anomalous currents before 
and during superfusion with 10 µM FM1-43 (F, L). C: n = 3, F: n = 3, I: n = 4, L: n = 5. 
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FIGURE 6-5 - Fractional block of anomalous currents in BAPTA 
pretreated OHCs by FM1-43 
                   
 
 
FIGURE 6-5 : Fractional block of anomalous currents in BAPTA pretreated OHCs by FM1-
43. FM1-43 blocks the anomalous current in a voltage dependent manner, with maximum 
block at -104 mV. A, B, Anomalous currents in the presence of 1 µM to 30 µM FM1-43, as a 
fraction of the currents in the control solution, from apical (A) and basal (B) OHCs. Numbers 
of cells A: 1 µM (n = 3), 3 µM (n = 3), 10 µM (n = 3), 30 µM (n = 3) B:  1 µM (n = 6), 3 µM 
(n = 4), 10 µM (n = 5), 30 µM (n = 1). 
 
169 
 
FIGURE 6-6 - 10 µM FM1-43 fractional block of MET current 
 
 
FIGURE 6-6 : 10 µM FM1-43 fractional block of MET current. Block by FM1-43 in apical 
and basal control OHC MET currents is similar. A, B, Fractional blocks by FM1-43 in 
control OHCs. 10 µM FM1-43 treated apical OHCs (A), n = 3. 10 µM FM1-43 treated 
basal OHCs (B), n = 3. 
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6.4.2 DHS acts as concentration and voltage dependent blocker of 
the anomalous current in apical OHCs but is two orders of 
magnitude less efficacious 
 
The block the anomalous currents in apical OHCs by DHS was evidently concentration 
dependent (FIGURE 6-7, 6-9 A, B, D, F, H) substantiated by using a two-way ANOVA followed 
by Bonferroni’s test (P<0.0001 for both), as is the block of the MET current (FIGURE 6-10; 
Marcotti et al., 2005). Additionally, also in line with DHS block of the MET current (6-12, A) the 
block of the anomalous current was voltage dependent (FIGURE 6-11, A) in apical OHCs. 
However, the concentration (P=0.1067; FIGURE 6-8, 6-9 C, E, G) and voltage dependence 
(P=0.6871; FIGURE 6-11, B) of the DHS block of the anomalous current in basal OHCs were not 
significant as determined by conducting a two-way ANOVA followed by Bonferroni’s test. This 
may be because of the low numbers of cells from which recordings were obtained. Further 
experiments would be required to ascertain whether or not the block in this region is 
concentration and voltage dependent. Withal, it seems parsimonious to suggest that a larger 
data set might show concentration and voltage dependence here, given the concentration and 
voltage dependence of the DHS block in apical OHCs and in apical and basal OHCs treated with 
FM1-43. 
 
DHS seemed an ideal additional candidate as it has a very different MET channel blocking 
profile to FM1-43, only blocking the MET current at negative membrane potentials. However, 
the anomalous current fractional blocking profiles of FM1-43 and DHS turned out to be similar 
in terms of voltage dependence, maximum block for both at -104 mV (FIGURE 6-5, 6-11). In 
apical OHCs, the block by DHS of the anomalous current displays the same voltage dependence 
as in normal OHCs, with maximum block around -104 mV (6-11, 6-12). Maximum block quoted 
at -84 mV in Marcotti et al. (2005) (FIGURE 6-8). 
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FIGURE 6-7 - Block of anomalous currents in apical OHCs by 
different concentrations of DHS 
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FIGURE 6-7 : Block of anomalous currents in apical OHCs by different concentrations of 
DHS. DHS is two orders of magnitude less efficacious at blocking anomalous currents in 
apical OHCs compared with MET currents. A, B, C, D, E, F, G, H, I, J, K, L, anomalous 
currents recorded from apical OHCs from BAPTA pre-treated CD-1 P2 mice, before (A, C, E, 
G, J ), during application of 100 µM (B) 300 µM (D), 1 mM (F), 3 mM (H) and 10 mM (K) 
DHS and after washout (I, L). Membrane potential stepped between -164 mV and +96 mV 
in 20 mV increments from a holding potential of -84 mV. Half the voltage steps used are 
shown for clarity. Driver voltage (45 Hz sinusoid, 40 V amplitude) plotted above the 
current traces. 
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FIGURE 6-8 - Block of anomalous currents in basal OHCs by 
different concentrations of DHS 
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FIGURE 6-8 : Block of anomalous currents in basal OHCs by different concentrations of 
DHS. DHS block of basal OHCs anomalous currents is two orders of magnitude less 
strong than that of MET currents. A, B, C, D, E, F, G, H, anomalous currents recorded 
from basal OHCs from BAPTA pre-treated CD-1 P2 mice, before (A, C, F), during 
application of 300 µM (B), 1 mM (D), 3 mM (G) DHS and after washout (E, H). 
Membrane potential stepped between -164 mV and +96 mV in 20 mV increments from 
a holding potential of -84 mV. Half the voltage steps used are shown for clarity. Driver 
voltage (45 Hz sinusoid, 40 V amplitude) plotted above the current traces. 
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FIGURE 6-9 - DHS current-voltage curves 
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FIGURE 6-9 : DHS current-voltage curves. DHS blocks the anomalous current at negative 
potentials, with no evident difference between block in apical and basal OHCs. The 
anomalous current does not display double-rectification characteristics. A, B, C, D, E, F, G, 
H, Average current-voltage curves of anomalous currents from BAPTA pre-treated apical (A, 
B, D, F, H) and basal (C, E, G) OHCs before and during superfusion of a solution containing 
100 µM (A), 300 µM (B, C), 1 mM (D, E), 3 mM (F, G)  and 10 mM (H) DHS. Number of cells, 
apical: 100 µM (n = 4), 300 µM uM (n = 6), 1 mM (n = 2), 3 mM (n = 4), 10 mM (n = 2), basal: 
300 µM (n = 4), 1 mM (n = 4), 3 mM (n = 1). 
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FIGURE 6-10 - DHS block of the MET current compared with the 
anomalous current 
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FIGURE 6-10 : DHS block of the MET current compared with the anomalous current. 
DHS block of anomalous currents is two orders of magnitude less strong than that of 
control MET currents in apical OHCs. A, B, D, E, G, H, J, K. currents recorded from P2 
CD1 OHCs (D, E, J, K), before (A, G), during application of 10 µM DHS(B, H)  compared 
with superfusion with the two orders of magnitude greater 1 mM DHS (E, K) on the 
anomalous current in the BAPTA pre-treated OHC, before recordings (D, J). Apical (A, 
B, D, E) and basal (G, H, J, K) cells illustrated. C, F, I, L. Average current–voltage curves 
of MET currents before and during superfusion with 10 µM DHS (C, I) and anomalous 
currents before and during superfusion with 1 mM DHS (F, L).  
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FIGURE 6-11 - DHS fractional blocks 
 
 
FIGURE 6-11 : DHS fractional blocks. DHS blocks the anomalous current in a voltage 
dependent manner, with maximum block at -104 mV, block is not released at more 
negative membrane potentials than this, indicating that DHS does not act as a permeant 
blocker here. Fractional block of anomalous currents in BAPTA pre-treated OHCs by DHS. A, 
B, Anomalous currents in the presence of 100 µM to 10 mM DHS, as a fraction of the 
currents in the control solution, from apical (A) and basal (B) OHCs. Numbers of cells A: 100 
µM (n = 4), 300 µM (n = 6), 1 mM (n = 2), 3 mM (n = 4), 10 mM (n = 2). B:  300 µM (n = 4), 
1 mM (n = 4), 3 mM (n = 1). 
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FIGURE 6-12 - Fractional blocks by DHS of MET currents in control 
OHCs 
 
 
 
FIGURE 6-12: A, B, C, Fractional blocks by DHS of MET currents in control OHCs. 10 µM 
DHS treated apical (A) 3 µM DHS treated basal (B) 10 µM DHS treated basal (C) OHCs. 
10 µM apical: n = 4 , 3 µM basal: n = 5, 10 µM basal: n = 6. 
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6.4.3 FM1-43 appears to be a permeant blocker of the 
protochannel, whilst DHS does not appear to permeate 
 
Whilst the voltage dependence of FM1-43 block of the anomalous current was different to 
MET current block, block of the anomalous current is still reduced at extreme negative and 
positive potentials (FIGURE 6-5), just as for the MET current (FIGURE 6-6;  Gale et al. (2001)). 
The release of block at extreme negative potentials, which occurs at membrane potentials 
which are more hyperpolarised than -104 mV, is characteristic of permeant block. This is in line 
with the finding by Gale et al. (2001) in myo7a6J mice in which, unlike in normal OHCs, FM1-43 
uptake does not occur due to the highly disorganised bundles, lack of tip links and thus lack of 
normal MET currents. With highly disorganised hair bundles, the hair cells of these mice just 
display the anomalous current, which can only be elicited by stimulation beyond the normal 
physiological range. The arising currents appear similar in so far that they are also elicited by 
inverse stimuli and have additional characteristics which appear alike, such as a peaky 
appearance and late onset. Gale et al. (2001) demonstrated that stimulating the myo7a6J hair 
bundles beyond the normal physiological range allows FM1-43 to enter the hair cells. 
Therefore, one might hypothesise that the anomalous currents in these mice and BAPTA pre-
treated CD1 mice arise from the same or similar source.  
Whilst the block by DHS is voltage dependent, blocking more strongly at hyperpolarised 
potentials, with maximum block near -104 mV, DHS block of the anomalous current does not 
show clear evidence of release at extreme negative potentials in apical or basal MET channel 
isoforms (FIGURE 6-11). Whereas, characteristic permeant block is evident where DHS blocks 
the MET current (FIGURE 6-12). This suggests that, unlike for the MET channel, DHS is unable 
to permeate the protochannel. 
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6.4.4 FM1-43 blocks the anomalous and MET currents to a similar 
degree, whilst DHS block is two orders of magnitude less effective 
at blocking the anomalous current. 
 
Gale et al. (2001) measured the KD of FM1-43 at -4 mV, as maximum block was near 0 mV. 
Here, I find that the maximum block achieved is at around -104 mV therefore that is where the 
KD has been measured. A previous study by Kim et al., 2013 also measured the KD at -104 mV 
although they did not state why, although this was presumably because they found that the 
maximum block was also at this potential. A KD of 2.88 µM in apical OHCs and in basal OHCs a 
KD of 3.87 µM (FIGURE 6-13) has been calculated at -104 mV, similar to the KD previously 
reported for FM1-43 of the normal MET current at -4 mV of 1.2 µM (Gale et al., 2001). In the 
control experiments that I conducted on normal untreated OHCs where 10 µM of FM1-43 was 
applied, the fraction of the current remaining in apical (FIGURE 6-10, A) at 0.36 ± 0.04 (n = 3) 
and very similarly 0.41 ± 0.14 in basal OHCs (n = 3) (FIGURE 6-10, B), suggesting that the KD will 
be somewhat higher than previously reported Gale et al. (2001). Further experiments would 
be needed to generate a dose response curve in order to ascertain the actual KD. 
DHS blocks the anomalous current in apical OHCs with a KD of 1.24 mM at a membrane 
potential of -104 mV and basal OHCs with a KD of 1.04 mM at -104 mV (FIGURE 6-14), at more 
than 100x greater than 7 µM at -84 mV (1.3 mM Ca2+) in apical OHCs previously reported 
(Marcotti et al., 2005) and the control experiments I conducted, the KD in basal cells appears to 
be somewhere between 3 µM and 10 µM at -104 mV, whilst data from apical OHC treatment 
with 10 µM DHS, suggests the block in the apex may surprisingly be stronger, with a fraction of 
0.17 ± 0.11 (n = 4) (FIGURE 6-12, A) compared with 0.34 ± 0.05 (n = 6) of the current remaining 
at -104 mV (FIGURE 6-12, C), although the standard error is quite large and thus more data is 
necessary to ascertain if this is the case. 
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6.4.5 No apical to basal gradient in channel block of the 
anomalous current is evident and a difference in pore properties 
between the normal MET channel and the protochannel is 
apparent 
 
All the range of different sized anomalous currents appear to occur in hair cells along the 
length of the cochlea and in consonance with this there is no significant difference in the level 
of the block by either FM1-43 (FIGURE6-13) or DHS (FIGURE 6-14) between apical and basal 
OHCs. There is, however, an apparent difference between DHS block of normal OHC MET 
currents, with greater block of apical (0.20 ± 0.14 of the current remaining at -104 mV) than 
basal (0.34 ± 0.05 remaining at -104 mV) currents (FIGURE 6-12). 
The DHS half blocking concentration of anomalous current is two orders of magnitude greater 
than of the MET current. The much lower affinity block by DHS of the anomalous current 
relative to the MET current again indicates a difference in pore properties of the protochannel 
channel. A possibility is that it lacks the highly negatively charged channel vestibule which may 
be important for interaction with some permeant blockers (Beurg et al., 2014b).  
The nH  for apical DHS is consistently negatively cooperative ranging from 0.39-0.97 
(FIGURE 6-15), whilst for MET currents treated with DHS, there is a neutral cooperativity of 1 
at all potentials (Marcotti et al., 2005). DHS is also negatively cooperative with its binding sites 
in the basal protochannel (nH = 0.60 in basal OHCs at -104 mV, FIGURE 6-14), unlike with the 
MET channel (nH = 1, (Marcotti et al., 2005)).This is illustrative of a difference in the binding 
site(s) for DHS between the MET channel and the protochannel. The negative cooperativity 
further indicates that there are at least two binding sites for DHS in the protochannel pore.  
Due to the difference in voltage dependence of the FM1-43 block of the anomalous current, 
compared with the normal MET current, the nH profile is completely altered. Negative 
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cooperativity is evident (nH = 0.76 at -104 mV in apical OHCs and nH = 0.51 in basal OHCs 
at -104 mV, FIGURE 6-13), very different to the blocking profile of the normal MET current, 
where nH is 1 at the extreme negative potentials, gradually increasing to its maximum of 2 near 
0 mV, then decreasing to 1 again at more positive potentials. The negative cooperativity does 
however suggest that there are also at least two FM1-43 binding sites in the protochannel.  
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FIGURE 6-13 - FM1-43 dose response curves 
 
 
 
 
 
FIGURE 6-13 : FM1-43 dose response curves. FM1-43 blocks anomalous currents in 
apical and basal OHCs to a similar degree. Dose-response curves at -104 mV in BAPTA 
pre-treated CD-1 OHCs. FM1-43 treated apical OHCs: blue closed symbols fitted with blue 
continuous line to the Hill equation (1), with KD = 2.77 µM ± 0.72 and nH = 0.76 ± 0.16. 
Number of cells from left to right: 1 µM (n = 3), 3 µM (n = 3), 10 µM (n = 3), 30 µM 
(n = 3). FM1-43 treated basal OHCs: red closed symbols fitted with red continuous line to 
the Hill equation with KD = 3.87 µM ± 1.85 and nH = 0.51 ± 0.20. Number of cells from left 
to right: 1 µM (n = 6), 3 µM (n = 4), 10 µM (n = 5), 30 µM (n = 1). 
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FIGURE 6-14 - DHS dose response curves 
 
 
 
 
 
 
FIGURE 6-14 : DHS dose response curves. DHS blocks anomalous currents in apical and 
basal OHCs to a similar degree. Dose-response curves at -104 mV in BAPTA pre-treated 
CD-1 OHCs. DHS treated apical OHCs: blue closed symbols fitted with blue continuous line 
to the Hill equation (1), with KD = 1.24 mM ± 0.385 and nH = 0.73 ± 0.17. Number of cells 
from left to right: 100 µM (n = 4), 300 µM (n = 6), 1 mM (n = 2), 3 mM (n = 4), 10 mM 
(n = 2). DHS treated basal OHCs: red closed symbols fitted with red continuous line to the 
Hill equation with KD = 1.04 mM ± 0.96 and nH = 0.60 ± 0.71. Number of cells from left to 
right: 300 µM (n = 4), 1 mM (n = 4). 
 
187 
 
FIGURE 6-15 - Average KD and nH of anomalous currents from DHS 
treated apical OHCs plotted as a function of the membrane potential 
OHCs 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 6-15 : Average KD and nH of anomalous currents from DHS treated apical OHCs 
plotted as a function of the membrane potential, from -164 mV to -64, including those 
shown in FIGURE 6-14. Number of cells included in each dose-response curve used for 
obtaining the KDs and nHs: 100 µM (n = 4), 300 µM (n = 6), 1 mM (n = 2), 3 mM (n = 4), 10 
mM (n = 2).  
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6.4.6 The anomalous current can be elicited in normal OHCs 
 
The anomalous current and MET current can sometimes be elicited and recorded at the same 
time (Marcotti et al., 2014). The MET and anomalous currents can be concurrently elicited 
during different phases of the same sine wave stimulus in the same cell and both currents 
simultaneously blocked by FM1-43 (FIGURE 6-16). In agreement with previous data obtained 
by Kim et al. (2013) and the other data presented here, FM1-43 blocks both to a similar 
degree, with 0.45 of the anomalous current remaining at -104 mV and 0.2 of the MET current 
remaining at -24 mV (the nearest potential to -4 mV (Gale et al., 2001) that it was possible to 
measure in my experiments due to noise) (n = 1, FIGURE 6-8), although, as previously 
mentioned, maximum block was at different membrane potentials for the two currents 
(FIGURE 6-10). It is also possible to elicit only the anomalous current without intending to in 
normal cells which have not been pre-treated with BAPTA (FIGURE 6-17), although this is 
anecdotal evidence from a single cell.  
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FIGURE 6-16 - The Anomalous current and MET current in same 
trace blocked by FM1-43 
 
 
 
 
 
 
 
 
 
FIGURE 6-16 : The Anomalous current and MET current in same trace blocked by FM1-
43. The MET and anomalous currents can be concurrently elicited during different 
phases of the same sine wave stimulus in the same cell. The MET current and the 
anomalous current being alternatingly elicited by a 45 Hz sinusoidal force stimulus, 
before (black trace) and during (red trace) the superfusion of 10 μM FM1-43. 
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FIGURE 6-17 - The anomalous in normal OHCs 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 6-17 : The anomalous in normal OHCs. The anomalous current alone was 
elicited in untreated, undamaged TRPC 1/3/6 triple knockout mouse OHC, without 
explicitly intending to. The OHCs otherwise had normal MET currents. This recording 
provides anecdotal evidence. Note the seal was lost during the voltage step to +76 mV. 
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6.5 Discussion 
6.5.1 Does eliciting the anomalous mechanosensitive current 
require a different kind of stimulation? 
 
It is apparent from my experience in conducting these experiments that after BAPTA 
pretreatment, in order to elicit the maximal anomalous current, it is necessary to put the fluid 
jet nearer to the bundle than normal, getting closer to the apical surface.  Using a larger fluid 
jet with a larger diameter (~14 µm) also aids in this. Eliciting anomalous currents in 
homozygous myo7a6J mutants requires stimulation such as this, which is so great that it is 
beyond the normal MET operating range (Kros et al., 2002).  However, these observations are 
somewhat incongruent with the fact that in untreated CD-1 mice the anomalous current can 
sometimes appear as if without specific experimental intention, so that it is possible to elicit 
the normal MET current and the anomalous current with alternating phases of the same sine 
wave stimulus. It is also, more rarely possible to elicit the anomalous current alone, without 
intending to (FIGURE 6-17). 
 
6.5.2 FM1-43 and DHS block the anomalous current differently to 
the MET current 
 
There are several distinctions between FM1-43 and DHS block of the anomalous current when 
compared with the MET current. Firstly, no apical to basal gradient in anomalous current block 
is evident for DHS, where DHS blocks the MET current of apical OHCs more strongly than basal 
OHCs. Whilst the KD for FM1-43 is similar in both the anomalous and the normal MET current, 
the block has altered voltage dependence, with maximum block at -104 mV instead of -4 mV as 
reported by Gale et al., (2001). DHS blocks the anomalous current two orders of magnitude 
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less strongly than the MET current. Its voltages dependence is also shifted, such that the block 
is not released at extreme negative potentials, indicating that DHS is unable to permeate the 
protochannel. Additionally, there is evident negative cooperativity of DHS that differs from the 
neutral cooperativity (nH = 1) that it has with its MET channel binding site(s). Whilst that Hill 
coefficient of 1 may indicate one binding site as previously mentioned, this does not negate 
the possibility of more than one binding site. The negative cooperativity may indicate that DHS 
has more than one available binding site in the protochannel, with both binding sites either 
having different DHS affinities or the binding of one molecule of DHS impeding the binding of 
additional molecules of DHS. FM1-43 is also negatively cooperative with its binding site, very 
different from its normal profile of positive cooperativity at intermediate potentials (nH = 2) 
and neutral cooperativity at extreme positive and negative potentials (nH = 1) (Gale et al., 
2001). 
Of additional interest is the fact that the control experiments on MET currents revealed that 
DHS appears to block currents in apical OHCs more strongly than in basal OHCs. As DHS 
appears to bind deep inside the vestibule, near the narrow part of the channel pore  (Marcotti 
et al., 2005), this may represent some degree of difference in the pores of apical and basal 
MET channels, in addition to differences in the size of the inside of the channel and any 
difference in vestibule isoforms. With the other compounds I have tested, where there has 
been a gradient in channel block, the strongest block has always been in basal OHCs. DHS block 
however is stronger in apical OHC MET channels. Results have previously been obtained 
showing the same pattern of stronger block in apical OHCs treated with the water-soluble 
peptide toxin GsMTx-4 (Beurg et al., 2014b).  
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6.5.3 Potential theories about the nature of the anomalous current 
and the associated channel  
 
A study which may offer an example of an analogous channel construction to that responsible 
for the anomalous current, but in a different system, was conducted on BK K+ channels by 
Zhang et al. (2006). The BK channel is formed of a transmembrane domain, four voltage 
sensing subunits, a pore domain which conducts K+ ions and a gating ring at the entrance of 
the inner vestibule, formed of eight negatively charged residues (FIGURE 6-18). The gating ring 
appears akin to MET channel vestibule. The removal of this gating ring decreases block by Mg2+ 
and the polyamine spermine and decreased inward rectification (Zhang et al., 2006). This is 
similar to the concept of removal of the vestibule resulting in a protochannel with altered DHS 
affinity and no apparent rectification of the anomalous current. 
 
Yuan, P. & Mackinnon, R. The Rockefeller University. 
from http://lab.rockefeller.edu/mackinnon/members/PengYuan (retrieved 05/06/15) 
FIGURE 6-18 Model of the BK channel 
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More recently Budelli et al. (2013) also studied the the Slo1 (BK) channel, using different Slo1 
channel constructs to attempt to see how the channel would function with and without the 
gating ring. Budelli et al. (2013) found that removing the 827 amino acid gating ring from the 
BK channel and replacing it with a short 11 amino acid tail resulted in decrease in single 
channel conductance of about 30% and although the channel was still voltage activated, the 
Ca2+ and Mg2+-dependent gating was gone. They noted that BK channels without a gating ring 
have a right shifted voltage conductance relationship, indicating that more voltage is required 
to open the channel in the absence of the gating ring, presumably to replace the passive 
opening force that was applied by the gating ring before it was removed. This is again akin to 
the altered voltage dependence of the FM1-43 block of the protochannel. 
Interestingly, as the channel model by Yuan, P. illustrates (FIGURE 6-18), the gating ring of the 
BK channel is a cytoplasmic domain, which is not embedded in the phospholipid bilayer which 
may be a good basis for envisaging a MET channel which resides, at least partially, in the 
extracellular space. As has been represented in diagrams of models presented previously, the 
narrow pore region is embedded in the phospholipid bilayer whilst the vestibule containing 
region may not be (Beurg et al., 2014b).  
In my anecdotal experience, having attempted to elicit anomalous currents in untreated CD1 
mice, pressing down with the fluid jet on the apical surface of the hair cell does not actually 
appear to work. Nor does more forceful stimulation generated by placing the fluid jet closer to 
the hair bundle. However, the anomalous current does appear to be evident in some 
recordings where there is no intention to elicit it.  
In the vast majority of instances of anomalous current occurrence, there is no evidence of 
normal MET current and the tip links are almost entirely obliterated. For LHFPL5 -/- around 
65% of tip links are absent and as a result one can elicit the anomalous current with inverse 
polarity stimuli. Interestingly the normal MET current can also be elicited, with the normal sine 
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wave stimulus pattern (Marcotti et al., 2014; Beurg et al., 2014). One would infer potential 
correlation between tip link damage and anomalous current appearance, however, what 
seems somewhat incongruent is the fact that TMC1 and TMC2 double mutant mice have intact 
tip links, yet only possess the anomalous current. Only normal MET currents could be recorded 
in the TMC1 -/-, TMC2 +/- and TMC1 +/-, TMC2 -/- mice (Kim et al., 2013), the currents in the 
latter potentially being somewhat smaller than normal.  
Knocking out any part of the MET machinery components that are known of and have 
subsequently been tested results in hair bundle stimulation which generates anomalous 
currents, therefore it seems likely that the other instances of anomalous current occurrence 
arise because the elements removed are part of the MET complex. TMC1 and TMC2 may 
indeed form some part of the channel, whether that is the vestibule or the narrow part of the 
channel pore, although the latter seems less likely.  The anomalous current could either be the 
result of relocation and reorganisation of the proteins to a location where they are opened by 
inverse stimuli or the unmasking of a distinct population of mechanosensitive protochannels.  
DHS may be less attracted into the channel, when the highly electronegative vestibule is not 
present, as has been suggested  (Beurg et al., 2014b). They postulate that the nature of the 
DHS molecule is the reason that they find DHS blocks the TMC double knockout channel less 
well, stating that it may lack an external vestibule which would draw the polycationic DHS into 
the channel.  
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6.6 Conclusions 
 
The anomalous current has clearly distinct features from the MET current. The anomalous 
current is elicited by stimuli of inverse polarity in the majority of recordings. There is little or 
no resting current evident in any traces at any membrane potentials. Although strong 
“adaptation” of the current is evident (FIGURE 6-1, 6-2, 6-3, 6-4), unlike for the MET current, 
this does not appear to depend upon Ca2+ as Marcotti et al. (2014) illustrated as they were able 
to elicit the strongly adapting anomalous current whilst the hair cells were bathing in a 
solution containing BAPTA, meaning there was no Ca2+ block. As Marcotti et al. (2014) also 
found there the anomalous current lacks the double rectification of the MET current.  
Both the FM1-43 and DHS data suggest a distinct lack of the normal apical to basal channel 
property gradient for the protochannel. DHS additionally illustrates the difference in 
characteristics between the MET and the anomalous channel, blocking the latter 100x less 
well.  
As previously mentioned, Kurima et al. (2015) have found that TMC1-mCherry and 
TMC2-AcGFP puncta remain localised, albeit very sparsely, along the length of mature 
stereocilia, which they suggest may represent a reserve pool of channels. Where tip links are 
missing or broken, this reserve pool of protochannels may be mobilised, re-locating to the 
previous MET channel location or near it, thus also being activated by stereociliary motion. 
Without the tip links to create cohesive motion, however, greater force is required in order to 
open the channels and the activation kinetics are slower. This may also explain the erratic 
nature of the currents in terms of their appearance and size. Whilst perhaps this seems at odds 
with the fact that the anomalous current can be elicited in double mutant TMC1 and TMC2 
mice, it may be the case that since all MET channel components seem to be required for 
normal MET, where TMC1 and TMC2 are absent a protochannel composed of the other 
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remaining components is formed at or near the correct MET channel position. Furthermore, 
although tip links are still intact the protochannel would in that scenario not be tethered or 
otherwise gated by them, therefore their ablation would have no effect (Kim et al., 2013).  
Alternatively, the observation that stronger stimulation is needed to activate the anomalous 
current could indicate that the channel is located on the apical surface of the hair cells and 
thus exerting pressure on the apical surface elicits it. However, in my experience, having 
attempted to elicit anomalous currents in normal untreated OHCs this method does not. 
The control data presented for DHS in itself interesting, as it is the first compound we have 
found that appears to block apical MET channels with a higher binding affinity than basal cells, 
although further experimentation is required to confirm this finding. 
 
6.7 Future experiments 
 
As presented in Chapter 4, the peptide data lead us to the conclusion that D-TAT binds further 
into the channel’s electrical field near the narrow part of the channel pore. Whereas, the data 
which illustrates the apparent apical to basal gradient in D-JNKi1 binding combined with the 
distinct energy profiles for apical and basal D-JNKi1, leads us to the conclusion that D-JNKi1 
binds in the highly electronegative vestibule nearer the extracellular side of the channel. This 
may indicate that this MET channel component may be one which varies from the apex to the 
base of the cochlea in either its size or the quantity of negatively charged residues within it. 
If we take the view that the anomalous current represents a reserve pool of protochannels 
which are lacking the highly negatively charged vestibule, then we would expect D-JNKi1 to 
block the anomalous current less effectively than D-TAT. This is because, whilst they both bind 
in the vestibule, the binding of D-JNKi1 appears more reliant on the concentrated negatively 
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charged residues in the centre of the vestibule, whereas D-TAT binds nearer the narrow region 
of the channel pore which may still form part of the protochannel. Therefore, testing the 
blocking potential of these compounds on the anomalous current may be useful, as the 
removal of the vestibule may have a greater influence on the binding affinity of D-TAT 
compared with D-JNKi1. However, the lack of the vestibule may still reduce the affinity of 
D-TAT block at least somewhat. The DHS data lends weight to this idea, as it is suggested that 
in the normal MET channel, DHS binds in the vestibule but nearer the narrow part of the 
channel pore (Marcotti et al., 2014) and additionally has a less great affinity for the 
protochannel. When binding in the protochannel, where the vestibule is absent, binding may 
effectively occur in the only remaining part of the channel, the narrow part of the channel 
pore, as this may be all that the protochannel is comprised from. This is near to where binding 
in the normal MET channel occurs, but yet further towards the intracellular side of the 
channel. Affinity would thus be reduced due to the presence of only a small number of 
positively charged residues residing in the narrow part of the channel pore, which may form 
the protochannel. This would explain why DHS block of the anomalous current is less great but 
the affinity for the smaller FM1-43 molecule is relatively unaffected.  
It would be interesting to see if Texas Red conjugated compounds, which are very large yet 
permeate through the MET channel pore, are also able to permeate through the anomalous 
channel pore. 
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7  MECHANO-ELECTRICAL TRANSDUCTION IN TRPC 
3/6, 1/3/6 AND 1/3/5/6 KNOCKOUT MICE IS 
NORMAL 
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7.1 TRP channels 
 
Transient receptor potential (TRP) channels are tetrameric channels formed of six 
transmembrane domain proteins. The majority of TRP superfamily channel types are either 
characterised as calcium selective (O‘Neil and Heller, 2005) or nonselective cation channels, 
permeable to Ca2+, K+ and Na+, with some types being having permeability to other ions such as 
Mg2+ (Nadler et al., 2001; Monteilh-Zoller et al., 2003), TRPM4 whilst activated by Ca2+, is 
impermeable to it (Launay et al., 2002). There are many categories of TRP proteins based on 
the alignments of their amino acid sequences which include TRPV, TRPM, TRPP and TRPC (Bon 
and Beech, 2013). Many TRP members have been hypothesised to be MET channel candidates 
due to some members being mechanically activated (Venkatachalam and Montell, 2007).  
TRP channels have been of interest in terms of their role in MET. TRPA1 channels are activated 
by pungent compounds such as AITC and facilitate mechanosensation in Drosophila (Walker et 
al., 2000) and zebrafish (Sidi et al., 2003). They were previously thought to be a candidate 
channel in the search for the MET channel as inhibiting TRPA1 protein expression in mice 
appeared to affect MET (Corey et al., 2004). In spite of this they have now been eliminated as 
TRPA1 knock-out mice show normal MET and hearing (Kwan et al., 2006). Additionally, 
application of TRPA1 activating pungent compounds does not alter MET (Kwan et al., 2006).  
7.1.1 TRPC channels 
 
TRPC1, TRPC2, TRPC3, TRPC4, TRPC5, TRPC6 and TRPC7 are all expressed in the mammalian 
genome, however in humans TRPC2 is not expressed as the human form of this protein is a 
pseudogene (Wes et al., 1995; Venkatachalam and Montell, 2007). TRPC1 and TRPC5 are 
expressed in sensory ganglia (Elg et al., 2007), as are TRPC3 and TRPC6 which are also 
expressed in cochlear hair cells (Quick et al., 2012). There are two subgroups; the first is 
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formed of TRPC1, TRPC4 and TRPC5. The second is formed of TRPC3, TRPC6 and TRPC7 (Bon 
and Beech, 2013). Ca2+ is a common modulator of both these subgroups (Hui et al., 2006).                                                                                                                                                                                                                                                                                                                                                 
As with other TRPC channels, the difficulty with identifying the TRPC channels that may 
potentially form part of the MET complex is that there are multiple TRPC isoforms. These 
multiple monomers, in a multitude of possible combinations, form heteromers to create ion 
channels. TRPC channels are particularly prolific forming heteromers with other TRPC channels 
as well as TRPV2, TRPV4 and Orai1 Ca2+ channels (Ma et al., 2010, Beech, 2012). This 
introduces a level of redundancy where knocking out one or more TRPC channels can be 
compensated for by replacement with other TRPC monomers to form heteromers.  
7.1.2 TRPC 3 and 6 channels 
 
Having found expression of TRPC3 and TRPC6 in cochlear hair cells, a recent publication (Quick 
et al., 2012) suggested that knocking out TRPC3 and TRPC6 channels had a detrimental effect 
on hearing in mice. TRPC DKO mice appeared to have a degree of hearing loss, assessed by 
exposure to high-intensity (around 20 kHz at 90 dB) sound and subsequent Preyer reflex 
response. Whilst single knockouts showed a normal Preyer reflex (startle response in to 
auditory stimuli), the DKOs did not.  Vestibular deficits were also apparent from trunk curl and 
swim test data. Moreover, they showed that the basal OHC MET channels of double knock-out 
TRPC3/TRPC6 mice exhibited MET currents of drastically reduced magnitude compared with 
wild-type controls. The results reported suggested that whilst MET currents in apical OHCs 
remained intact in terms of their size, those in basal OHCs  only reached 20-25% of control 
mice (Quick et al., 2012). It was postulated that they may have a role in the control of 
intracellular levels of Ca2+ in OHCs. Single knock-outs of either of these channels did not result 
any alteration in behavioural phenotype, however knocking out both of these channels caused 
hearing deficits. Auditory brain stem responses were utilised, which are measurements of 
auditory evoked potentials in the brain taken using electrodes attached, in this case, to the 
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vertex between the ears and the mastoid behind the ears of the mice. The ABRs were recorded 
from 4 – 12 week old mice. The required threshold (in dB) to elicit a response at a given 
frequency was determined by auditory tone pip stimuli and recordings were made at 8, 24, 32 
and 45 kHz. The results showed elevated response thresholds in DKO animals compared to 
wild-types (Quick et al., 2012) and later unpublished data shows significantly higher response 
thresholds in quadruple TRPC 1/3/5/6 knockout mice, when compared with WT and double 
TRPC 3/6 knockout animals. 
The data published by Sexton et al. (2016) on TRPC quadruple TRPC 1/3/5/6 knockout mice 
showed deficits in light touch sensitivity in both TRPC 3/6 DKO and 1/3/5/6 QKO animals, when 
withdrawal reaction was tested with von Frey hairs and dynamic cotton swab application. 
Whilst deficits in the former tests were of equal magnitude for both DKO and QKO animals, an 
additional deficiency was noted for QKO relative to DKO animals were the latter stimuli was 
concerned.  They also investigated the potential for involvement of TRPC channels in 
transduction of noxious heat, based on responses to noxious heat stimuli, however no evident 
impairment was found. Behavioural tests have unveiled some level of impairment in the 
auditory and vestibular function of TRPC DKO and QKO knockout mice. The trunk curl test, a 
rudimentary measure of vestibular function, demonstrated some potential deficits in 
vestibular function in QKO mice.  
 
7.2 Results 
 
Following from the tests on double knock-out (TRPC3, TRPC6, DKO) mice conducted by Quick 
et al. (2012) triple knock-out (TRPC1, TRPC3, TRPC6, TKO) and quadruple knock-out (TRPC1, 
TRPC3, TRPC5, TRPC6, QKO) mice were created and tested. I conducted the same set of whole-
cell patch clamp electrophysiology experiments on DKO, TKO and QKO mice. Interestingly, 
unlike previous findings Quick et al. (2012) suggest, basal OHCs in TRPC DKO (FIGURE 7-1 C) 
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mice produce MET currents within the range seen in WT mice (FIGURE 7-1 A, B). There is in 
fact no deficit in MET in these mice. The basal (FIGURE 7-2 B) OHCs of TRPC TKO mice also 
exhibit MET currents of comparable size to those witnessed in wild-type mice (FIGURE 7-2 A). 
Furthermore,  one would expect a difference in size between MET currents exhibited by apical 
and basal OHCs to be apparent (FIGURE 3-2; Kim and Fettiplace, 2013). The MET currents of 
apical (FIGURE 7-3 C) and basal (FIGURE 7-3 D) OHCs in the QKO mice are within the range of 
WT MET current (FIGURE 7-3 A, B), however, unlike in the WT controls, the currents in apical 
and basal OHCs are the same size (FIGURE 7-3 E). Recordings should be made from apical TRPC 
DKO and TKO OHCs in order to see if there is also a lack of gradient in these mice. Moreover, a 
greater number of recordings from TRPC QKO apical and basal OHCs will also be necessary to 
establish if this is in fact a robust trend.    
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FIGURE 7-1 - TRPC 3/6 DKO 
 
 
FIGURE 7-1 : TRPC 3/6 DKO. MET in WT (C57/SV129) and TRPC3/TRPC6 double 
knockout (DKO) OHCs. A, B, C, MET currents in response to 45 Hz sinusoidal force 
stimuli from a fluid jet in C57/SV129 control (A, B) and TRPC3/TRPC6 (C) OHCs. The 
holding potential was -84 mV and the membrane potential was stepped in 20 mV 
increments from -164 mV to +96 mV. Driver voltage (DV, amplitude 40 V) waveform to 
the fluid jet is shown above the current traces. Positive DV moves the hair bundles in 
the excitatory direction towards the kinocilium. C57/SV129 control OHC, mid-apical coil, 
P2 + 1 (A).  C57/SV129 WT OHC, mid-basal coil, P2 + 2 (B). TRPC3/TRPC6 DKO OHC, mid-
basal coil, P2 + 2 (C). D, Current-voltage curves averaged from 5 C57/SV129 WT OHCs 
from the mid-apical coil (black open circles), 4 C57/SV129 WT OHCs from the mid-basal 
coil (black closed circles), 3 mid-basal coil TRPC3/TRPC6 DKO OHCs (blue circles). 
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FIGURE 7-2 - TRPC 1/3/6 TKO 
 
 
 
FIGURE 7-2 : TRPC 1/3/6 TKO. MET in WT (C57/SV129) OHCs and TRPC1/TRPC3/TRPC6 
triple knockout (TKO) OHCs. A, B, MET currents induced by a 45 Hz sinusoidal force 
stimuli from a fluid jet in C57/SV129 WT (A) and TRPC1/TRPC3/TRPC6 OHCs (B). The 
holding potential was -84 mV and the membrane potential was stepped in 20 mV 
increments from -164 mV to +96 mV. Driver voltage (DV, amplitude 40 V) waveform to 
the fluid jet is shown above the current traces. Positive DV moves the hair bundles 
towards the kinocilium. C57/SV129 WT OHC, mid-basal coil, P2 + 2 (A). TRPC3/TRPC6 
TKO OHC, mid-basal coil P2 + 2 (B). C, Current-voltage curves averaged from 4 
C57/SV129 WT OHCs from the basal coil (black circles), 4 TRPC1/TRPC3/TRPC6 OHCs 
from the basal coil (blue circles).  
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FIGURE 7-3 - TRPC 1/3/5/6 QKO 
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FIGURE 7-3 : TRPC 1/3/5/6 QKO. MET in C57/SV129 WT and 
TRPC1/TRPC3/TRPC5/TRPC6 quadruple knock-out (QKO) OHCs. A, B, C, D, MET 
currents in response to 45 Hz sinusoidal force stimuli from a fluid jet in CD-1 (A, B) and 
TRPC1/3/5/6 (C, D) OHCs. The holding potential was -84 mV and the membrane 
potential was stepped in 20 mV increments from -164 mV to +96 mV. Driver voltage 
(DV, amplitude 40 V) waveform to the fluid jet is shown above the current traces. 
Positive DV moves the hair bundles in the excitatory direction towards the kinocilium. 
C57/SV129 WT OHC, mid-apical coil, P2 + 1 (A).  C57/SV129 WT OHC, mid-basal coil, P2 
+ 2 (B). TRPC3/TRPC6/TRPC5/TRPC6 QKO OHC, mid-apical coil, P2 + 1 (C), 
TRPC1/TRPC3/TRPC5/TRPC6 QKO OHC, mid-basal coil, P2 + 2 (D). E, Current-voltage 
curves averaged from 5 C57/SV129 OHCs from the apical coil (black open circles), 4 
C57/SV129 OHCs from the basal coil (black closed circles), 2 apical-coil TRPC1/3/5/6 
QKO OHCs (blue open circles), 3 basal-coil TRPC1/3/5/6 QKO OHCs (small blue circles). 
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Average apical current size 
(pA) 
 
Average basal current size 
(pA) 
 
WT control (C57/SV129) 
 
-983 ± 47  
 
-1185 ± 121 
 
DKO 
 
N/A 
 
-1091 ± 187 
 
TKO 
 
N/A 
 
-738 ± 373 
 
QKO 
 
-994 ± 120 
 
-997 ± 37 
 
TABLE 5 - TRPC 3/6 DKO, TRPC 1/3/6 and TRPC 1/3/5/6 knockout mice MET currents 
A comparison of currents in control, double knockout (DKO) TRPC 3/6, triple knockout (TKO) 
TRPC 1/3/6 and quadruple knockout (QKO) TRPC 1/3/5/6 mice. Mean MET current sizes 
averaged ± S.E.M. from C57/SV129 apical OHCs (n = 5), C57/SV129 basal OHCs (n = 4), TRPC 
3/6 DKO basal OHCs (n = 3), 4 TRPC1/TRPC3/TRPC6 TKO basal OHCs (n = 4), TRPC 1/3/5/6 QKO 
apical OHCs (n = 2) and TRPC 1/3/5/6 QKO basal OHCs (n = 3). 
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7.3 Discussion and conclusions 
 
Unlike previous data suggested, it does not appear that TRPC channels form part of the MET 
complex. MET current recordings from DKO, TKO and QKO basal OHCs were of comparable size 
to WT OHCs. This supersedes the previous finding that MET currents recorded from basal DKO 
OHCs were around 75% smaller than those in WT OHCs (Quick et al., 2012). The likelihood is 
that the previously published result was obtained due to some unidentified issue with the 
state of the cells. Whilst it appears that TRPC1, TRPC3, TRPC5 and TRPC6 do not form part of 
MET channel or the MET complex itself, it is possible that they contributed to the viability of 
the cells in some way. It was noted by several people in the lab including myself that the basal 
cells from all the knockout mice did seem quite fragile.  
As mentioned, the only apparent difference in MET current characteristics was the lack of 
difference in the size of the currents between apical and basal QKO OHCs, but, given the small 
number of cells recorded from, further investigation would be necessary to determine 
whether or not this result is robust. 
Knocking out TRPC channels seems to have a combined effect, such that deficits in some areas 
are increased after knocking out additional TRPC channels, which makes sense as fewer TRPC 
monomer candidates are available to form compensatory heteromers. These defects, while 
they do not pertain to the MET complex itself, appear to indirectly play a role in cutaneous 
reception and some aspect of vestibular and hearing related mechanosensory reception. 
Incongruent with the aforementioned results, but nonetheless indicative of TRPC3s role in hair 
cell MET Wong et al. (2013) found that TRPC3 -/- mice have hyperacusis at 8-16 kHz, which 
corresponds to somewhere in the region of 4mm to 6mm in FIGURE 3-1. As previously 
mentioned, DPOAE are a measure of resultant distortion products emanating from the 
cochlea, after two simultaneous pure tone stimuli are presented. Where a mean primary 8 kHz 
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tone was used at 20 – 50 dB SPL, stronger DPOAE gain was witnessed, suggesting that basilar 
membrane motion was enhanced in TRPC 3/6 knockout mice.  
They also found a 40% reduction in re-entry of Ca2+ following depletion of intracellular calcium 
in TRPC 3/6 knockout mice. Together they interpret these data to suggest that TRPC3 is at least 
partially responsible for the cytosolic Ca2+ negative feedback system in hair cells. When TRPC3 
absent Ca2+ homeostasis is disrupted, resulting in enhancement of OHC electromotility, causing 
hyperacusis.  The MET complex and the motor protein prestin are regulated by Ca2+ and thus if 
homeostasis is disrupted, this will have effects OHC motility (Housley and Ashmore, 1992; 
Zheng et al., 2000).  
The great number of interactions between TRPC monomers and with other TRP channel types 
makes pinning down which interaction is of mechanistic significance difficult. Withal, it does 
seem that TRPC channels are indeed involved in mechanosensation in some capacity. Further 
investigation on mature TRPC knockout mice, would help to ascertain what hearing deficits 
these mice exhibit, how these develop and the cause of any hearing defects witnessed. Further 
investigation of knocking out TRPC channels in conjunction with other channels which they 
form heteromers with may also be of use. 
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8 FINAL CONCLUSIONS AND SUGGESTIONS FOR 
FUTURE EXPERIMENTS 
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Further evidence of the apical to basal gradient in macroscopic MET current size is presented 
here, where currents increase in size along the length of the cochlea (FIGURE 3-1), allowing for 
calculations of number of the number of MET channels for OHCs in each region to be made 
(TABLE 1). The finding that there is a gradient in D-JNKi1 block of IHCs is intriguing, as it 
provides the first published evidence of any kind of gradient in the properties of IHC MET. The 
difference in IHC MET channel isoforms between apex and base must be one that does not 
affect single channel conductance, as this known to be uniform between the two regions in 
IHCs (Beurg et al., 2006). Additional recordings in the presence of the concentrations of 
compounds already tested are necessary as well as testing other concentrations in order to 
develop a comprehensive view of the gradient in IHCs. Using a protocol which applies square 
mechanical steps to look at the kinetics of the block of IHCs would be useful. First an inhibitory 
mechanical step is applied and then a excitatory step, before and during the application of the 
drug, whilst the cell is being held at -84 mV (see Marcotti et al., 2005). A curve can then be 
fitted to the current in the presence of the drug, which yields information about the kinetics of 
the block. Additionally such data would allow for creation of energy profiles for the binding of 
the compounds and allow us to see the entry rates of the compounds into IHCs which would 
yield more information about the differences between the apical and basal IHC isoforms. To 
create an even more comprehensive picture, other known channel blockers could be utilised 
to see if there are other gradients of channel block in IHCs. 
There is no doubt the molecular identity of the MET channel is a highly significant mystery to 
solve as its discovery will allow for further elucidation of the complexities of MET in the 
cochlea. A great deal of searching and repeating measures is necessary. The complexities that 
may arise are evident for the TMC knockouts, where even after apparently establishing an 
abolishment of MET currents in TMC1 TMC2 double knockout mice (Kawashima et al., 2011), 
the use of stronger stimuli unveiled that the anomalous current was present in these mice 
(Kim et al., 2013). Establishing how a deficit manifests at the cellular level is challenging and 
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the TRPC knockout mice provide further illustration of this, where a previously identified 
deficit was not in fact the result of a problem with MET. To establish exactly what it is that is 
causing a particular deficit may require many experiments.  
TRPC clearly is not part of the MET channel or the MET complex itself, however, if TRPC3 does 
have a role in cystolic Ca2+ homeostasis (Wong et al., 2013), this may have developmental 
impact upon the hair cells which results in hearing defects in mature TRPC knockout mice. 
Perhaps OHCs in TRPC knockout mice are more fragile than those in WT mice and thus their 
viability is affected. I would also be intrigued to see if indeed the apical and basal OHC MET 
currents are the same size, as they appeared in the modest number of recordings I have 
conducted, in QKO mice and what implications this may have. 
What we can do to attempt to elucidate further information about the structure of the MET 
channel is to piece together the data that has been already collected. Experiments over many 
years have contributed to the finding that the MET channel is a non-specific cation channel 
(Corey and Hudspeth, 1979), Ca2+ having high permeability and being able to occlude the 
channel pore (Ricci et al., 2005). As well as this the MET channel can be blocked and 
permeated by a myriad of channel blockers (Gale et al., 2001; Farris et al., 2004; Marcotti et 
al., 2005). The MET channel has been localised to the tip links of the two shortest rows of 
stereocilia (Beurg et al., 2009). Moreover, some of the properties of the MET channel are still 
debated such as the double-rectification (Kros et al., 1992; Pan et al., 2012) of the MET current 
and the origination and Ca2+ dependence of fast and slow adaptation (Peng et al., 2013; Corns 
et al., 2014). 
The binding profiles of D-TAT and D-JNKi1, with their concentration and voltage dependence 
have distinctive energy profiles, when fitted with the two-barrier one binding site model. The 
binding sites for the two peptides are at different electrical distances form the extracellular 
face of the MET channel, indicating that they bind in different regions of the channel pore. The 
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conclusion is that there are a minimum of two binding sites in the MET channel pore: one in 
the centre of the vestibule and another which is also in the vestibule but nearer the narrow 
pore region. We think that D-TAT binds nearer the narrow pore region due to the distance 
from the extracellular face of the channel being substantially further towards the intracellular 
side than that of D-JNKi1. Whereas the shorter distance from the extracellular side of the 
channel of D-JNKi1, leads us to the conclusion that D-JNKi1 binds in the middle of the highly 
electronegative channel vestibule as this is thought to reside there. The fact that there is a 
variation in the energy profiles of D-JNKi1 binding in the apical and basal OHCs provides 
further evidence for the notion that the vestibule is the MET channel component which varies 
from the apex to the base of the cochlea, in either its size or the quantity of negatively charged 
residues within it. Because of the positioning of its binding site(s), D-JNKi1 is affected by the 
difference in vestibule isoform, whereas D-TAT is not. Binding and thus channel block of 
D-JNKi1 may be stronger in the basal MET channel isoform because of its more negatively 
charged vestibule, indicated by the slightly deeper energy well of the D-JNKi1 binding site in 
the basal OHC MET channel. D-TAT, because of its smaller dimensions and the positioning of its 
binding site is not affected by the size of the channel or the amount of positively charged 
residues in the vestibule. Additionally, it may be the vestibule which is the MET channel 
component which is lacking in the anomalous current protochannel, like the BK channel 
without a gating ring (Budelli et al., 2013).   
The size of the narrow part of the MET channel pore must clearly be re-estimated, in light of 
the finding that D-TAT and D-JNKi1 are able to permeate the channel. Both have an end on 
diameter of 1.5 nM, and if we assume that the compounds have the unfolded structure 
presented in FIGURE 4-2, then the narrow pore region of both MET channel isoforms must be 
at least this wide. Additionally, if we assume, based on the lower free energies of the 
extracellular and intracellular barriers for D-JNKi1, that the basal MET channel isoform is larger 
than the apical isoform then its dimensions will be even greater than this.  
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It seems that the most likely form of channel conducting the anomalous current is some form 
of protochannel, perhaps mobilised from a reserve pool as is indicated by the work of Kurima 
et al. (2015). The many instances in which the anomalous current can be recorded suggest that 
it originates from a protochannel formed of different subunits to the normal MET channel. 
Knocking out, point mutating, or ablating any MET channel subunit or part of the MET channel 
machinery has an effect on the operation of the channel, affecting the onset kinetics, 
“adaptation”, shape and rectification of the currents which flow through it. The notion of the 
vestibule being what is lacking has been previously postulated (Marcotti et al., 2014; Beurg et 
al., 2014b). Different subunits may then form distinct channel isoforms, through which 
mechanosensitive currents of different magnitudes flow. These protochannel isoform(s) have 
been shown to be differentially susceptible to the channel block and entry into the hair cells by 
DHS and lack the apical to basal gradient in channel block which is evident for MET channels. 
Using D-JNKi1 to block the anomalous current, with its defined apical to basal gradient of the 
MET current, would provide further proof of the lack of gradient. 
If we take the view that the anomalous current represents a reserve pool of protochannels 
which are lacking the highly negatively charged vestibule, then we would expect D-JNKi1 to 
block the anomalous current less effectively than D-TAT. Therefore, to further test the theory 
that it is the electronegative vestibule which the protochannel is lacking, testing the blocking 
potential of D-TAT and D-JNKi1 may be illuminating. The hypothesis is that as D-JNKi1 binds in 
the middle of the vestibule, its KD for the protochannel will be much reduced compared to that 
for the MET channel. As D-TAT binds near the narrow part of the channel pore, its binding in 
the protochannel may be less reduced. If results supported this prediction it would support the 
anomalous current arises from a protochannel which is missing the subunit(s) which comprise 
the vestibule. 
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The information I have obtained taken together has allowed me to develop an idea of the 
structural architecture of the MET channel (FIGURE 8-1). It seems clear that it is formed of 
multiple subunits but as to how many there are remains to be unveiled. I have represented the 
distinct subunits which form the vestibule, of which there may be many isoforms of different 
sizes with different numbers of positively charged residues within them. Sitting nearer the 
intracellular face of the channel are the narrow pore region subunits. I have represented two 
binding sites, as characterised by the blocking and energy profiles of D-TAT and D-JNKi1. There 
is one in the centre of the vestibule and one nearer the narrow part of the channel pore. 
Whilst most of the residues which form the latter binding site are in the vestibule forming 
subunit, I have drawn some in the narrow pore region itself. I feel that this is necessary to 
account for the assumption that the protochannel lacks the vestibule forming subunit(s) yet 
FM1-43 blocks the channel to a comparable degree with the MET channel, albeit with altered 
voltage dependence and DHS does still block the channel to some degree in spite of its 
reduced affinity. Additionally there are two barriers, represented by the negative charges, at 
the extracellular and intracellular faces of the channel. The MET channel pore length is 3.1 nm  
and as suggested by Farris et al. (2004) the plasma membrane in which the MET channel is 
embedded is in the region of 2.4 nm in width, a third of 7.2 nm (7.2nm / 3) (Farris et al., 2004). 
I have thus illustrated the MET channel as protruding slightly at its extracellular face of the 
phospholipid bilayer.  
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FIGURE 8-1 - MET channel model 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 8-1 : MET channel model, based on the findings presented in this thesis and the 
data obtained by others discussed within. 
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